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SUMMARY
The work described in this thesis concerns the 
development and characterization of an in vitro system for 
the initiation of adenovirus type 4 DNA replication and the 
first steps towards the purification and characterization of 
the individual components of the system.
The study was suggested by the differences observed in 
the minimal DNA sequence requirements for adenovirus type 2 
(Ad.2) and adenovirus type 4 (Ad.4) DNA replication in vivo 
(Hay,1985afb ) . The minimal Ad.2 origin of replication 
consisted of the terminal 45b.p. of the genome containing 
two important sequence elements: The 10b.p. AT-rich sequence 
conserved in all the human adenoviruses (Stillman ejt 
al_, 1982) between nucleotides 9-18 and the consensus binding 
site for the cellular protein nuclear factor I (NFI) between 
nucleotides 19-45 (Nagata et_al,1983). In contrast the A d .4 
origin of replication comprised only the terminal 18b.p. of 
the genome, which were identical to the terminal 18b.p. of 
Ad.2 (Hay,1985b). An in vitro study was seen as the best way 
to further define the mechanistic differences between A d .2 
and Ad.4 DNA replication.
Initially full-length Ad.4 DNA was isolated from 
virions by a number of treatments leaving it associated with 
either the terminal protein and core polypeptides (Ad.4 
cores), the terminal protein alone (Ad.4 DNA-prot.), or 
completely protein-free (Ad.4 DNA) and it was shown that
these templates could support initiation of DNA replication 
in vitro. Initiation was defined as the formation of a 
covalent complex between 5'-dCMP and the 80,000-dalton 
precursor terminal protein (pTP-dCMP complex). In Ad.2 the 
formation of this complex is catalysed by the viral DNA 
polymerase which is tightly associated with the pTP. Use of 
(o(32p)dcTP enabled the detection of this product by 
SDS-polyacrylamide gel electrophoresis and autoradiography.
Subsequent experiments utilized a plasmid containing 
the terminal 140b.p. of Ad.4 as a template for reasons of 
stability and reproducibility of results. Formation of a 
pTP-dCMP complex was shown to be catalysed by either nuclear 
or cytoplasmic extract of Ad.4 infected cells alone. An 
inhibitory activity in nuclear extracts meant that 
cytoplasmic extracts were used exclusively to characterize 
the reaction. Various parameters of the reaction were 
studied including the formation of pTP-dCMP complex at 
different protein concentrations, the time course of 
pTP-dCMP complex formation and the nucleotide specificity of 
the reaction. The activity of cytoplasmic extract in forming 
pTP-dCMP complex was studied at varying concentrations of 
ATP and divalent cations and in varying conditions of ionic 
strength.
By including in the reaction dATP, dTTP and ddGTP it 
was shown that the pTP-dCMP complex could be elongated, 
presumably by the Ad.4 specific DNA polymerase, to the first 
dG residue in the sequence - the 30th nucleotide. This
resulted in the formation of an additional product with an 
apparent molecular weight of 90,000-daltons.
The template requirements for the formation of a 
pTP-dCMP complex were studied: Both the DNA sequence and 
template conformation requirements were investigated using
both single- and double-stranded DNA. It was shown that the 
double-stranded DNA sequence requirements were the same as 
in vivo.
Finally the Ad.4 specific DNA polymerase was partially 
purified from Ad.4 infected HeLa cells and the response of 
this DNA polymerase to various inhibitors studied. A factor 
from uninfected HeLa cell nuclei that stimulated pTP-dCMP 
complex formation by cytoplasmic extract of Ad.4 infected 
cells was partially purified. This factor was shown to 
stimulate pTP-dCMP complex formation on a template 
containing only 18b.p. from the Ad.4 terminus, indicating 
that it might specifically recognize sequences within that 
region.
ABBREVIATIONS
A adenine.
& angstrom.
Ad. adenovirus.
ATP adenosine-5 1-triphosphate.
b.p. base pairs(s).
BuDR 5-bromo-2'-deoxyuridine.
C cytosine.
°C degrees centigrade.
curies, 
cm. centimetres.
DBP DNA-binding protein.
dAMP 2-deoxyadenosine-5'-monophosphate.
dATP 2-deoxyadenosine-5'-triphosphate.
dCMP 2-deoxycyt idine-5'-monophosphate.
dCTP 2-deoxycytidine-5'-triphosphate.
dGMP 2-deoxyguanosine-5'-monophosphate.
dGTP 2-deoxyguanosine-5'-triphosphate.
dNMP any 2-deoxyribonucleoside-5'-monophosphate (dAMP,
dCMP, dGMP or dTMP). 
dNTP any 2-deoxyribonucleoside-5'-triphosphate (dATP,
dCTP, dGTP or dTTP). 
dTMP 2-deoxythymidine-51-monophosphate.
dTTP 2-deoxythymidine-5'-triphosphate.
ddCTP 2,3-dideoxycytidine-5'-triphosphate.
ddGTP 2,3-dideoxyguanosine-5'-triphosphate.
ddTTP 2,3-dideoxythymidine-5'-triphosphate.
DMS dimethylsulphate.
DNA deoxyribonucleic acid.
DNA-prot. DNA attached to terminal protein.
DNase deoxyribonuclease.
DTT dithiothreitol.
EDTA ethylene-diamine tetra-acetic acid sodium salt,
fmole femtomole(s ).
g gramme.
G guanine.
GC moles percent deoxyguanosine and deoxycytidine
residues.
h . hour(s ).
h.p.i. hours post infection.
ITR inverted terminal repeat.
K 1000-dalton molecular weight,
k b . kilobase(s ).
1 . litre(s).
M molar.
microcurie ( s ) . 
mg mi H i  gramme ( s ) .
ug microgramme(s ).
min . minute(s ) .
ml. millilitre(s ) .
u l . microlitre(s ).
mm. millimetre(s ).
mM millimolar.
uM micromolar,
mmole millimole.
mRNA messenger ribonucleic acid.
m.u. map units (for adenovirus lm.u. = 359
nucleotides).
M.W. molecular weight.
NFI nuclear factor I.
NFII nuclear factor II.
NFIII nuclear factor III.
ng nanogramme(s ).
nm. nanometre(s ).
nM nanomolar.
ORF open reading frame.
oriC Escherichia coli origin of DNA replication.
PAGE polyacrylamide gel electrophoresis,
pfu plaque forming units,
pmole picomole(s ).
PMSF phenyl-methyl-sulphonyl-fluoride.
pTP precursor terminal protein.
pTP-pol precursor terminal protein - DNA polymerase
complex.
rATP adenosine-5'-triphosphate.
rCTP cytidine-5'-triphosphate.
rGTP guanosine-5'-triphosphate.
rNTP any nucleoside-5'-triphosphate (rATP, rCTP, rGTP
or rUTP). 
rUTP uraci1-5'-triphosphate.
RNA ribonucleic acid.
RNase ribonuclease.
rpm revolutions per minute.
SDS sodium dodecyl sulphate,
sec. second(s ).
T-Ag. Simian virus 40 large T antigen.
TP terminal protein.
ts temperature sensitive.
VP viral protein.
v/v volume to volume (ratio).
w/v weight to volume (ratio).
INTRODUCTION
1The aim of this introduction is to provide a 
background to the adenoviruses in general and adenovirus DNA 
replication in particular. Adenovirus DNA replication will 
be compared with other well characterized DNA replication 
systems, both procaryotic and eucaryotic. To this end I 
propose to cover 5 areas as follows:
1) To introduce the adenoviruses and describe the various
components of the virions.
2) To describe the adenovirus transcriptional programme,
relating it where possible to the life cycle of the 
virus by discussing the functions of the gene
products.
3) To chart the developments in the understanding of
adenovirus DNA replication and review the current 
state of knowledge regarding the proteins and DNA
sequences involved. I shall also propose a model for
the mechanism of adenovirus DNA replication based on 
the available facts.
4) To discuss 2 other in vitro viral DNA replication
systems (SV40 and 029) which are relevant to the 
adenovirus system and the work of Kornberg and 
colleagues in elucidating the mechanism of Escherichia 
coli DNA replication - pioneering work in the
understanding of DNA replication in general.
25) To describe the properties of other eucaryotic DNA
polymerases so far characterized, both viral and 
cellular, to compare them with the adenovirus DNA 
polymerases.
1:1 THE ADENOVIRIDAE
The Adenoviruses (family Adenoviridae) are a large 
group of viruses with DNA genomes. The viruses are divided 
into two genera depending on their natural hosts: The 
Mastadenovirus genus consists of 78 or more serotypes whose 
natural hosts are mammalian. These viruses infect a wide 
range of mammals including humans, cattle, horses, sheep, 
pigs, dogs, monkeys, mice and tree-shrews (Ishibashi and 
Yasue,1984). The Aviadenovirus genus consists of at least 15 
serotypes that infect birds. These viruses infect chickens, 
turkeys, ducks and pheasants. In addition to these two 
genera an adenovirus-like agent has been isolated from the 
leopard frog (Clark et a l ,1973).
Human adenoviruses were discovered almost 
simultaneously by Rowe et al (1953) and Hilleman and Werner 
(1954). Since then 41 distinct serotypes of human 
adenoviruses have been identified. They produce a number of 
acute diseases in humans including ocular, respiratory, 
gastro-intestinal and urinary infections. The viruses are 
ubiquitous throughout the human population, affecting all 
ages and races, and both sexes equally.
3Adenoviral infections are not very often associated 
with fatal diseases, and indeed the majority of infections 
are probably asymptomatic. Nevertheless they are considered 
important human pathogens. The initial motivation for 
studying the structure and function of adenoviruses was 
naturally the result of clinical requirements, but in the 
last 25 years their use as a tool in the study of eucaryotic
molecular biology has been recognized and capitalized on.
1:2 THE STRUCTURE OF THE VIRION
Virion morphology is remarkably conserved throughout 
the adenoviruses. The virion consists of two major 
components- an icosahedral protein shell and an inner core 
containing the DNA. The dimensions of an icosahedron are 
derived mathematically from the edge. The edge of the 
adenovirus type 5 (Ad.5) capsid has been reported as 43nm 
(Nermut,197 5) and 52nm (Devaux et a l ,1983), giving a 
diameter around the five-fold axis of symmetry of either 
73nm or 8 8 nm.
1 : 2 : 1  CAPSID STRUCTURE
The icosahedral protein shell consists of 252 
capsomers- 240 hexons (designated viral protein IIsVPIl) and 
12 pentons, each made up of a base and a fibre (VPIII and 
VPIV) (Valentine & Pereira,1965). Each of the penton bases, 
present at the vertices of the icosahedron, is surrounded by 
5 'peripentonal 1 hexons. The remaining 180 hexons dissociate 
into ‘groups of nine' (GON's) after various treatments:
4heating at 56°C for lOmin. (Russell et a l ,1967); or trypsin 
or deoxycholate treatment (Pereira & Wrigley,1974). The 
G O N 's appear in electron micrographs as left or right-handed 
depending on whether the inner or outer surface is 
visualized (Pereira & Wrigley,1974). Differences in the 
appearance of the G O N 's indicates a morphological difference 
between each end of the hexon, the outer face displays three 
identical subunits whilst the inner face has a large central 
hole. The intact hexon was shown (Jornvall et al f1981) to 
consist of three identical subunits of 108,000 molecular 
weight (108K).
The crystal structure of the hexon has recently been 
elucidated (Roberts et a l ,1986a): The complete hexon
consists of two parts; a pseudo-hexagonal base 52A high with
a triangular top 64A high consisting of three 'towers'. Each 
subunit consists of two domains PI and P2 which each 
comprise an 8 -stranded p-barrel with loop-out regions 
between the strands. The two domains Pi and P2 each have 
corresponding schematic structure, which is related to that 
found in the coat proteins of small spherical plant viruses, 
rhinoviruses and poliovirus. The towers are formed from 
loops li and I4 from domains Pi and P2 in adjacent subunits 
and loop I2 from the third subunit. This interpenetration of 
the three subunits within the tower explains the hexon's 
resistance to denaturation and may also explain the
requirement for the 100K protein in hexon assembly.
61:2:2 CORE STRUCTURE
The core consists of the viral DNA and three core 
proteins VPV, VPVII and mu. VPVII is an 18K protein shown to 
be closely associated with the DNA (Ginsberg,1979, Sato & 
Hosokawa,1981) whereas VPV, a less abundant 45K protein, is 
easily dissociated from the DNA-VPVII complex and has been 
shown to be situated adjacent to the hexon, penton and 
VPIIIa (Everitt,1975).
Electron microscopic analysis of cores in various 
stages of relaxation has shown a 'beads on a string' 
appearance or rod-like elements (Nermut,1979). In addition 
micrococcal nuclease treatment of cores produced DNA 
fragments from 150b.p. (Mirza & Weber,1982) to 200b.p. 
(Corden et a l ,1976). These data suggest two models for the 
organization of the nucleocapsid: Firstly the continuous 
helix model proposes a linear helical filament made up of 
VPVII, around which the DNA is wound. However that model is 
based on the assumption that only one protein is present in 
the core structure (Nermut,1980). The currently accepted 
model is the 'nucleosome' or discontinuous helix model 
(Corden et a l ,1976). This model proposes nucleosome beads 
consisting of 6 VPVII molecules with two turns of DNA per 
bead (164b.p.) and a spacer of 30b.p. between nucleosomes. 
It has been suggested (Vayda et al ,1983) that the 4K protein 
mu has some role in maintaining the nucleosome structure. Mu 
is extremely basic, consisting of 54% arginine, and as such 
would neutralize the charge on the tightly packed DNA.
The hexons are associated with several other viral 
structural proteins: VPVI was shown to be closely associated 
with the hexon (Everitt et a l ,1975) although it was 
subsequently shown to be a DNA-binding protein (Russell & 
Precious,1982). VPVI cannot be labelled by iodination of 
intact virions, suggesting that it is located inside the 
hexon shell. VPVIII is associated with single hexons but not 
with G O N ' s (Everitt & Philipson,1974) whereas VPIX is 
associated with the G O N 's (Boulanger,1979). VPIX is present 
at a ratio of 15 copies per GON and is thought to locate at 
the hexon contact points.
The 12 pentons each consist of a penton base and one 
(human adenoviruses) or two (avian adenoviruses) 
antennae-like projections called fibres. The base is a 
trimer, each polypeptide chain (VPIII) having a molecular 
weight of 85K (Devaux et a l ,1982). An additional protein 
VPIIIa (Devaux et a l ,1982) bridges the gap between the 
penton base and the 5 peripentonal hexons.
The fibre consists of a shaft 2nm in diameter varying 
in length between 9-31nm depending on the serotype 
(Norrby,1969), terminated by a knob 4nm in diameter. The 
fibre is thought to be a dimer of VPIV polypeptides, each 
having a molecular weight of 62K (Green et a l ,1983). The 
interaction between the fibre and the base is thought to be 
hydrophobic, as they can be dissociated by guanidine, 
pyridine or deoxycholate (Nermut,1984).
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1:2:3 GENOME STRUCTURE
7
All adenovirus serotypes have a linear, 
double-stranded DNA genome of approximately 35-36,000 base 
pairs (35-36Kb.) in length, corresponding to a molecular 
weight of 19-24 xlO6 daltons (Green et a l ,1967), except for 
the avian adenovirus Chick Embryo Lethal Orphan virus (CELO)
(Laver,1971), which has a much larger genome of 30 xlO6 
daltons. A protein of apparent M.W. 55K is linked to the 
ends of the genome. This terminal protein (TP) was shown to 
be covalently linked to the DNA by virtue of the resistance 
of the DNA-protein complex to boiling and SDS (Robinson et_ 
al^ , 1973, Rekosh et a l , 1977, Carusi , 1977 ) . DNA-protein 
complex and deproteinized DNA (which is linked to residual 
amino-acids) were both resistant to digestion with 
phosphatase and exonuclease VII and could not be labelled
with polynucleotide kinase. However they were sensitive to
loAaeAlmq WltW
digestion with exonuclease III and^terminal transferase 
(Carusi,1977, Sharp et a l ,1976), thus indicating that the TP 
was bound to the 5' ends of the genome. The linkage was 
shown to be a phosphodiester bond between the hydroxyl group 
of a serine residue in the TP to the 5' phosphate group of 
the terminal deoxycytidine of the genome (Desiderio & 
Kelly,1981).
Green et al (1979) showed that the TP's of five 
different human serotypes were very similar by tryptic 
peptide analysis, suggesting a common cellular origin. 
However Rekosh (1981) showed that they had different
8apparent molecular weights, suggesting that TP was a 
conserved viral protein. Stillman et al (1981) identified an 
mRNA originating from between coordinates 11-31.5 on the
1-strand that was translated in vitro to give a protein with 
apparent M.W. 87k . This protein was identical to an 80K 
protein found attached to the 5' ends of viral DNA strands 
synthesized in vitro (Challberg,1980). The 80K/87K protein 
was structurally related to TP, suggesting that TP is
synthesized as a precursor (pTP). Further evidence comes 
from studies with the temperature-sensitive (t_s) mutant 
Ad2t_sl. t_sl cannot cleave viral precursor proteins to the 
mature forms (Bhatti & Weber,1979) at the non-permissive 
temperature. As a result Ad2tsi virions contain an 80K
instead of a 55K TP (Stillman et a l ,1981).
It was noticed (Garon et a l ,197 2, Wolfson & 
Dressier,1972) that when denatured adenoviral DNA was 
renatured at low concentrations and examined by electron 
microscopy single-stranded circles were seen. These circles 
had high thermal stability and were not seen after
exonuclease III treatment. This suggested the presence of
inverted terminal repeat sequences (ITR’s). Early estimates 
of the size of these ITR's, based on data from exonuclease 
III experiments, put them between 350-1400b.p. (Garon e_t
ai^ , 1972). Nucleotide sequence analysis later showed these to 
be overestimates: The length of the ITR's varies from 63b.p. 
for CELO virus (Alestrom,1982) to 162b.p. for Ad.12 
(Shinigawa & Padmanabhan,1980). The first ITR to be 
sequenced, that of A d .5 (Steenbergh et a l ,1977), is 103b.p.
9long and shows features common to all adenoviruses. The 
distribution of GC and AT base pairs is asymmetrical, the 
first 50b.p. are 72% AT, whereas the second 50b.p. are 27% 
AT. All serotypes have a dCMP residue at the 5' termini 
except CELO virus, which has a dGMP (Alestrom,1982). The 
sequence 5'ATAATATACCTTAT from nucleotides 9-22 is conserved 
in all human adenoviruses (Tolun et a l ,1979) and has been 
shown to be important in the initiation of DNA replication. 
There are other blocks of high homology within the ITR's of 
various serotypes (Tolun et a l ,1979), some of which have 
been shown to bind cellular factors during DNA replication.
The entire nucleotide sequence for the Ad.2 genome has 
now been determined (Roberts et a l ,1986b) and comprises 
35,937b.p. This data, in conjunction with data obtained from 
DNA-RNA hybridizations, in vitro transcription and 
translation, R-loop and SI mapping (Weinmann et a l ,1984) has 
built up a detailed map of the organization of the Ad.2 
genome. There are 10 transcription units which can loosely 
be classified as early or late, depending on whether they 
are transcribed before or after the onset of DNA 
replication. However the temporal regulation of adenoviral 
transcription is complex and mRNA species are now generally 
referred to as pre-early, early, intermediate or late. By 
convention the two strands of the viral genome are 
classified according to the direction of transcription: The 
genome consists of a GC—rich and an AT—rich half, designated 
left and right respectively. The strand transcribed to the 
right is termed the r-strand and the strand transcribed to
10
the left the 1 -strand (Bachenheimer et a 3 ,1977). 69% of the 
viral genes are transcribed from the r-strand, the remainder 
from the 1 -strand.
1:3 VIRAL TRANSCRIPTION
The adenovirus genes are transcribed from nine 
initiation sites by cellular RNA polymerase II (Price & 
Penman,1972, Wallace & Kates,1972), (and RNA polymerase III 
in the case of the VA RNA's) in the nucleus of the infected 
cell. mRNA species are capped and polyadenylated (Philipson 
et a l ,1971).
1:3:1 EARLY TRANSCRIPTION
The first mRNA species can be detected as early as 
45min p.i. (Nevins et al ,1979) and are transcribed from the 
pre-early Ela transcription unit. Transcription from Ela 
reaches a maximum at about 3h. p.i. and remains constant for 
at least a further 6h. Ela has been mapped to the r-strand 
between map units (m.u.) 1.3 and 4.6 (Berk & Sharp,1977) and 
transcribes 3 mRNA's of sedimentation coefficients 13S, 12S
and 9 S . These mRNA's share common 5 ‘ and 3 ‘ ends and only 
differ in the site of internal splicing. Early in infection 
(up to 6h . ) the level of the 9S mRNA is only 5% of the 13S 
and 12S, but after 8-12 h.p.i. the 9S mRNA becomes the most 
abundant of the three (Spector et a l ,1978). This change can 
be explained in terms of increased message stability or 
changes in splicing activity. It has been shown (Svensson et_ 
al,1983) that the three mRNA's are generated by separate 
splicing events from a single precursor.
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The 13S and 12S mRNA's are predicted to give rise to 
proteins of 289 and 243 amino-acids in length, with 
molecular weights 31.9 and 26.5K (Perricaudet et a l ,1979). 
However in practice the Ela proteins are heterogenous and 
have greater apparent M.W.'s than predicted (Lewis et^  
a_l, 1979), the latter due to the high percentage of proline 
residues in the proteins. The 9S mRNA gives rise to a 
protein 55 amino-acids long with a predicted M.W. 6 .IK and 
observed M.W. 28K. All the proteins share a common 
N-terminus but the 9S product differs after the splice 
junction.
The Ela proteins are involved in both the regulation 
of transcription and the process of cellular transformation. 
An Ela product has been shown (Jones & Shenk,1979; Berk et_ 
311,1979) to increase transcription from other early viral 
promoters 50-fold, whilst only increasing it's own
transcription 5-fold. Ela has also been shown (Nevins,1982; 
Wu et a l ,1986) to increase transcription from the cellular 
heat shock 70 protein promoter 8 -fold, to repress 
transcription from the SV40 early promoter (Velcich &
Ziff,1985) and to induce cellular DNA synthesis in
quiescent, G0-arrested cells (Kaczmarek et al ,1986). It is 
now generally accepted that transcriptional control mediated 
by Ela is accomplished via interactions with various 
cellular proteins (Imperiale & Nevins,1986).
Ela is also important in cell transformation by 
adenoviruses. Ruley (1983) showed that Ela products could
12
induce primary cells to proliferate but could not induce 
complete morphological transformation alone. The latter 
requires the presence of Elb (van der Eb & Bernards,1984), 
or other transforming proteins such as ras or polyoma virus 
middle-T antigen (Ruley,1983).
The next mRNA's to be transcribed are from the Elb, E3 
and E4 regions. These mRNA's are detected 1.5-2h.p.i. and 
reach a maximum level at 6-7h.p.i. for Elb, and 3-4h.p.i. 
for E3 and E4. Soon after the activation of these 
transcription units the E2 mRNA's are transcribed and reach 
a peak at 3-4h.p.i. (Nevins et a l ,1979).
The Elb transcription unit is located on the r-strand 
from m.u. 4.6-11.2 and was originally thought to produce 3 
mRNA's, two early in infection, the 22S and 13S (Berk & 
Sharp,1978). Two additional early mRNA's, 14S and 14.5S, 
have recently been described (Virtanen & Pettersson,1985). 
All these mRNA's have common 5' and 3' ends and are produced 
by differential splicing of a precursor. The 14S and 14.5S 
mRNA's are identical to the 13S with the addition of a third 
exon. In the 22S mRNA two AUG's can be used for translation, 
giving rise to a 55-58K protein and, in a different but 
overlapping reading frame, a 19-21K protein. The latter is 
also coded for by the 13S, 14S and 14.5S mRNA's (Bos et 
al,1981; Virtanen & Pettersson,1985).
In addition all these mRNA's contain the coding 
regions for VPIX, a 14.3K structural protein associated with
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the G O N *s (Boulanger,1979). However this protein is not 
translated from these mRNA’s but from an additional mRNA 
synthesized at intermediate times in infection, between 
8-12h.p.i. (Wilson et a l ,1979). This mRNA is unspliced 
(Alestrom et a l ,1980), making it unique amongst adenovirus 
mR N A ’s .
The precise functions of the Elb proteins is 
uncertain. Mutations affecting the 55-58K protein reduce 
virus yield 1 0 0 -fold, by reducing late transcription and 
translation (Babiss & Ginsberg,1984). In transformed cells 
the 55-58K is found complexed to the cellular protein p53 
(Sarnow et a l ,1982). p53 levels have been shown to increase 
in transformed cells and quiescent cells stimulated by serum 
(Reich & Levine,1984). p53 also complexes with the SV40 
T-antigen and the formation of this complex increases the 
half life of p53 from 20min. to greater than 24h. (Oren et_ 
aJL, 1981). This may represent an important mechanism in 
adenoviral transformation.
The E3 region maps on the r-strand from m.u. 76.8-85.9 
(Berk & Sharp,1978). There are at least 9 mRNA's transcribed 
from this region, produced by differential splicing of two 
precursors. The mRNA's have a common 5' end and there are 
two major and one minor polyadenylation sites at m.u. 85.9,
82.9 and 85. The E3 region overlaps with L5, the late region
30% of
that contains the gene for the fibre protein.^The fibre mRNAs 
haye. three leaders x,y and z, the splice sites of which 
coincide with some of the E3 splice junctions (Chow &
Broker,1978).
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So far only three proteins have been assigned to the 
E3 region- a 19K glycoprotein (Persson et a l ,1980), an 11.6 K 
protein (Wold et a l ,1984) and a 14K protein which has not 
been precisely mapped (Persson et a l ,1978). The 19K 
glycoprotein has been shown to complex with the heavy chain 
of the class I transplantation antigens (Signas et al,1982) 
and appears to result in the reduction of the class I 
antigens on the cell surface. The E3 region has been shown 
to be dispensable for lytic growth in tissue culture 
(Berkner & Sharp,1983).
Region E4 is transcribed from the 1-strand between 
m.u. 99.1-91.3 (Berk & Sharp,1978, Chow et a l ,1979). A 
primary transcript is spliced into 12 different mRNA's, all 
with identical 5' and 3' ends (Virtanen et al ,1984). 
Sequence analysis (Roberts et a l ,1986tj predicts the 
existence of 7 open reading frames (ORF’s) encoding proteins 
from 6-34K in size. Transcription of the E4 region is 
induced by a product of the Ela region (Berk et a l ,1979, 
Jones & Shenk,1979) and inhibited by a product of the E2
region (Nevins St Winkler, 1980), later shown to be the 72K 
DNA binding protein (Handa et a l ,1983).
The functions of the E4 proteins are unknown. A 25K 
protein assigned to the E4 region was shown to be associated 
with the Elb 55-58K protein in productively infected cells 
(Sarnow et a l ,1984). Deletions in both these proteins 
(Halbert et_al,1985; Babiss St Ginsberg, 1984; Pilder et_ 
al,1986) have similar phenotypes: They exhibit low levels of
15
late mRNA and protein synthesis and inefficient shut-off of 
host-cell protein synthesis. In addition the E4-25K mutant 
exhibited low levels of viral DNA synthesis. These data 
suggest that the 25K-55K complex is involved in the 
regulation of late transcription, late translation and 
shut-off of host-cell macromolecular synthesis. This theory 
was strengthened by the work of Weinberg and Ketner (1986) 
using a deletion mutant d!808 which lacked most of the E4 
region. In HeLa cells this mutant exhibited low levels of 
late mRNA, protein and viral DNA synthesis, but overproduced 
the 72K D B P . In a cell line expressing the E4 region (W162 
cells) the mutant had a wildtype phenotype.
The E2 region is transcribed from the 1-strand 
between m.u. 75.4 and 11.3 (Chow et a l ,1979). It is unique 
amongst adenovirus transcription units in that two promoter 
sites are used at different times in infection. E2
transcripts terminate at one of two possible
poly-adenylation (poly-A) sites, on this basis they are 
termed E2a or E2b mRNA’s. E2a mRNA's are transcribed early 
in infection from a promoter at m.u. 75.4 and from a second 
promoter at 72.2 late in infection, and terminate at a
poly-A site at 62.4 (Baker et a l ,1979). E2b mRNA's bypass 
this poly-A site and terminate at 11.3 (Stillman et
al,1981). In addition to the leader at 75.4/72.2, all E2 
mRNA's have a common leader at 6 8 .8 . E2b mRNA's also have a 
leader at 39.
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The only protein assigned to the E2a group is the 72K 
single-stranded DNA binding protein (DBP) (Lewis et. 
al,1976). DBP is a multi-functional protein: It has a role 
in DNA replication, where it is thought to bind to displaced 
single-strands (van der Vliet & Sussenbach,1975, van der 
Vliet et a l ,1977) and increase the processivity of the viral 
DNA polymerase (Field et a l ,1984). It regulates it's own 
production (Carter & Ginsberg,1976; Nicholas et_al,1982) and 
in addition regulates El and E4 transcription (Babich &
Nevins,1981; Nevins & Winkler,1980). Whereas human
adenoviruses normally undergo an abortive infection in 
monkey cells mutants in the N-terminus of the DBP are able 
to replicate normally in these cells (Klessig & 
Grodzicker,1979). This suggests a role for DBP in late mRNA 
splicing as the block to human adenovirus replication in
monkey cells is thought to involve aberrant splicing of the
fibre mRNA (Klessig & Chow,1980).
Three mRNA's are transcribed from the E2b region 
(Stillman et a l ,1981). The precursor terminal protein (pTP) 
(Stillman et a l ,1979) and the 140K DNA polymerase (Stillman, 
Tamanoi & Mathews,1982) have been assigned to two of these 
mRNA's. These proteins are present as a stoichometric 
complex in infected cells (Lichy et a l ,1982) and together 
with the DBP and 2 cellular factors (Nagata et al ,1983b) are 
required for DNA replication (see Section 1:5). The third 
mRNA has an ORF coding for a 22.8 K polypeptide, which has 
not been identified as yet.
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1:3:2 INTERMEDIATE AND LATE TRANSCRIPTION
The E2b region completely overlaps with the mRNA for 
VPlVa2, a 50K protein involved in virion morphogenesis 
(Persson et a l ,1979). This mRNA is transcribed at 
intermediate times during infection from it's own promoter 
at m.u. 16.1 and is co-terminal with the E2b mRNA's (Lewis 
et a l ,1977) . The class of intermediate mRNA's also includes
the mRNA for VPIX. These two mRNA's can be detected prior to 
the onset of DNA replication (Wilson et a l ,1979) but have 
since been shown to require DNA replication for maximal 
transcription (Crossland & Raskas,1983).
Following the onset of DNA replication (6 -8h.p.i.) 
(Green et a l ,1970), transcription from early sites is 
increased 3-10 fold (Shaw & Ziff,1980) presumably because of 
the increase in DNA template numbers. The onset of DNA 
replication also brings about a major change in the 
transcriptional programme. At late times in infection (from 
8h . onwards) the majority of mRNA's are transcribed from the 
major late promoter (MLP) which is situated on the r-strand 
at m.u. 16.8 (Ziff & Evans,1978). The 5' end of all these 
mRNA's consists of a 201b.p. tripartite leader sequence 
present at m.u. 16.8, 19.8 and 26.9 (Berget et al ,1977,
Akusjarvi & Pettersson,1979). The tripartite leader is 
spliced to as many as 16 acceptor sites to generate a large 
number of unique mRNA species. These mRNA's are classified 
into five families Ll to L5, each with a common poly-A site 
(Evans et a l ,1977; Nevins & Darne11,1978). The primary 
transcript extends to m.u. 99 although the last poly-A
signal (for L5) is at 91.3 (Fraser et a l , 1979) .
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The LI region generates 3 major mRNA species with a 
poly-A signal at 39.3 and 5' cap sites at 29, 30.7 and 34. 
LI is also transcribed early in infection (Shaw & Ziff,1980) 
but in this case the mRNA’s have an additional leader from 
m.u. 21.5-23. This leader has an ORF coding for a 
hypothetical 15.9K polypeptide (Chow et_al,1979). The Ll 
mRNA’s encode two structurally related proteins of 52K and
55K (Miller et a l ,1980) whose function is unknown. The third 
mRNA codes for VPIIIa, a 6 6 K protein associated with the 
hexons (Akusjarvi & Persson,1981).
The 3 major mRNA's from L2 have 5* cap sites at 39.4, 
44.1 and 45.9 and a poly-A signal at 50 (Chow et_al,1980; 
Alestrom et a l ,1984). They code for the structural proteins 
III, V and VII (Miller et a l ,1980; Akusjarvi & 
Pettersson,1981). L2 also contains a fourth ORF which codes 
for a hypothetical polypeptide of 85 amino-acids. This has 
been speculated to be the precursor for polypeptide mu, a 
component of the virus core.
L3 contains three mRNA's with 5' cap sites at 50.1, 
52.3 and 60.2 and a poly-A signal at 62.4. These mRNA's code 
for VPVI-a protein associated with the hexon, the hexon 
itself (VPII) and a 23K endopeptidase, which is involved in 
the maturation of V P ’s VI,VII,VIII and the terminal protein 
(Bhatti & Weber,1979).
The L4 region contains 4 mRNA's with a poly-A signal 
at 78.5. Proteins have been assigned to 3 of these mRNA’s
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(Miller et a l ,1980) . A 100K protein that is thought to 
function in hexon assembly (Gambke & Deppert,1984) which 
accumulates to high levels late in infection but is not 
present in virus particles. A 33K non-structural protein 
whose function is unknown and VPVIII, a structural protein 
associated with the hexon.
L5 differs from the other 4 late regions in that it 
only produces one mRNA, which codes for the fibre protein. 
30% of fibre mRNA's also have various combinations of three 
ancillary leader sequences termed x,y and z (Uhlen e_t 
al,1982).
Two other mRNA's are transcribed from the adenovirus
genome late in infection. These are the virus associated
RNA's- VA RNA I and II. They are transcribed from the
r-strand from two promoters at 29.5 and 30.2, within the
non-coding region of LI (Akusjarvi et al,1980) and
5 6accumulate to high levels ( 1 0  - 1 0  /cell) late in infection. 
Unlike other adenoviral mRNA's they are transcribed by RNA 
polymerase III (Weinmann et a l ,1976). The VA RNA's are 
similar to each other, being about 160b.p. long, and are 
capable of forming similar secondary structures (Akusjarvi 
et a l ,1980). VA RNA II appears to be non-essential but VA 
RNA I has been shown to be required for late translation 
(Thimmapaya et a l .1982).
VA RNA I acts to facilitate late viral translation by 
maintaining the activity of the eucaryotic initiation factor 
eIF2 (Schneider et a l ,1985; Reichel et a l ,1985). eIF2 is a
Figure 1:1 The adenovirus transcriptional programme.
The genome is divided into 100 map units (m.u.). 
Transcripts in the top half of the diagram are transcribed 
from the r-strand, in a left-to-right direction. Transcripts 
in the bottom half of the diagram are transcribed from the 
1-strand, in a right-to-left direction. Thick lines 
represent transcripts produced early in infection (prior to 
the onset of DNA replication). Thin, arrowed lines represent 
transcripts produced intermediate in infection (prior to and 
during DNA replication) and double lines represent 
transcripts produced late in infection. Gaps in lines 
represent intervening sequences which are spliced out. 
Polypeptides are designated by roman numerals in the case of 
structural proteins (see table 1 :1 ), by their molecular 
weights (in kilodaltons - K) or by abbreviations in the case 
of the replication proteins. Adapted from Akusjarvi et al 
(1986).
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trimeric protein required for the initiation of eucaryotic 
translation. It is inactivated by phosphorylation of it's 
subunit. This phosphorylation is mediated by a protein 
kinase that is induced by interferon and inhibited by high 
concentrations of double-stranded RNA. VA RNA I prevents the 
activation of this kinase and thus allows translation to 
continue. It is not known whether VA RNA I acts directly to 
inhibit the kinase or whether the effect is due to the 
increased levels of double-stranded RNA within the cell.
1 : 4  THE STUDY OF ADENOVIRUS DNA REPLICATION
l s 4 : 1  EARLY IN VIVO STUDIES
A large number of workers throughout the 1970's used 
pulse-labelling and electron microscopic techniques to study 
the mechanics of adenovirus (Ad) DNA replication in infected 
cells.
Pulse-labelling techniques were first used to identify 
and characterize replicative intermediates. A proportion of 
the labelled DNA extracted from Ad-infected cells after a 
short pulse with (3H )-thymidine was shown to have a greater 
sedimentation rate in neutral sucrose gradients than mature 
viral DNA (Pearson & Hanaualtf1971; van der Eb,1973; 
Pearson, 1975) . Replicating DNA had a greater buoyant density 
in caesium chloride (CsCl) gradients than mature DNA 
(Pearson & Hanaualt,1971; van der Eb,1973; Pettersson,1973; 
Robin et a l ,1973? Pearson,1975) suggesting the presence of 
single-stranded regions. This was confirmed by showing that
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the higher buoyant density was abolished by treatment with 
SI nuclease (Pettersson,1973; Robins et al ,1973; 
Pearson, 1975) and that binding of replicating DNA to 
BND-cellulose was characteristic of DNA containing 
single-stranded regions (van der Eb,1973; Robins et 
al,1973).
Electron microscopic analysis of replicating DNA 
molecules revealed the presence of two classes of 
replicating molecules (van der Eb,1973; Ellens et al,1974; 
Lechner & Kelly,1977). Duplex molecules of genomic length 
with between one and four single-stranded branches were 
termed Type I replicative intermediates. Linear molecules 
with a single-stranded region extending from one end were 
termed Type II replicative intermediates. Ellens et al 
(1974) showed that when replication was synchronized after 
the release of a hydroxyurea block, branched (Type I) 
intermediates predominated early and unbranched (Type II) 
molecules at later times. Lechner & Kelly (1977) showed that 
terminal transferase would add dTTP residues to the terminus 
of the nascent strand to form poly(dT) tails. These were 
visible in electron micrographs at the growing points of 
Type I molecules and the double to single-strand transitions 
of Type II molecules. This indicated that both Type I and II 
synthesis proceeded in a 5' to 3 ‘ direction.
The right half of the A d .2 genome is more easily 
denatured than the left half, due to the lower percentage of 
G-C base pairs (Doerfler & Kleinschmidt,1970). Thus after
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partial denaturation the polarity of A d .2 DNA molecules is 
easily determined by electron microscopy. This method was 
used to determine at which end of the molecules initiation 
was occurring. Ellen et al (1974) indicated that initiation 
occurred almost exclusively at the right end but Lechner & 
Kelly (1977) and Revet & Benichou (1981) subsequently showed 
that in fact initiation occurred at each end with equal 
frequency.
On the basis of all this data Lechner & Kelly (1977) 
proposed a model of Ad. DNA replication. In this model Type 
I molecules are formed by initiation at one molecular end 
(or in a few cases at both ends) and elongation of the 
nascent strand occurred in a 5' to 3 1 direction with
concomitant displacement of the non-template strand.
Replication of the displaced strand then occurs by 
initiation at the 3' terminus and proceeds to the 5' end, 
thus generating a full-length duplex Ad.2 DNA molecule.
It has been proposed (Daniell,1976) that the ITR's of 
the displaced strand could associate to give a
single-stranded circle with a double-stranded 'panhandle'
structure. Incorporation of this proposal into the Lechner & 
Kelly model suggests that initiation events leading to the 
formation of both Type I and II molecules are identical. 
Evidence for panhandle formation comes from later 
experiments by Stow (1982) and Hay et al (1984). Stow (1982) 
showed that Ad.2 genomes with deletions within the left ITR 
would generate progeny virus with two intact ITR's after
Figure 1x2 A model for adenovirus DNA replication.
Taken from Lechner and Kelly (1977). Thin lines 
represent parental DNA, thick lines represent 
newly-synthesized DNA. Arrows show the direction of DNA 
synthesis.
5 -
3 “
■3 '
•5'
ai
TYPE 1
o*
23
transfection into permissive cells. This evidence was 
substantiated by the work of Hay et al (1984) using a 
linearized plasmid containing inverted repeats of a 94b.p. 
E.coli DNA fragment with a 570 b.p. Ad.2 terminal fragment 
at one end. After cotransfection of this plasmid into 
permissive cells with A d .2 wildtype DNA, progeny molecules 
an extra 0.5Kb in length were generated. These studies 
indicate that during adenovirus infection the ITR's at each 
end do interact, possibly by means of a panhandle structure.
The sites of initiation and termination of replication 
were determined by studying the distribution of label in 
Ad.2 restriction fragments after pulse-labelling. After a 
pulse shorter than the time required for one round of 
replication, label in mature molecules would be 
preferentially accumulated in restriction fragments 
containing the termination sites (Tolun & Pettersson,1975; 
Schilling et a l ,1975; Sussenbach & Kruijk,1977). These 
studies showed that the restriction fragments from the 
termini of the genome also contained the sites for 
termination of DNA synthesis. These studies were extended by 
Ariga & Shimojo (1978) who used various combinations of 
degradative enzymes to reduce newly replicated DNA to 
oligonucleotides after pulse—labelling. Their data showed 
that initiation occurred within 20—30b.p. of the 5' ends and 
termination occurred at the extreme 3' end.
Using an Ad.5 temperature-sensitive mutant (ts!25) 
defective for initiation of DNA replication Sussenbach &
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Kuijk (1978) showed that label was present predominantly in 
terminal restriction fragments after pulse-labelling and 
shift down to the permissive temperature. This indicated 
that initiation occurred at, or near, the genomic termini.
By pulse—label1ing it was also possible to determine 
the rate of chain elongation in vivo. Bodnar & Pearson
(1980) estimated that one round of DNA. replication took
2 0 min. at a temperature of 370c, corresponding to a rate of
appproximately 1700 bases/min.
1:4:2 THE FIRST IN VITRO SYSTEMS: ELONGATION OF DNA 
CHAINS INITIATED IN VIVO
A number of groups have studied the in vitro 
elongation of nascent DNA chains that were initiated in 
vivo. These experiments were performed both in nuclei 
isolated from infected cells and in nuclear extracts.
Winnacker (1975) found that in nuclei isolated from 
infected cells Ad.2 DNA synthesis was discontinuous. After a 
30sec. incubation newly synthesized viral DNA was found 
mainly in a slowly sedimenting (10S) band whereas after 
60min. newly synthesized DNA comigrated with mature viral 
DNA (32S). He also found that in infected cells treated with 
hydroxyurea, short (10S) A d .2 DNA fragments could be chased 
into full-length DNA after removal of the drug. Hydroxyurea 
reduces the pool of dNTP's in eucaryotic cells by 
inactivating the B2 subunit of ribonucleotide reductase, 
suggesting that formation of 10S fragments of Ad.2 DNA in
isolated nuclei does not truly represent in vivo 
replicat ion.
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A number of methods were used to isolate A d . 2 
replication complexes from infected nuclei. These included 
treatment of nuclei with the polyanion sodium heparin and 
exclusion chromatography of the products (Yamashita e_t 
ad, 1977), treatment with 0.15-0.3M ammonium sulphate (Brison 
et a l ,1977; Kaplan et al ,1977? Horwitz et al,1978; Shaw et 
al,1979) and treatment with 0.27% Sarcosyl followed by
collection of the complexes on a glass-fibre disc 
(Frenkel,1978).
These isolated complexes required Mg2+ and dNTP’s to 
synthesize viral DNA (Yamashita et al , 1977; Kaplan e_t 
al^ , 1977) and were stimulated by ATP (Kaplan et al , 1977 ?
Frenkel,1978). Analysis of replicated DNA after incubation 
with BuDR revealed the presence of hybrid heavy/light (HL) 
DNA but no heavy/heavy (HH) DNA (Yamashita et a l ,1977;
Brison et a l ,1977). This indicated that no initiation events
were occurring in vitro, only elongation of DNA chains 
initiated in vivo. Large amounts of the viral 72K DBP were 
associated with these complexes (Arens et al,1977; Horwitz 
et al,1978; Shaw et_al,1979). Horwitz et al (1978) also 
showed that the activity of extracts made from H5tjsl25 (a ts 
mutant in the 72K DBP) infected cells at the non-permissive 
temperature was enhanced by addition of purified wild-type 
DBP, implying a role for this protein in elongation.
Both DNA polymerase alpha (Arens et_al,1977? 
Frenkel,1978) and gamma activity (Arens et al,1977; Brison 
e t a l , 1977) were detectable in replication complexes, 
leading to the conclusion that these enzymes were involved 
in Ad. DNA synthesis.
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H o w e v e r  system?: c a p a b l e  of e l o n y a t i o n  of DNA c h a i n s  
initiated in v i vo were of limited use in analysing A d .DNA 
replication. Their main drawbacks were that they did not 
support initiation of replication and contamination with 
cellular polymerases, obscured the presence of a viral 
polymerase later discovered (Enomoto et a l ,1981).
1:4:3 THE DEVELOPMENT OF SYSTEMS CAPABLE OF BOTH
INITIATION AND ELONGATION IN VITRO
Probably the most important step in the understanding 
of adenovirus DNA replication was the development by 
Challberg and Kelly (1979a) of a cell-free extract capable 
of replicating exogenous templates. The vital component of 
this system was a salt extract of nuclei isolated from 
infected cells 22h.p.i. The cells had been treated with 
hydroxyurea from 2-22h.p.i. to inhibit DNA synthesis but at 
the same time allowing the synthesis of proteins to continue 
(Sussenbach & van der Vliet,1973). In the presence of A d .DNA 
protein complex (Ad. DNA-prot) purified from virions and all 
four dNTP's the system catalysed the incorporation of 
(cN32P)dTTP into ac id-prec ipi tat ible radioactivity. In vitro 
replication proceeded via Type I (branched) intermediates to 
produce long adenovirus strands (40-60% of full length) 
hydrogen-bonded to the template strands. The fact that most 
of the nascent strands were hydrogen bonded to the template 
ruled out the involvement of a repair-like reaction.
Replication originated at each end of the genome 
(Challberg & Kelly,1979b; Kaplan et a l ,1979) and was
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semi-conservative, as judged by the presence of HL DNA after 
replication in the presence of BUdR. By separating the two 
strands of terminal restriction fragments isolated from 
newly replicated DNA it was shown that the r-strand was 
preferentially labelled at the right end and the 1 -strand at 
the left end. This indicated that strand synthesis was 
occurring in a 5' to 3' direction.
The system was improved by the finding that in vitro 
replication was supported by a combination of cytosol from 
infected cells and uninfected nuclear extract (Ikeda et_ 
al,1980; Lichy et a l ,1981). Horwitz and Ariga (1981) showed 
that a 25-60% ammonium sulphate fraction of infected cytosol 
was active in this system. The modified two-component system 
was then used as a basis for the purification of the 
proteins involved in Ad.DNA replication. A number of assays 
were developed to analyse various aspects of the replication 
process in detail.
Rekosh et al (1977) had shown that a 55K protein (TP) 
was attached to the 5' ends of the genome and they proposed 
that it acted as a primer in DNA replication. Stillman et al
(1981) showed that this protein was synthesized as an 80K 
precursor and was processed late in infection to the mature 
55K form. Lichy et al (1981) showed that the initiation 
event involved the formation of a covalent complex between 
an 80K precursor terminal protein (pTP) and the first 
nucleotide of the sequence- 5'dCMP. They developed an assay 
to detect this complex in which uninfected nuclear extract,
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infected cytosol and Ad.DNA-prot. were incubated with 
(0C32P)dCTP. Complex was detected as a labelled 80K species 
on SDS-PAGE. The reaction was template dependent and 
required Mg2+ and ATP. They also showed that the complex 
could act as a primer for limited elongation at least as far 
as nucleotide 26, the first G in the sequence. Horwitz and 
Ariga (1981) developed an assay to look at more extensive 
elongation. They showed that when uninfected nuclear and
infected cytoplasmic extracts were incubated with Xba-I cut 
Ad.DNA-prot., the terminal fragments of the Ad.DNA-prot were 
specifically labelled. These assays also showed that a 
second round of DNA replication could initiate at the
termini, thus displacing the 5' strand synthesized during 
the first round.
These assays, in combination with the original assay 
of Challberg and Kelly (1979a) which measured the 
incorporation of labelled dNTP1s in acid-precipitatible
radioactivity, were used to follow the purification of the 
components of the adenovirus DNA replication system.
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1:5 VIRAL PROTEINS REQUIRED FOR ADENOVIRUS 
DNA REPLICATION
1:5:1 THE ROLE OF THE TERMINAL PROTEIN AND THE
TERMINAL PROTEIN PRECURSOR
As mentioned above the 5' end of newly-synthesized Ad. 
DNA is covalently linked to an 80K protein (pTP) (Challberg 
et a l ,1980) which is processed late in infection to a 55K 
form (Stillman et a l ,1981). The role of the pTP in 
replication was determined by purifying it from infected 
cells and studying it's replicative activity when combined 
with purified DBP and uninfected cell extracts.
Ikeda et al (1981) purified a fraction from Ad.2 
infected HeLa cell cytosol through 3 columns: 
DEAE-cellulose, phosphocellulose and denatured-DNA 
cellulose. In the presence of uninfected nuclear extract 
and Ad.DBP the fraction catalysed the incorporation of 
dNlffP ' s into acid-insoluble radioac t i vi ty using Ad.DNA-prot. 
as template. The products formed were covalently linked to 
an 80K protein at the 5' end and were approximately 25-50% 
of genomic length; full-length products were only observed 
in the presence of uninfected cytosol. The uninfected 
extract could be replaced with a mixture of purified 
polymerase alpha and beta.
This purification scheme was subsequently improved 
(Enomoto et al,1982) by the use of phosphate rather than 
Tris buffer in the purification and by the addition of a
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native DNA-cellulose column and a glycerol gradient. The 
active fraction sedimented in the latter as a single peak of 
apparent M.W. 180K which separated on SDS-PAGE into two
major equimolar bands of 80K and 140K. This fraction alone
catalysed the formation of the pTP-dCMP complex showing that 
it contained pTP. The level of complex formation was 
stimulated 8 -fold by the presence of uninfected nuclear 
extract (Enomoto et al , 1 9 8 2 7 Stillman et al,1982). The 80K 
protein was shown to be pTP by comparison of it's tryptic 
peptide map with that of TP purified from virions. A DNA 
polymerase activity which differed from the three cellular 
polymerases in both it's inhibition profile and
chromatographic properties, copurified with the Ad-protein
fraction. Lichy et al (1982) and Stillman et al (1982)
separated the 80K and 140K proteins on glycerol gradients 
containing urea and showed that the Ad-specific polymerase 
activity resided in the 140K protein. Both pTP-dCMP 
formation and Ad-DNA replication in vitro required both
proteins. Ikeda et al (1982) showed that the Ad-protein
fraction (pTP-pol complex) would also form pTP-dCMP complex 
on single-stranded 0X174 DNA templates. pTP-dCMP formed on 
single strands could elongate to produce chains of about 200 
nucleotides in length but further elongation required either 
E.coli DNA polymerase I or eucaryotic polymerase beta. In 
contrast to initiation on Ad-DNA-prot, ATP and uninfected 
nuclear extract were inhibitory, as was DBP.
Rijnders et al (1983a) showed that an antiserum raised 
against TP purified from virions would inhibit both pTP-dCMP
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formation and specific labelling of Ad.DNA-prot. terminal 
fragments. Van Bergen et al (1983) showed that a cloned A d .2 
terminal fragment was specifically replicated by infected 
nuclear extract when the plasmids were linearized to expose 
the origin. This replication was also inhibited by anti-TP 
serum showing that inhibition was due to an effect on pTP, 
not the mature TP attached to the template. Rijnders et al 
(1983b) also showed that the anti-TP serum did not affect 
the polymerase activity of purified pTP-pol. These data 
indicate that functional pTP is required for initiation of 
Ad.DNA replication.
The binding of purified pTP-pol complex to duplex DNA
was studied by Rijnders et al (1983b). The affinity of
binding of adenoviral DNA was higher than that to calf 
thymus or pBR322 DNA. By analysing the binding to plasmids 
containing sequences from the Ad. DNA terminus, a sequence 
between nucleotides 9-22, which is perfectly conserved 
amongst all human adenoviruses (Stillman et al,1982), was 
implicated as a specific binding site for pTP-pol.
Van Bergen et al (1983), Tamanoi and Stillman (1982)
and Guggenheimer et al (1984a) reported that protein-free
DNA is less efficient as a template for initiation and 
elongation than Ad.DNA-prot. In addition, initiation did not 
always occur at the Ad. genomic terminus in protein-free 
templates- any G residue between 4-8 b.p. 3' of the 
conserved sequence could be used. Tamanoi and Stillman
(1982) found that crude extracts would only catalyse
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pTP-dCMP formation with Ad.DNA-prot. whereas partially 
purified extracts would utilize both Ad.DNA-prot. and 
protein-free templates. These data suggest several roles for 
the mature TP on viral DNA; TP could have a role in 
preventing exonuclease digestion of Ad. DNA during infection 
(Dunsworth-Browne et al,1980). Alternatively it could 
prevent aberrant internal starts. Robinson et al (1973) 
first demonstrated that Ad.DNA-prot. purified from virions 
by disruption with guanidinium-HCl would form duplex circles 
that were converted to linear molecules by protease 
treatment. This led to the suggestion that the TP's on 
mature virion DNA could interact. Such an interaction could 
occur between the TP on the genome and the incoming pTP, 
facilitating the initiation reaction. The greater efficiency 
of Ad.DNA-prot implies that TP has a role in the initiation 
of replication, it could possibly facilitate the unwinding 
of the helix (van Bergen et al ,1983).
1:5:2 THE ADENOVIRUS-SPECIFIC DNA POLYMERASE
As mentioned in the previous section Enomoto et al
(1981) purified a fraction from infected cytosol that was 
capable of catalysing the formation of a pTP-dCMP complex 
alone. The two major components of this fraction were an 80K 
protein (shown to be the p T P ) and a 140K protein. The 
fraction also contained an unique DNA polymerase activity 
that could be distinguished from cellular DNA polymerases. 
Lichy et al (1982) separated this fraction on a glycerol 
gradient containing urea and showed that the 140K protein 
contained the DNA polymerase activity.
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Stillman et a 1 ( 1982) used a different approach to
purify the DNA polymerase; They showed that nuclear extracts 
from cells infected with an Ad. 5 ts mutant (tsllffl) which 
contained a mutation in the N-complementation group could 
not initiate DNA replication in vitro at the non-permissive 
temperature. They ^purified the DNA polymerase by it's 
ability to complement tsl ' extracts for initiation and 
synthesis at the non-permissive temperature. They also 
showed that the DNA polymerase fraction contained two major 
proteins of 140K and 80K which co-sedimented through a 
glycerol gradient. They separated the two proteins on a 
glycerol-urea gradient and showed that the DNA polymerase 
activity coincided with the purified 140K protein, 
confirming the results obtained by Lichy et al (1982). 
pTP-dCMP formation and Ad. specific replication required 
both proteins but DNA polymerase activity of the 140K did 
not require p T P . No other DNA polymerases could function in 
the pTP-dCMP reaction; those tried included eucaryotic DNA 
polymerases alpha, beta, and gamma from various sources, 
bacteriophage T4 DNA polymerase, and E.coli DNA polymerases 
I, II and III (Lichy et al ,1982,1983).
Both the pTP-dCMP synthesizing and DNA polymerase 
activities of the 140K protein were inactivated by 5mM 
N-ethylmaleimide or by heating at 55°C for 15min. The Ad. 
DNA polymerase activity resembled eucaryotic DNA polymerase 
alpha both in it's use of nicked duplex (activated) DNA as 
template and in it's sensitivity to ara-CTP and NaCl. It 
differed from DNA polymerase alpha in it s resistance to
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aphidicolin and it's sensitivity to ddTTP. However the 
replication of Ad.DNA both in vivo (Longiaru et al ,1979) and 
in vitro (Nagata et al ,1983) is inhibited by aphidicolin. 
'^ ie in vitro studies show that whereas in the presence of 
aphidicolin pTP-dCMP formation and elongation to the 26th 
nucleotide are unaffected (Lichy et_al,1981), the products 
of more extensive elongation accumulate as DNA chains 
approximately 10Kb. in length (Nagata et al ,1983). Thus the 
effect of aphidicolin on the Ad. DNA polymerase is only 
apparent after extensive elongation.
The Ad. DNA polymerase also resembled DNA polymerase 
alpha in it’s use of homopolymer template:primers. Both 
enzymes were most active on activated DNA but would also use 
poly(dC):oligo(dG), poly(d C ):oligo(rl), poly(dT):oligo(dA) 
and poly(dT):oligo(rA). Neither enzyme would use templates 
containing poly(dG), poly(dl) or poly(dGC). The relative 
efficiencies of utilization of these templates varied 
bwtween the two enzymes (Field et al,1984).
The purified Ad. DNA polymerase contained a 3'-5' 
exonuclease that was 1 0 -fold more active on single-stranded 
than on duplex DNA (Field et al,1984). The exonuclease 
activity of the Ad. DNA polymerase is in common with other 
viral and procaryotic DNA polymerases including the vaccinia 
virus DNA polymerase, E.coli DNA polymerases I, II and III 
and T4 DNA polymerase. It is thought that this exonuclease 
activity increases the fidelity of replication by removing 
misincorporated nucleotides (Brown et al,1982). Reha—Krantz
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and Bessman (1977) supported this model by showing that 
mutations which reduce the 3'— 5' exonuclease activity of 
bacteriophage T4 DNA polymerase also increase the rate of 
spontaneous mutations and vice-versa.
The Ad. DNA polymerase exonuclease activity is 
inhibited up to 7-fold by the Ad. 72K DBP. This inhibition 
was shown to be due to a direct effect upon the DNA 
polymerase, rather than by binding to and protection of DNA 
(Lindenbaum et a l ,1986). The DBP also has several other 
profound effects on the DNA polymerase; DNA synthesis on 
poly(d T ):oligo(dA) is stimulated 10-100 fold by the presence 
of DBP and can yield nascent chains of up to 30kb. in 
length, indicating that in the presence of DBP the Ad. DNA 
polymerase is a highly processive enzyme (Field et al,1984). 
This effect is template-specific as shown by the finding 
that synthesis on poly(dA):oligo(dT) was not affected by the 
presence of DBP. Lindenbaum et al (1986) studied the effect 
of DBP on the thermal stability of the Ad.polymerase. In the 
presence of an excess of DBP, the DNA polymerase activity 
was stable at 45°C for at least 2h., both in the presence 
and absence of DNA. DNA (in the form of poly(dT):oligo(dA)) 
was highly destabilizing in the absence of DBP; after 2h. at 
45°C only 1% of the DNA polymerase activity was still 
present.
Despite the functional interactions between the two 
proteins it has not been possible to isolate DNA 
polymerase—DBP complexes (Lindenbaum et al,1986). The
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presence of pTP reduced by two-thirds the amount of DNA 
synthesized by Ad. DNA polymerase and DBP using 
poly(dT):oligo(dA) as template. This suggests that the tight 
binding of pTP to the DNA polymerase inhibits elongation. 
The role of DBP in vivo may be to dissociate the complex and 
allow the DNA polymerase to move along the genome.
1 : 5 : 3  THE 72,000 DALTON MOLECULAR WEIGHT VIRAL
DNA-BINDING PROTEIN
The first report of an adenovirus-infected cell 
specific DNA-binding protein was by van der Vliet and Levine 
(1973). They found two polypeptide species of apparent 
M.W.'s 72K and 48K which bound specifically to 
single-stranded DNA but not to duplex DNA. It was 
subsequently shown (Levinson & Levine,1977) that the 48K 
polypeptide was a breakdown product of the 72K.
Fowlkes et al (1979) and Schechter et al (1980) showed 
that in fact the 72K DNA-binding protein (DBP) bound to both 
duplex and single-stranded DNA. Melting studies using 
polynucleotide duplexes revealed that the protein stabilized 
the helix. Binding to duplex DNA was specific for the 
termini of a linear molecule, closed circular molecules were 
not bound to any great extent. However Kedinger et al (1978) 
showed by electron microscopic analysis of replicative 
intermediates isolated from infected cells that only the 
single—stranded regions were thickly covered with DBP, 
suggesting that in vivo the binding of DBP to DNA differs 
from that observed in vitro.
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Van der Vliet et a 1 ( 1977 ) and Kedinger et al ( 1978) 
first suggested that DBP was involved in elongation of 
nascent DNA chains when they observed that an anti-DBP 
antibody slowed down the rate of chain elongation. The role 
of DBP in DNA replication in vitro has been studied using 
the temperature-sensitive mutants of Ad.5: H5tsl25 and 
H5t_£l07. Both these mutants carry base substitutions within 
the DBP gene and are defective for DNA replication at the 
non-permissive temperature. Nuclear extracts of H5tsl25 
infected cells were defective for full-length Ad.DNA 
synthesis in vitro on both endogenous (Horwitz,1978) and 
exogenous (Kaplan et a l ,1979) templates. In both cases this 
activity was restored by the addition of purified wildtype 
DBP. However DBP did not appear to be required for 
initiation in vitro: Lichy et al (1981) showed that addition 
of purified wildtype DBP had no effect on the formation of a 
pTPdCMP complex in vitro by crude infected cell extracts. 
Friefeld et al (1983) showed that extracts derived from 
H5tsl25 infected cells could support wildtype levels of 
pTP-dCMP complex formation at the non-permissive 
temperature. Nagata et al (1983a) subsequently showed that 
pTP-dCMP formation by purified pTP-pol was inhibited by DBP, 
this inhibition was overcome by a host factor (see Section 
4:5:1). Formation of the pTP.26mer limited elongation 
product by H5tsl25 extracts at the non-permissive 
temperature was reduced and could be restored to 75% of 
wildtype levels by DBP. Friefeld et al (1983) also showed 
that purified ts!25 DBP would complement wildtype pTP-pol 
and uninfected nuclear extract in assays to detect specific
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labelling of Ad.DNA-prot. terminal restriction fragments at 
30°C, but not at 38°C. These results confirmed that 
functional DBP was required for elongation.
Partial chymotryptic digestion of DBP produces a 44K 
C-terminal and a 26K N-terminal fragment (Klein et al,1979). 
The C-terminus is highly conserved- 60-80% at the amino-acid 
level- between adenoviruses of various subgroups 
(Kitchingman,1985). The N-terminus, which unlike the 
C-terminus is phosphorylated (Klein et al,1979), is less 
highly conserved- 30-40% at the amino-acid level.
The 44K C-terminal fragment was shown to complement 
tsl25 extracts for Ad.DNA replication in vitro (Ariga et 
al^1980). This fragment has recently been crystallized 
(Tsernoglou et alf1984,1985) and the elucidation of it's 
three-dimensional structure will be extremely informative. 
Furthermore a 34K C-terminal fragment derived by more 
extensive chymotryptic digestion was also active (Friefeld 
et al ,1983). Thus the unphosphorylated C-terminus of the DBP 
contains all the requirements for DNA replication. However 
the requirements for DNA-binding and DNA replication may not 
coincide: Recently Krevolin and Horwitz (1987) found that
the intact ts!07 DBP exhibited wildtype binding to DNA but 
was temperature sensitive for Ad.DNA replication. However 
the 34K fragment of the ts!07 DBP was temperature sensitive 
both for DNA replication and DNA-binding, indicating that 
the amino terminal domain of the DBP, whilst not affecting 
the role of the DBP in DNA replication, is involved in
binding of the protein to DNA.
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1:6 CELLULAR FACTORS INVOLVED IN ADENOVIRUS 
DNA REPLICATION
1:6:1 NUCLEAR FACTOR I
Lichy et al (1981,1982) and Ikeda et al (1981) 
demonstrated that uninfected nuclear extract was required 
for optimal initiation and elongation in the presence of 
either infected cytosol or purified pTP-pol and DBP. Nagata 
et al (1982) purified an activity from uninfected HeLa cell 
nuclei that enhanced both initiation and elongation. The 
active fraction contained no detectable nuclease, 
topoisomerase, ATPase, RNA or DNA polymerase activities and 
contained a single major polypeptide of 47K, as revealed by 
SDS-PAGE (Nagata et al ,1982). This protein was termed 
nuclear factor I (NFI).
The activity of NFI in stimulating initiation was 
affected by DBP. In the absence of DBP, NFI stimulated 
pTP-dCMP formation by purified pTP-pol 2-fold. The presence 
of DBP alone was inhibitory, but the further addition of NFI 
overcame this inhibition, giving a 6-fold increase in 
pTP-dCMP formation. ATP further enhanced the reaction 
2-fold. NFI also enhanced the formation of the pTP-26mer 
limited elongation product (Nagata et al,1983a), and 
stimulated incorporation of labelled dTTP into 
acid—precipitatible radioactivity using Ad.DNA-prot. as 
template 5-fold (Lichy et_al,1983). However these effects 
are likely to be an indirect effect of increased initiation 
efficiency.
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Several groups looked at the specific binding of NFI 
to the adenovirus origin. DNase I protection experiments 
showed that NFI protected a region between nucleotides 17-48 
(Nagata et al ,1983b; Rawlins et a l ,1984; Leegwater et 
al,1985). Binding did not require ATP or Mg^+ and was 
resistant to high ionic strength. Again DBP had an effect on 
NFI activity; Nagata et al (1983b) showed that DBP would 
protect an entire 451b.p. terminal Ad.5 fragment against 
digestion with DNase I, but in the presence of both NFI and 
DBP a small amount of DNase I digestion was observed at 
either edge of the region protected by NFI alone. This 
suggested that NFI displaces DBP from it's binding site at 
the origin. This data also correlates with the finding that 
DBP inhibited initiation in the absence of NFI and that NFI 
could overcome this inhibition (Nagata et al,1982).
The region bound by NFI has two-fold rotational 
symmetry and therefore has the potential to form a hairpin 
structure. Methylation protection experiments (De Vries et 
al,1987) demonstrated that NFI protected symmetrically 
arranged G residues from methylation by DMS. DMS methylates 
G residues in the major groove, suggesting that NFI binds to 
that side of the helix. NFI thus appears to be analogous to 
the lambda repressor and cro proteins which also protect 
symmetrical G residues from methylation. Both repressor and 
cro bind to the same three 17b.p. repeats that also have the 
potential to form hairpin structures (Ptashne et al,1980). 
It has been suggested (Nagata et al,1983b) that this hairpin 
structure may be required for NFI binding. However Leegwater
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61 a 1 ( 1985) subsequently showed that the 16b.p. region 
between nucleotides 25 to 40 was both necessary and
sufficient for NFI binding. This excludes most of the
possible hairpin structure, thus arguing against hairpin 
formation as a requirement for NFI binding. It seems likely 
however, given the comparison with the repressor/cro
situation that NFI binds as a dimer. The radius of an NFI 
molecule, calculated from it's molecular weight (47K) is 27a 
(Nagata et a l ,1983b). The length of the 32b.p. protected 
sequence is 110A suggesting that two molecules interact with 
each binding site. Thus it is possible that a monomer of NFI 
could bind to half of the recognition sequence.
The role of NFI binding in initiation of Ad.DNA 
replication was demonstated using plasmids containing 
deletions within the Ad.2 terminal sequence. Tamanoi and 
Stillman (1982) showed that a plasmid containing an Ad.2 
terminal fragment (the origin of replication), linearized 
such that the origin was placed at a molecular end, was 
active as a template for initiation of replication. Tamanoi 
and Stillman (1983) made sets of deletions extending both 
towards and away from the Ad. terminus. Their initial 
studies showed that the terminal 20b.p. of the genome were 
sufficient for efficient initiation, although in some c a s e s  
the addition of sequences up to 35b.p. enhanced the 
efficiency slightly. These results were reiterated by 
Challberg and Rawlins (1984) who showed that the terminal 
18b.p. constituted a functional origin of replication. 
However these studies were carried out using high
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concentrations of template DNA which masked the effect of 
NFI. Lally et al (1984), using crude A d .2 nuclear extracts, 
showed that a plasmid containing the terminal 38b.p. was 
three times more active than one containing the terminal 
21b.p. It was only when purified NFI was used in these 
assays, and the concentration of template DNA was reduced, 
that the requirement for the NFI binding site on the 
template became more apparent.
Guggenheimer et al (1984a) showed that pTP-dCMP 
formation by purified pTP-pol and DBP on plasmids containing 
at least the terminal 48b.p. of the Ad. genome was 
stimulated 5-7 fold by NFI. These plasmids were also 
efficiently bound by NFI. Plasmids containing between 18 and 
35b.p., although exhibiting a low level of activity, were 
not stimulated by, and did not bind to, NFI. Plasmids 
containing deletions extending either 7 or 15b.p. from the 
terminus were completely inactive in initiation although 
they bound efficiently to NFI. Rawlins et al (1984) showed 
that, whereas the terminal 18b.p. of the genome were 
sufficient for pTP-dCMP formation, addition of sequences up 
to 67b.p. greatly enhanced the efficiency of the reaction. 
In addition they showed that deletions that abolished 
enhancement also abolished binding of NFI.
NFI sites have also been found in a wide variety of 
eucaryotic DNA sources: Borgmeyer et al (1984) described a 
protein which bound to the sequence 5 TGGCA(N3)TGCCA 
upstream of the chicken lysozyme gene. Nowock et al (1985)
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subsequently showed that this TGGCA-binding protein bound to 
sites in the MMTV LTR, the BK virus enhancer and the 
adenovirus origin of replication, tentatively identifying it 
as NFI. Leegwater et al (1986) showed that the TGGCA protein 
and NFI were one and the same by extensive functional 
comparisons. NFI sites were also shown to be present
upstream of the IgM heavy chain gene (Hennighausen et
al,1985) and within the promoter and first intron of the 
human cytomegalovirus major immediate-early gene 
(Hennighausen & Fleckenstein,1986), the expression of which 
is entirely dependent on host factors.
Gronostajski et al (1984,1985) isolated and analysed 
NFI sites from HeLa cell DNA. They estimated that one site 
was present per 100Kb. of DNA and derived a consensus
sequence 5 1TGG(N6-7)GCCAA for the binding site. Gronostajski 
(1986) then analysed the precise requirements for NFI 
binding using oligonucleotides. He showed that the spacer 
between the TGG and GCCAA motifs had to be 6 nucleotides. 
4,5,7 or 8 nucleotide spacers were not bound by NFI. By 
synthesizing oligonucleotides with random sequences within 
the spacer and the 3b.p. either side of the conserved motifs 
he showed that the precise sequence within these regions was 
of minor importance for binding. De Vries et al (1985) 
showed that point mutations within the conserved motifs 
reduced binding to NFI. However reduced binding efficiency 
did not always result in a correspondingly reduced ability 
to enhance Ad. initiation. In addition a double point mutant 
at positions 22 and 23 on the Ad.2 ITR (outside the
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conserved motifs) still bound NFI but was negative for 
enhancement of replication. These results indicated that 
binding of NFI and stimulation of Ad. initiation are not 
identical functions of the protein.
De Vries et al (1987) used various techniques such as 
methylation protection, methylation and ethylation
interference and substitution with 5-BrdU to show that NFI 
interacted with pairs of symmetrically arranged G residues 
within the binding site. Using computer graphics they 
demonstrated that the contact points were located in two 
blocks showing dyad symmetry to each other. They also 
demonstrated that, as a consequence of this dyad symmetry, 
the NFI site enhanced Ad. initiation in either orientation 
(relative to the conserved sequence).
Adhya et al (1986) demonstrated that initiation in 
vitro was unaffected when the NFI site within the Ad. origin 
was replaced with a cellular NFI site. The HeLa NFI site was 
also active in either orientation but the distance from the 
conserved sequence was important. The centre to centre 
distance between the conserved sequence and the NFI site had 
to be less than 23b.p. The presence of two or more NFI sites 
did not further enhance the efficiency of initiation.
A number of physical studies have recently been 
performed on NFI. Rosenfeld and Kelly (1986) and Diffley and 
Stillman (1986) both purified NFI by affinity 
chromatography. Both groups constructed plasmids containing
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many tandem repeats of the NFI binding site, linked them to 
cellulose and used the matrix as the final stage in NFI 
purification. Both groups however made different 
observations as to the size of NFI. Nagata et al (1982) had 
shown that NFI was a single polypeptide of M.W. 47K. 
Rosenfeld and Kelly observed several bands between 52-66K 
and a minor band at 32K on SDS-PAGE. These bands had similar 
polypeptide patterns after limited proteolysis. Diffley and 
Stillman however observed a major band at 160K on SDS-PAGE. 
They suggested that NFI consisted of two globular domains 
with a linker peptide that was highly sensitive to 
proteolysis. One domain (47-66K) was sufficient for DNA 
binding and stimulating Ad. replication. By analysing the 
stoichiometry of binding they predicted that 2 molecules of 
a 160K polypeptide bound to one binding site.
These studies show that there are two domains within 
the Ad.2 ITR that are required for initiation of 
replication. The region from nucleotides 1-18 is absolutely 
required, deletions into this region abolish initiation 
(Guggenheimer et a l ,1984a). Base changes within the highly 
conserved region from nucleotides 9—18, suggested as the 
binding site for the pTP-pol complex (Rijnders et al,1983a), 
also abolished initiation (Tamanoi & Stillman,1983; 
Challberg & Rawlins,1984). The presence of the region 
between nucleotides 19—48 greatly enhanced the efficiency of 
initiation, and this has been shown to be due to the binding 
of NFI. The requirements for these two regions have also 
been examined in in vivo replication systems (see Section
4:6) .
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1:6:2 NUCLEAR FACTOR II
In the presence of pTP-pol, DBP and NFI the products 
of DNA synthesis on Ad.DNA-prot. are only 25% of the size of 
full-length DNA (Nagata et a l ,1983r Lichy et al,1983). 
Full-length synthesis required the presence of a second 
factor from uninfected HeLa nuclei, termed nuclear factor II 
(NFII). NFII was purified through 4 columns by Nagata et al
(1983). SDS-PAGE of purified NFII revealed the presence of 2 
major bands of 14.5K and 15.5K, and a minor band at 30.5K. 
NFII preparations contained no detectable nuclease, ATPase, 
RNA or DNA polymerase activities but did contain Type I 
topoisomerase activity. Type I topoisomerases from 
eucaryotic, but not procaryotic, sources could substitute 
for NFII in Ad.DNA replication. Both eucaryotic 
topoisomerase and NFII were dependent on the presence of NFI 
for the formation of full-length Ad.DNA products.
1:6:3 NUCLEAR FACTOR III
Recently a third host cell factor affecting Ad.DNA 
replication has been identified. Nuclear factor III (NFIII) 
was purified from uninfected HeLa nuclei (Pruijn et al,1986) 
and was shown to stimulate the initiation efficiency 4-6 
fold in the presence of NFI. Replication of a plasmid 
containing the terminal 73b.p. of the Ad.2 ITR was 
stimulated by both NFI and NFIII, whereas a plasmid 
containing only 40b.p., or one containing the complete ITR 
with a point mutation at position 46, were only stimulated 
by NFI. DNase I footprinting analysis revealed that NFIII 
bound to the ITR between nucleotides 36 and 54, overlapping
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the NFI site. Despite this overlap both proteins could bind 
simultaneously. Methylation protection experiments showed 
that NFI protected a G-residue at position 36 and NFIII 
protected a G-residue at position 42, suggesting that the 
proteins bound to opposite sides of the helix. NFIII only 
stimulated initiation in the presence of NFI, but the 
binding of NFIII to the origin was unaffected by NFI.
The NFIII consensus sequence- 5'PuPyGNTAATGAPuATNC has 
several homologies in eucaryotic DNA sequences. These 
include the histone H2B promoter, human and mouse 
immunoglobulin V and V promoters, upstream from the human 
interferon gene and upstream from the U1 and U2 snRNA genes 
in various species. It seems likely therefore that, as is 
the case for NFI, the virus is using a bona-fide cellular 
function to aid its replication. Whether NFIII has a role in 
Ad.DNA replication in vivo remains to be seen. Hay and 
McDougall (1986) (see Section 1:7) constructed viruses 
lacking parts of the left ITR and demonstrated that deletion 
of the NFIII site had no detectable effect on virus 
replication. In contrast deletion of the NFI site produced a 
non-infectious virus genome.
1:6:4 FACTOR pL: A HOST PROTEIN REQUIRED FOR
REPLICATION OF TERMINAL PROTEIN-FREE TEMPLATES 
Guggenheimer et al (1984b,c) purified a protein from 
uninfected HeLa nuclei that was specifically required for 
initiation on plasmid—borne origins of replication. Factor 
pL had no effect on the replication of Ad.DNA prot. but was
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required for the replication of pronase treated Ad.DNA. Gel 
filtration studies indicated that factor pL had an apparent 
M.W. of 44K. The purified protein contained no RNA or DNA 
polymerase, double-stranded endonuclease or topoisomerase 
activities. Factor pL did not inhibit the binding of NFI to 
the origin of replication; initiation in the presence of pL 
was stimulated 8-10 fold by the presence of NFI.
Guggenheimer et al (1984c) suggested that pL displaces 
a DNA strand at the terminus, allowing the pTP-pol complex 
to initiate. Alternatively it is possible that pL digests 
the 5'- end of the genome, thus allowing the pTP-pol direct 
access to the 3'- end of the template strand. This would 
explain why pL has no effect on the replication of 
Ad.DNA-prot., as it is known that the TP protects the 5'- 
end of Ad.DNA-prot. from 5'-3’ exonuclease activity. The 
fact that pL has no effect on the replication of 
Ad.DNA-prot. suggests that it does not play a role in 
replication in vivo.
1:7 STUDIES TO ELUCIDATE THE SEQUENCE REQUIREMENTS FOR 
ADENOVIRUS DNA REPLICATION IN VIVO.
Several groups of workers have recently looked at the 
sequence requirements for replication in vivo. Hay et al
(1984) demonstrated that plasmids containing two inverted 
adenoviral termini were replicated in vivo after 
co-transfection with wildtype viral DNA to provide 
replication functions. Efficient replication required the
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ITR's to be present at the ends of a linear molecule, 
although a low level of replication was observed from 
internal origins. These replicons underwent multiple rounds 
of replication and reached high copy numbers (greater than 
10,000 copies per cell). Newly replicated molecules were 
attached to protein, suggesting that they were replicated by 
the same mechanism as Ad.DNA.
Deletions were introduced into the ITR by Bal31 
exonuclease and these molecules used to construct plasmids 
containing two inverted copies of partially-deleted ITR's 
(Hay,1985a). Analysis of the replication of these molecules 
demonstrated that the terminal 45b.p. were the minimum 
requirement for replication in vivo; molecules containing 
36b.p. or less were not replicated to any detectable extent. 
Thus the NFI binding site, which enhances replication in 
vitro up to 10-fold, is absolutely required in vivo. This 
finding was repeated by Bernstein et al (1986) who also 
found that point mutations within the TGG and GCCAA motifs 
of the NFI binding site or within the 9-18 conserved 
sequence reduced replication at least 10-fold. Interestingly 
they found that point mutations at nucleotides 4 or 57 also 
reduced replication 5—10—fold. Nucleotide 57 may form part 
of the recognition site for NFIII, although it is not 
protected from DNase I digestion by NFIII (Pruijn et 
al,1986b).
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Wang and Pearson (1985) modified this approach by 
constructing linear recombinants containing inverted repeats 
of pUC8 sequences with one copy of an Ad. terminal fragment 
at one end. After cotransfection with wildtype helper DNA 
these recombinants were replicated provided that they 
contained at least the terminal 30b.p. Molecules containing 
either 30 or 36b.p., lacking the complete NFI site, showed 
consistently less than 50% of wildtype replication levels. 
Wildtype levels were obtained by plasmids containing at 
least 67b.p. The products of replication were larger than 
the input molecules because they contained a copy of the 
Ad.DNA sequence at each end. This fact provides further 
evidence for the involvement of a panhandle structure in 
Ad.DNA replication as proposed by Daniell (1976) (see 
Section 1:4:1).
Although there are some minor discrepancies in the 
data presented by different laboratories these could be due 
to slight differences in the assays used. A general 
consensus seems to be that the NFI site is more important in 
vivo than in vitro. A possible reason for this is given by 
De Vries et al (1985). They demonstrated that the 
stimulation of replication by NFI was directly proportional 
to the concentration of DBP in the reaction, and that in the 
absence of NFI replication was inhibited by DBP. Thus in the 
presence of high concentrations of DBP, such as might be 
expected to occur in the nuclei of infected cells, NFI would 
appear to be absolutely required.
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Hay and McDougall (1986) constructed A d .2 genomes with 
deletions within the left ITR. They demonstrated that the 
terminal 45b.p. sequence, which was defined as the minimal 
Ad. origin in vivo by the plasmid replication system, also 
fulfilled all the requirements for replication of genomic 
Ad.DNA in vivo. Thus adenovirus genomes containing only 
45b.p. of the left ITR showed wildtype growth kinetics, 
plaque morphology, viral DNA synthesis and Ela mRNA 
synthesis. This raises the question of the function of the 
remaining ITR sequences. These include several copies of the 
sequence GGGNGGAG which is conserved amongst the 
adenoviruses and is present in the SV40 origin of 
replication (Stillman et al ,1982a). It could be that the 
copy of these sequences at the right end of the genome is 
sufficient for expression of their function.
1:8 A MODEL FOR THE MOLECULAR MECHANISM 
OF ADENOVIRAL DNA REPLICATION
Evidence from other in vitro DNA replication systems 
(eg. E.coli oriC, see section 1:11) has shown that 
initiation of replication involves the formation of a large 
nucleoprotein complex at the origin. Formation of this 
complex will require both protein-protein and 
protein—nucleic acid interactions. It seems likely that this 
situation also applies to adenovirus DNA replication.
Like these other systems initiation of adenoviral DNA 
replication requires a specific DNA sequence. In adenovirus
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this sequence is located at the termini of the genome. 
Clearly therefore the first stage in initiation must involve 
interactions between cellular sequence-specific DNA binding 
proteins and the terminus of the adenovirus genome. Two 
cellular proteins have so far been shown to bind to specific 
sequences in the A d .2 ITR; Nuclear Factor I (NFI; Nagata et 
aJ, 1983b) and Nuclear Factor III (NFIII; Pruijn et al, 1986) . 
Both these proteins are thought to be involved in eucaryotic 
transcriptional activation (Jones et al ,1987). A third 
sequence-specific DNA-binding protein which binds to the 
terminal 15b.p. of the A d .2 ITR has recently been identified 
(Kelly, personal communication). However this protein did 
not appear to enhance pTP-dCMP formation under the
conditions employed in vitro so may not have a role in
initiation. The multiple proteintDNA interactions at the 
origin may also involve the Ad. 72K DNA-binding protein 
(DBP), which binds with high affinity to single-stranded DNA 
but also binds non-specifically to double-stranded DNA, and 
the terminal protein (TP) attached to the 5' ends of the 
genome. Evidence for the role of TP in forming the 
initiation complex comes from data showing that DNA attached
to TP is more efficient than DNA lacking TP in acting as a
template for initiation (Tamanoi & Stillman,1982; van Bergen 
et a l ,1983; Challberg & Rawlins,1984) .
Secondly the ends of the genome are unwound with the 
concomitant hydrolysis of ATP. This process is likely to 
involve the site—specific DNA-binding proteins (unwinding 
must also occur during transcription so they may perform the
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same function in two different processes) and may also 
involve the DBP. Binding of the pTP-pol complex to the 
single-stranded terminus may then occur. This interaction 
may involve either the non-specific binding of pTP-pol to 
single-stranded DNA, or recognition of a specific 
nucleoprotein structure at the origin. It may also involve 
the terminal protein, DBP and cellular sequence-specific 
DNA-binding proteins.
There is evidence to suggest that binding of pTP-pol 
to the termini occurs prior to unwinding (Rijnders et 
cil, 1983a). However both binding of pTP-pol and unwinding 
must occur before the final stage- transfer of dCMP on to 
pTP by the action of the Ad. DNA polymerase. The transfer 
reaction will not occur in the absence of a template 
suggesting that binding of pTP-pol to the terminal 
nucleo-protein complex enables the polymerase to catalyse 
the transfer of a dCMP residue to the pTP. The formation of 
a pTP-dCMP complex is stimulated by cellular factors 
including NFI and NFIII. This stimulation could occur at any 
of the stages of initiation, although the precise mechanism 
of stimulation is not known. There may be other factors 
involved in initiation: Kelly (personal communication)
suggests that another fraction has to be added to NFI and 
NFIII to attain levels of pTP-dCMP synthesis comparable to 
those seen with crude extracts.
The pTP-dCMP complex then acts as a primer for DNA 
synthesis by the Ad. polymerase. Ad.DBP is known to increase
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the processivity of the polymerase (Lindenbaum et al,1986) 
so it is likely that these two proteins act in concert to 
elongate the nascent strand. None of the other proteins 
known to be involved in Ad. DNA replication possess either 
helicase or DNA-dependent ATPase activities so the DBP and 
the polymerase must also act to unwind the helix. It is not
known whether any of the sequence-specific DNA-binding
proteins are involved in elongation. After synthesis of DNA 
chains approximately 10Kb in length further elongation 
requires the action of eucaryotic topoisomerase I. This 
activity is probably required to relax positive superhelical 
turns generated near the replication fork to allow it's 
translocation (Champoux,1978).
One round of DNA replication results in the 
displacement of a complete single-strand. This strand may 
form a panhandle structure, in which the ITR's associate to 
form a duplex region attached to a single-stranded loop. In 
this case initiation of replication on the displaced strand 
is mechanistically identical to initiation on the fully
duplex genome. In the absence of panhandle formation
initiation must occur on a single-stranded template. 
Presumably initiation on a single-strand would not involve 
sequence—specific DNA-binding proteins as there is no 
precident for the recognition of a specific single—stranded 
DNA sequence by a sequence-specific DNA-binding protein. 
Thus initiation would involve recognition of the terminus of 
a linear, single—stranded DNA molecule. The fact that 
initiation on single-stranded DNA would be relatively 
non-specific argues for the involvement of panhandle 
formation in adenovirus DNA replication.
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1*9 PAPOVAVIRUS DNA REPLICATION IN VITRO
An in vitro system for the cell-free replication of 
exogenously added Simian Virus 40 (SV40) DNA was developed 
by Ariga and Sugano (1983). In the presence of uninfected 
HeLa nuclear extract and SV40-infected Cos-1 cell cytoplasm 
an exogenously added DNA template, either intact SV40 DNA or 
a plasmid containing the SV40 origin region (from map units 
0.67-0.71), was replicated semiconservatively. Li and Kelly
(1984) improved on this system by using a soluble extract of 
whole SV40-infected Cos-1 cells. Their system was more 
active than that of Ariga and Sugano (1983), synthesizing 
320pmoles of DNA/ug of template as opposed to 9pmoles/ug of 
template. Both groups modified the system to include 
uninfected cell extract and purified SV40 large-T antigen 
(T-Ag).
The system was absolutely dependent on the presence of 
T-Ag and the origin region on the DNA template: In the 
absence of T-Ag, or after the addition of anti-T antiserum 
(Ariga & Sugano,1983), only a non-specific repair reaction 
was observed. Templates lacking the SV40 origin, or 
containing a 4b.p. deletion within the origin that abolished 
replication in vivo (Li & Kelly,1984), were not replicated. 
Further experiments (Ariga,1984) showed that the system 
would replicate plasmids containing the human Alu family 
repeat sequences. However Li and Kelly (1985) subsequently 
showed that their system would not use these Alu repeat 
sequences as origins of replication. It would use origins of
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replication isolated from the human papovaviruses BKV and 
JCV at an efficiency of 10-20% of the SV40 origin. In 
addition the reaction required ATP and MgCl2 -
Replication was shown to be semiconservative and to 
proceed bidirectionally from the origin region (Ariga & 
Sugano,1983; Stillman & Gluzman,1985). Stillman and Gluzman
(1985) also found that after replication in the presence of 
BUdR 12% of the products migrated as fully substituted 
heavy-heavy DNA on CsCl gradients, indicating that multiple 
rounds of replication had occurred. The products of the 
reaction in the absence of uninfected nuclear extract were 
relaxed, circular DNA molecules. In the presence of nuclear 
extract these molecules were negatively supercoiled.
SV40 DNA replication in vivo is semidiscontinuous; 
synthesis on the forward strand is continuous whereas 
synthesis on the lagging strand involves the formation of
4-5S Okazaki fragments from heterologous 9-10 nucleotide RNA 
primers (Hay et a l ,1984a). There is no concrete evidence as 
yet for the involvement of RNA primers in SV40 replication 
in vitro. Incubation of extracts with RNase A (Ariga & 
Sugano,1983; Wobbe et a l ,1985) reduced DNA synthesis by 
60-70% but RNase H, which digests the RNA strand of DNA-RNA 
hybrids, had no effect. The effect of RNase A was studied in 
more detail by Wobbe et al (1986). Stillman and Gluzman
(1985) had shown that when HeLa cytosol, T—Ag, SV40 origin 
DNA and dNTP's were incubated there was a lag phase of 
10-20min. before elongation occurred. Wobbe et__al (1986)
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showed that this lag phase could be abolished by incubating 
the components without dNTP’s for 10-30min. Addition of 
RNase A to the pre-elongation mixture inhibited subsequent 
elongation, but RNase A had no effect on the level of dNMP 
incorporation if added directly to the elongation reaction. 
However RNase A did prevent the occurrence of multiple 
rounds of replication.
1:9:1 THE ROLE OF LARGE-T ANTIGEN
Tegtmeyer (1972) first demonstrated that the product 
of SV40 gene A (the tumour or T-antigen) was required for 
DNA replication in vivo. T-antigen (T-Ag) has since been 
shown to be the only virally-encoded protein required for 
DNA replication both in vivo (Tooze,1980) and in vitro 
(Ariga & Sugano,1983; Li & Kelly,1984).
T-Ag is a multi-functional protein required for 
transcriptional control, initiation of DNA replication and 
cellular transformation. The protein binds non-specifically 
to DNA with higher affinity for single-stranded than duplex 
DNA. It also exhibits specific DNA-binding properties, 
binding to three sites located within or adjacent to the 
SV40 origin of replication (Tjian,1978). In vivo it appears 
that part of site I and all of site III are dispensable for 
Initiation of replication (Subramanian & Shenk,1978). Site 
II is a perfect 27b.p. palindrome and together with part of 
site I (which consists of a 17b.p. palindrome and part of a 
15b.p. palindrome) and an A-T rich region adjacent to site 
II constitutes a 65b.p. minimal origin in vivo (Subramanian
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& Shenk,1978; Gutai & Nathans,1978; Myers & Tjian,1980; 
Bergsma et a l ,1982). In addition to these properties T-Ag 
has a DNA-dependent ATPase activity and a recently 
discovered DNA helicase activity (Stahl et al,1986).
Stillman et al (1985) demonstrated that the sequence 
requirements for replication in vitro were the same as those 
in vivo. Sequences to the early side of the 65b.p. minimal 
origin affected the efficiency of replication but were not 
absolutely required whereas sequences on the late side, 
including the three 21b.p. repeats, were not required. 
Stillman et al (1985) also looked at replication in vitro 
with purified mutant T-Ag's. None of the mutants tested had 
any replicative activity, even when they retained the 
wildtype ATPase and origin-binding activities. However they 
would all compete with purified wildtype T-Ag for 
replication. Clearly binding of T-Ag to the origin is not 
sufficient for DNA replication. In this respect T-Ag is 
similar to the Ad.2 72K DNA-binding protein (DBP) (see 
Section 1:5:3). Krevolin and Horwitz (1987) observed that a 
temperature —sensitive mutant in the DBP (ts107) bound to DNA 
like the wildtype protein but was ts for replication. 
Presumably the DNA helicase activity of T—Ag is important in 
DNA replication.
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1:9:2 t h e  ROLE OF THE CELLULAR DNA POLYMERASE
ALPHA:DNA PRIMASE COMPLEX
Studies of SV40 DNA replication in vivo with 
inhibitors implied that cellular polymerase alpha was the 
only polymerase involved (Krokan et a l ,1979). Several lines 
of evidence suggest that this is also the case in vitro: The 
initial experiments (Ariga & Sugano,1983; Li & Kelly,1984) 
showed that replication in vitro was inhibited by 
aphidicolin, an inhibitor of DNA polymerase alpha, and 
N-ethyl-maleimide, an inhibitor of polymerases alpha and 
beta. In contrast ddTTP, an inhibitor of polymerases beta 
and gamma, had no effect on replication. Wobbe et al (1985) 
demonstrated that treatment of extracts with anti-polymerase 
alpha antiserum abolished their replicative ability.
Murakami et al (1986a) purified polymerase alpha 
together with it's tightly associated DNA primase activity 
and showed that both activities were absolutely required for 
SV40 DNA replication in vitro: HeLa cell extracts that were 
depleted of polymerase alpha/primase complex by passage 
through an immuno-affinity column were inactive. This 
activity was restored by the addition of purified polymerase 
alpha/primase complex from either HeLa or Cos-1 cells. These 
cell types are permissive for SV40 replication in vivo. 
However the addition of polymerase/primase complex from 
cells that are non-permissive for SV40 replication (mouse or 
calf thymus) did not restore activity. Mouse cell extracts 
which did not support SV40 DNA replication in vitro, were 
complemented toy complex purified from HeLa cell
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These studies were extended (Murakami et al,1986b) to 
show that in vitro replication of polyoma virus (Py) DNA 
also required the presence of polymerase alpha/primase from 
permissive cells, in this case mouse cells. They also 
demonstrated that Py T-Ag could not function in SV40 DNA 
replication and vice-versa. The fact that both the T-Ag and 
the polymerase alpha/primase complex requirements are 
virus-specific suggests that there is a specific interaction 
between these proteins. These studies show that firstly the 
host-cell polymerase alpha/primase complex is of prime 
importance in papovavirus DNA replication and secondly that 
this enzyme complex is important in determining host-cell 
permissivity.
1:9:3 OTHER HOST-CELL REQUIREMENTS
Wobbe et al (1986) separated the HeLa cytosol required 
for SV40 DNA replication in vitro into two ammonium sulphate 
fractions- 0-40% (AS40) and 40-65% (AS65). AS40 had low
activity that was stimulated 5-fold by AS65, which was by 
itself inactive. No DNA synthesis was detected when both 
fractions were treated with micrococcal nuclease. However if 
one fraction (either AS40 or AS65) was untreated the rate of 
synthesis was undiminished. This suggested that a nucleic 
acid component required for replication was present in both 
fractions.
Ariga (1986) fractionated an uninfected mouse cell 
extract into three components which, in conjunction with 
SV40-infected Cos-1 cell cytosol, would efficiently
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replicate plasmid DNA containing the SV40 origin region. One 
fraction contained the polymerase alpha/primase complex, and 
the second contained a DNA topoisomerase activity. 
Presumably topoisomerase activity is required both for 
unwinding during chain elongation and for segregation of 
progeny molecules. The third fraction contained a 
DNA-binding activity (termed factor I) which bound 
specifically to the SV40 origin. Factor I alone enhanced the 
initiation of replication by SV40-infected Cos-1 cytosol as 
judged by the preponderance of 4-5S Okazaki fragments. 
Full-length synthesis required the addition of both the 
other fractions.
Stillman (personal communication) recently purified a 
36K polypeptide that was required for efficient SV40 DNA 
replication in vitro. The protein sedimented as a dimer, had 
no DNA-binding properties and was highly hydrophobic and 
acidic in nature. He demonstrated that the protein was 
functionally homologous to three other previously identified 
proteins: Cyclin, a cell-cycle regulatory protein not
present in quiescent cells, proliferating cell nuclear 
antigen and the polymerase delta auxiliary protein (see 
Section 1:12:2; Tan et al ,1986) which increases the 
processivity of polymerase delta. This result suggests that 
polymerase delta may have a role to play in SV40 DNA 
replication.
Although the analysis of SV40 DNA replication in vitro 
has yielded valuable information as to the DNA and protein
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requirements there is clearly much work to be done before 
our level of understanding of the system approaches that of 
the Adenovirus system. This knowledge will only be obtained 
by the purification and characterization of all the cellular 
proteins involved.
1:10 {)29 DNA REPLICATION IN VITRO
)^29 is a bacteriophage of Bacillus subtilis. It is 
discussed here because it's mode of replication is 
essentially the same as adenovirus. The genome of the phage 
is a linear, double-stranded DNA molecule of 18Kb. Like 
adenovirus it has a protein covalently linked via a 
phosphodiester bond from a serine residue to a 5'-dAMP, the 
terminal nucleotide of the genome. The protein is the 
product of gene 3 and has an apparent M.W. on SDS-PAGE of 
between 28-31K (Salas et al,1978). 029 has an inverted 
repeat of 6b.p. at each terminus, the sequence of which is 
5'-AAAGTA (Yoshikawa et a l ,1981).
The presence of terminal proteins and inverted
terminal repeats (ITR's) is a common feature to several 
bacteriophage species including the B .subti1is phages 015, 
Nf, M2Y and GAl, Streptococcus pneumoniae phages Cp-1, Cp-5 
and Cp—7, and an E .coli phage PRDl (Escarmis et al,1985). In
addition the linear plasmid pSLA2 from Streptomyces rochai
and the linear mitochondrial DNA's Si and S2 from 
cytoplasmic male-sterile maize share these features. The 
lengths; of the ITR's vary from 6b.p. in 029 to 614b.p. in
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pSLA2. The sequence AAAGTA is also we 11-conserved between 
the phages and the mitochondrial DNA termini (Escarmis et 
al,1985)
1:10:1 INITIATION OF #29 DNA REPLICATION
Initiation of 029 DNA replication involves a
protein-priming mechanism analogous to that seen in the
(
adenovirus system. Incubation of 029-infected B.subtilis 
celjl extracts with («32p)dATP reSults in the transfer of 
dAMP to the terminal protein p3, this complex is then 
detected by SDS-PAGE and autoradiography (Penalva & 
Salas,1982). In the presence of dTTP, dGTP and ddCTP the 
p3-dAMP complex was elongated to the first C residue in the 
sequence:9b.p. from the left end or 12b.p. from the right 
end of the genome. The reaction required Mg2+, ATP and the 
presence of 029 DNA-p3 complex, deproteinized DNA was not 
active (Penalva & Salas,1982). Garcia et al (1984) showed 
that purified terminal restriction fragments of the DNA-p3 
complex would support initiation provided that they were at 
least 26b.p. in length. A fragment of 10b.p. was inactive, 
although activity could be restored by ligation of an 
unspecified sequence, suggesting a topological requirement 
for a longer DNA fragment rather than a specific sequence 
requirement. Crude extracts would not support the formation 
of complex on protein—free templates, however the subsequent 
use of purified proteins (see Section 1:10:2) (Gutierrez et_ 
al,1986) overcame this problem.
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1:10:2 THE PROTEIN REQUIREMENTS FOR 029 DNA
REPLICATION
The 029 genes 2, 3, 5, 6 and 17 have been implicated 
in viral DNA replication in vivo by genetic analysis 
(Salas,1983). However as yet only the products of genes 2, 3 
and 6 have been shown to be involved in replication in 
vitro: As mentioned previously the product of gene 3 is the 
28-31K terminal protein p3. Extracts from B.subtilis 
infected with a gene 3 mutant sus3 did not support p3-dAMP 
formation indicating the absolute requirement for p3 in 
replication.
The product of gene 2 is a 68K DNA polymerase (p2) 
which was shown to be absolutely required for initiation of 
replication in vitro (Blanco & Salas, 1984; Watabe et_ 
a_l, 1984). p2 and p3 copurify through a phosphocellulose 
column and on a glycerol gradient but appear to dissociate 
on a dnDNA cellulose column (Watabe et al,1984). This 
suggests that the terminal protein and the polymerase are 
associated but not so intimately as the corresponding 
adenovirus proteins. As in the adenovirus system the 
terminal protein (p3) and the polymerase (p2) are sufficient 
to catalyse initiation (Watabe et al,1984; Blanco & 
Salas,1984; Gutierrez et al,1986). This reaction was 
strongly stimulated by the presence of an extract from 
uninfected B .subtilis or E.coli cells (Blanco & Salas,1984), 
suggesting that, as for adenovirus, host factors are 
required for efficisnt initiation. Unlike initiation with 
crude extracts (Penalva & Salas,1982) ATP was not required
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and in fact was inhibitory (Blanco & 53138,1985), Mg2+ was 
still required.
Unlike the adenovirus system p2 and p3 were sufficient 
to produce full-length 029 DNA, no topoisomerase activity 
was required (Blanco & Salas,1985). However the rate of 
elongation was low, suggesting that host factors might be 
required for efficient elongation. Unusually ATP was not 
required for the elongation reaction.
Pastrana et al (1985) demonstrated that the purified 
product of gene 6 stimulated initiation in vitro up to
5-fold. Their preliminary results suggested that p 6 was a 
single-stranded DNA binding protein. In vivo experiments 
with a t_s mutant in gene 6 suggested that it was involved in 
elongation. If this is the case p 6 would appear to be
analogous to the adenovirus 72K DBP which stimulates both 
initiation and elongation.
The question of whether the mechanisms of 029 and 
adenovirus DNA replication are completely analogous will 
only be answered when both systems have been completely 
reconstituted from purified proteins. Clearly both viruses 
require host cell factors for efficient initiation and 
elongation, It seems likely that these host factors will
have similar functions given the striking similarities 
between the two replication systems observed so far. The 
existence of both procaryotic and eucaryotic viruses that 
utilize this unusual mode of DNA replication implies a form
of divergent evolution.
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1 : 1 1  INITIATION OF ESCHERICHIA COLI CHROMOSOMAL
DNA REPLICATION
The replication of the Escherichia coli (E.coli) 
chromosome has been extensively studied over the last 2 0  
years mainly by the group of Kornberg at Stanford
University. Initiation of DNA replication takes place at a 
single site on the chromosome between map units 82 and 83 
(Yasuda & Hirota,1977) termed oriC. OriC has been defined as 
a 245b.p. region (Oka et al ,1980) consisting of two types of 
sequence elements (Asada et_a_l, 1982) ; repeated sequences 
constituting protein binding sites and spacer sequences 
serving to position the binding sites correctly. Tabata et_ 
al (1983) demonstrated that although oriC provides all the 
sequence requirements for initiation, DNA replication 
initiates at a site adjacent to or iC and proceeds
bi-directionally.
Baker et al (1986) showed that initiation is a 
multi-step process that starts with the formation of a 
pre—priming complex. This complex consists of or iC DNA and 
the products of genes dnaA, dnaB and dnaC. The reaction
requires ATP and Mg2"*- and is stimulated by the presence of
the protein HU- a double-stranded DNA-binding protein. The 
oriC sequence must be present on a supercoiled molecule 
(Funnell et al,1986), relaxed molecules are only active when 
treated with gyrase. DnaA was shown to be a site—specific 
DNA-binding protein which bound to a 9b.p. ‘dnaA box', 
present throughout the genome with 4 copies located in or_iC.
67
DNase I protection experiments (Fuller et al,1984) 
demonstrated that dnaA binding to oriC is highly 
co-operative; 20-30 protein molecules bind and protect 
250b.p. from DNase I digestion. The dnaB and dnaC proteins 
interact to form a complex consisting of 6 dnaC molecules 
and one dnaB hexamer (Kobori & Kornberg,1982). This then
interacts with the dnaA-oriC complex to form the complete 
pre-priming complex.
The next stage in initiation involves the unwinding of
the DNA at oriC (Baker et a l ,1986). This requires the
presence of the gyrase protein (a Type I topoisomerase) and 
SSB (the E.coli single-stranded DNA binding protein). In 
addition unwinding is dependent on a DNA helicase activity 
which is supplied by dnaB. Replication on the pre-primed 
template is initiated by the synthesis of a short RNA 
primer. Priming is mediated by either the primase, RNA 
polymerase or a combination of the two proteins (Ogawa et_ 
ad,1985; van der Ende et a l ,1985). At low levels of the 
auxiliary proteins HU, RNase H and topoisomerase I (which 
act as specificity factors by inhibiting DNA synthesis that 
is not dependent on dnaA and oriC) primase alone could prime 
the template. However in the presence of high levels of 
these proteins primase alone is inactive and the addition of 
RNA polymerase is required for efficient priming. RNA
polymerase would prime but only at very low efficiency. 
Priming is dependent on intact pre—priming complex; oriC D N A  
that has been pre—primed and then deproteinized does not 
support priming and subsequent elongation.
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Elongation is performed by DNA polymerase III 
holoenzyme, a large and complex multi-subunit enzyme. 
Addition of this enzyme and dNTP1s results in a burst of DNA 
synthesis, the rate of which slowly declines (Funnell et 
al,1986). In addition to the holoenzyme dnaB, dnaC and 
gyrase are required for elongation. Funnell et al (1986) 
also showed that the production of complete daughter 
molecules requires the action of DNA polymerase I and 
ligase. This process is stimulated by RNase H. The combined 
action of these three enzymes results in the excision of 
primers, filling in and ligation of the DNA strands to 
produce covalently closed circles, which are then 
supercoiled by the gyrase present throughout the reaction.
1:12 EUCARYOTIC DNA POLYMERASES
In this section I wish to briefly describe the various 
eucaryotic DNA polymerases that have so far been identified. 
I shall deal only with the DNA-dependent DNA polymerases, 
the RNA-dependent DNA polymerases (reverse transcriptases) 
encoded by the retroviruses will not be discussed.
1:12:1 OTHER VIRUS-CODED DNA POLYMERASES
Apart from adenoviruses there are several other DNA 
viruses with large genomes that encode, or induce in 
infected cells, an unique DNA polymerase. These include 
poxviruses, herpesviruses and baculoviruses. In addition the 
Dane particle of Hepatitis B virus and the Killham Rat 
parvovirus particle contain an endogenous DNA polymerase
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activity that differs from the cellular DNA polymerases.
Poxvirus specific DNA polymerase activity was first 
demonstrated by Jungwirth and Joklik (1965) who detected an 
altered and enhanced DNA polymerase activity in HeLa cells 
after infection with vaccinia virus. The vaccinia virus
specific enzyme was purified to homogeneity by Challberg and 
Englund (1979a) and consisted of a single polypeptide of 
apparent M.W. 110-115K. In common with other viral and 
procaryotic DNA polymerases it co-purified with a 3'-5' 
exonuclease activity which was most active on 
single-stranded DNA. The DNA polymerase activity required a 
divalent cation and was inhibited by aphidicolin, sodium
chloride and N-ethylmaleimide. Maximal activity was observed 
on gapped duplex (activated) DNA, as is the case for the Ad.
DNA polymerase. However the vaccinia enzyme would also
elongate on a primed single-stranded DNA template, albeit 
inefficiently. Elongation was impeded by the presence of 
hairpin loops (Challberg & Englund,1979b).
Keir et al (1966) showed that there were alterations 
in cellular DNA polymerase activity after infection with 
herpes simplex virus (HSV). HSV DNA polymerase activity was 
separated from other viral proteins by Powell and Purifoy 
(1977). The major component of the purified DNA polymerase 
fraction was a polypeptide of apparent M.W. 150K. In 
addition there was a minor polypeptide of 54K. The DNA 
polymerase activity was inhibited by aphidicolin, 
phosphonoacetic acid and anti-serum to HSV-infected cells
70
but, unlike the other viral DNA polymerases discussed had 
optimal activity at high salt concentrations (75-150mM). 
Knopf (1979) showed that in common with the other viral DNA 
polymerases HSV DNA polymerase co-purified with a 3'-5* 
exonuclease activity. All members of the herpesvirus group 
have subsequently been shown to encode their own DNA 
polymerases (Weissbach,1979).
DNA polymerase activity is also stimulated in 
baculovirus infected cells although as yet this activity has 
not been shown to be virus coded (Kelly,1981). An infected 
cell specific DNA polymerase activity was purified (Wang & 
Kelly,1983) and shown to consist of a single polypeptide 
with apparent M.W. 126K. The activity was inhibited by 
aphidicolin and bromovinyl-deoxyuridine triphosphate (BVdU 
triphosphate) but not by BVdU. The authors did not look for 
exonuclease activity in the study.
In addition to these DNA viruses with large genomes 
the core of the Hepatitis B virus (HBV) Dane particle 
contains an associated DNA polymerase activity 
(Feitelson,1985) . It is not known yet whether this DNA 
polymerase is virus or host-cell coded, however there is an 
open—reading frame on the 3.2Kb Dane particle DNA molecule 
which has the capacity to encode a 90K polypeptide, the 
approximate size of the DNA polymerase molecule. There is 
only one other example of the association of a specific DNA 
polymerase activity with a DNA virus possessing a small 
genome; Particles of the Killham Rat parvovirus were
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reported to contain an endogenous DNA polymerase activity 
(Salzman,1971; Salzman et al,1978). However this finding has 
not been repeated and DNA polymerase activity has not been 
found in association with any other parvoviruses (Bates et 
al,1976) suggesting that this result was due to 
contamination with a cellular DNA polymerase.
It seems a reasonable assumption that viruses with 
small genomes will have to rely on host—cell functions to a 
much greater extent than those with larger genomes. Thus DNA 
viruses of small genome size are likely to use host-cell 
polymerases for replication of their genomes, as has been 
shown to be the case for papovaviruses both in vivo (Krokan 
et a l ,1979) and in vitro (Murakami et al ,1986). If HBV is 
shown to encode it's own DNA polymerase it will be unique 
amongst small DNA viruses. Conversely it is highly probable 
that the baculovirus induced DNA polymerase will be shown to 
be virus—coded, given the large size of the baculovirus 
genome (130Kb.: Guarino & Summers,1986).
1:12:2 CELLULAR DNA POLYMERASES
It is now accepted that there are four different 
classes of cellular DNA polymerases: alpha, beta, gamma and 
delta (Kornberg, 1982) . They can be distinguished by means of 
four different criteria (Weissbach,1977); sensitivity to 
various inhibitors, selectivity in template usage, 
chromatographic properties, molecular weight and more 
recently by the use of monoclonal antibodies.
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DNA POLYMERASE ALPHA: DNA polymerase alpha is the principal 
enzyme involved in eucaryotic chromosomal replication 
(Kornberg,1982; Hubscher,1984). It is ubiquitously present 
in the nuclei of actively growing cells in many species 
ranging from humans to yeast (Weissbach,1977) and comprises 
up to 90% of the intracellular DNA polymerase activity. As 
with it's procaryotic counterpart DNA polymerase III, DNA 
polymerase alpha exists as a multi—subunit holoenzyme 
(Hubscher,1984). The polymerizing subunit has an apparent 
M.W. of between 110-185K, depending on the species. In 
Drosophila melanogaster (the best characterized holoenzyme) 
the polymerizing subunit is 182K and is termed the alpha 
subunit. In addition the Drosophila holoenzyme has two other 
subunits- beta and gamma- of M.W.'s 60K and 50K.
Apart from the polymerizing subunit the holoenzyme 
contains a primase activity (Conaway & Lehman,1982) capable 
of synthesizing the short RNA fragments required to initiate 
DNA synthesis on the discontinuous (lagging) strand. In 
Drosophila the primase activity appears to be part of the 
beta and gamma subunits whereas in calf thymus both DNA 
polymerase and primase activities locate on a single subunit 
(Hubscher,1984) .
DNA POLYMERASE BETA; DNA polymerase beta is a low molecular 
weight DNA polymerase that is the predominant activity in 
quiescent or GQ_phase cells (Weissbach,1977), whose main 
function appears to be DNA repair (Hubscher,1984). The 
mammalian enzyme is a single polypeptide of 45K apparent
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M.W. whereas the avian enzyme is present as a 27K form in 
the cytoplasm and a 50K dimer in the nucleus 
(Weissbach,1977). This dimerization m a y  be involved in 
activation of the enzyme.
DNA POLYMERASE GAMMA: DNA polymerase gamma is associated
with mitochondrial DNA replication (Hubscher,1984). Multiple 
forms of the enzyme exist, with reported M.W.'s from 
100K—300K. Unlike the other cellular DNA polymerases gamma 
will copy synthetic ribohomopolymers such as poly(A). 
However it will not copy natural RNA and is not inhibited by 
antibodies to viral reverse transcriptases, suggesting that 
there is little if any structural or evolutionary 
relationship between these enzymes.
DNA POLYMERASE DELTA: DNA polymerase delta was the last
cellular DNA polymerase to be discovered and is the only one 
to possess a 3 '-5 ' exonuclease or 'proof-reading' activity 
(Byrne et a l ,1976), in common with most procaryotic and 
viral DNA polymerases. The core enzyme has an apparent M.W. 
of 173K and consists of two subunits of 125K and 48K (Lee et 
al,1984). Recently two high M.W. forms of DNA polymerase 
delta (240K and 290K) which also possess primase activity 
have been discovered (Crute et al,1986). In addition a DNA 
polymerase delta auxiliary protein has recently been 
characterized (Tan et al , 1986). This protein is a dimer of 
3 7 k subunits which has no detectable enzymatic activity 
itself but increases the ability of DNA polymerase delta to 
copy primed single-stranded templates by 1 0 0 - 1 0 0 0
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fold. It has no effect on the ability of DNA polymerase 
delta to copy gapped duplex DNA. Tan et al (1986) showed 
that although the auxiliary protein does not bind to DNA it 
increases the affinity of DNA polymerase delta for 
poly(dA)/oligo(dT).
MATERIALS
AND
METHODS
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2:1 VIRUS STOCKS
One Adenovirus serotype was used in this study. 
Adenovirus type 4 was originally obtained from W.C.Russell 
(St.Andrews) and consisted of a stock freeze-dried by 
M.R.Hilleman in 1957. The stock used in these experiments 
had been taken through 2 rounds of plaque purification 
before large scale production.
2:2 CELLS
The 293 cell line (Graham et al,1977) was used to 
prepare and titrate virus stocks. Nuclear and cytoplasmic 
extracts were made from the Hela WS cell line.
2:3 TISSUE CULTURE MEDIUM
Cells were cultured in Glasgow-modified Eagles medium 
supplemented with 100 units/ml of penicillin, lOOug/ml of 
streptomycin, 0.002% (w/v) phenol red and either 5% (Hela WS 
cells) or 10% (293 cells) foetal calf serum. All components 
were obtained from Gibco Ltd., Trident House, Renfrew Road, 
Paisley, PA3 4EF, Scotland.
2:4 BACTERIAL HOSTS FOR THE PROPAGATION OF 
PLASMIDS AND BACTERIOPHAGE M13mpl8
All plasmids used in this study were propagated in the 
E.coli K12 strains DH1 (F~, recAl, endAl, gyrA96, thi-1, 
hsdR17 [rK-,mK+], supE44, A-; Maniatis et_al,1982) and C600
(F“ , thi-1, thr-1, leuB6 , tonA21, supE44, A -7 Maniatis et 
al,1982) .
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Bacteriophage M13mpl8 was propagated in E.coli K12 
strain JM101 (lacprodel, supE thi, F ’traD36, proAB, laclq, 
ZMl5de^; Messing,1979).
2:5 BACTERIAL CULTURE MEDIUM
Bacteria were propagated in Luria Broth (LB) : 10g/l 
Difco bacto-peptone and 5g/l yeast extract in 177mM NaCl pH 
7.5 prior to sterilization. Agar plate cultures contained LB 
supplemented with 1.5% agarose. Culture media were 
supplemented where appropriate with lOOug/ml ampicillin.
2 : 6  BUFFER SOLUTIONS
The following buffers were routinely used:
TE: lOmM Tris/HCl pH 8 , ImM EDTA.
TEN: lOmM Tris/HCl pH8.3, ImM EDTA, lOOmM NaCl.
T B E : 89mM Tris/HCl pH 8 , 89mM Boric acid, ImM EDTA. 
Running Buffer: 6.32g/l Tris, 4g/l Glycine, lg/l SDS. 
Resolving Gel Buffer: 1.5M Tris, 0.4% SDS, pH 8.9.
Stacking Gel Buffer: 0.42M Tris, 0.4% SDS, pH6.7.
Gel Fix: 47:47:6 Methanol -.Water :Glac ial Acetic Acid. 
Hypotonic Buffer: 20mM Hepes/KOH pH7.5, 5mM KC1, 0.5mM 
MgCl2 , 0.5mM DTT.
Nuclear Resuspension Buffer: lOmM Tris/HCl pH7.5, 
1 0 %(w/v) sucrose.
Tris/Saline: 140mM NaCl, 30mM KC1, 0.28mM Na 2HP0 4 , 
lmg/ml dextrose, 25mM Tris/HCl PH7.4, 0.0015% phenol 
red, supplemented by lOOunits/ml penicillin, lOOug/ml 
streptomyc in.
Buffer A: 25mM Tris/HCl PH7.5, ImM DTT, ImM EDTA, 20% 
glycerol, 0.01% Nonidet P-40.
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2:7 RESTRICTION ENDONUCLEASES
All restriction endonucleases were obtained either 
from Northumbria Biologicals Ltd. or Boehringer Mannheim, 
Ltd. and used as specified by the manufacturers.
2:8 REAGENTS
Reagents were obtained from the following sources: 
Sigma Ltd., Fancy Road, Poole, Dorset, BH17 7NH, 
England:
Agarose, aphidicolin,
N-2-Hydroxyethylpiperizine-N'-2-ethanesulphonic acid 
(Hepes), Gelatin, Lysozyme, Dithiothreitol (DTT), 
Dimethylsulphoxide (DMSO), ara-CTP, dideoxythymidine 
triphosphate (ddTTP), dideoxyguanidine triphosphate (ddGTP), 
all four deoxynucleoside triphosphates (dNTP's), 
Phenylmethylsulphonylfluoride (PMSF), Ethidium bromide, 
Hydroxyurea.
Koch-Light Ltd., Haverhill, Suffolk, England: 
Acrylamide, Boric acid, Dimethylsulphoxide (DMSO), 
Glycerol, Trichloro-acetic acid (TCA), Tetra-sodium 
pyro-phosphate, Caesium chloride.
May & Baker Ltd., Dagenham, Essex, England:
Glacial acetic acid, chloroform, concentrated 
hydrochloric acid.
Boehringer Corporation Ltd., Bell Lane, Lewes, East 
Sussex, England:
Tr is(hydroxymethyl)aminomethane (Tris).
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Biorad, Richmond, California:
Ammonium persulphate (APS), Coomassie Brilliant Blue
R250.
James Burroughs Ltd., 70 Eastways Industrial Park,
Witham, Essex, England.
Absolute Ethanol.
All other reagents were of Analar grade and were 
obtained from BDH Chemicals Ltd., Broom Road, Poole, Dorset, 
BH12 4NN.
2:9 VIRUS PURIFICATION
293 cells in 80oz roller bottles were infected with 10
pfu/cell of virus in a volume of 5ml Tris/Saline
supplemented with 2% calf serum per roller bottle. Virus was 
adsorbed for 90min. at 37°c and 1 0 0 ml of medium with 2 % calf 
serum was added per bottle. Cells were incubated at 37°c 
until complete CPE was observed, routinely about 48h. 
post-infection. Cells were shaken into the medium and 
pelleted by centrifugation at 2000rpm for lOmin. in an MSE
Coolspin centrifuge. The cell pellet was washed once in
Tris/Saline ,repelleted and resuspended in 1ml Tris/Saline 
per roller bottle .
The cell suspension was frozen and thawed 3 times and 
virus was extracted by shaking with an equal volume of 
Arcton equilibrated with Tris/Saline. The aqueous phase was 
recovered, layered on top of a discontinuous
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glycerol/caesium chloride gradient (2ml 40% glycerol in lOmM 
Tris/HCl pH7.9, ImM EDTA, 3ml 0.32g/ml CsC1 in lOmM Tris/HCl 
PH7.9, 2ml 0.418g/ml CsCl in lOmM Tris/HCl pH7.9) and
centrifuged for 90min. at 25000rpm and 4 ° c  in a Sorvall 
Tst-41 rotor. The lower opalescent virus band was recovered 
by bottom puncture, dialysed overnight against 41 TE, and an 
equal volume of sterile glycerol was added. Virus stocks 
were stored at - 2 0 °c.
2:10 PREPARATION OF VIRAL CORES
An aliquot (50 ul) of banded and dialysed virions was 
treated with 0.5% sodium deoxycholate (DOC) for 45sec. at 
56°c and cooled on ice for 2-3 min. The DOC treated virions 
were layered on top of a 4ml 15% -60% glycerol gradient and 
centrifuged for 90min. at 30,000rpm at 4°c (Goding & 
Russell,1983). Glycerol gradients were prepared as step 
gradients using 15%, 30%, 45% and 60% glycerol solutions in 
5mM Tris/HCl pH7.8 and allowed to stand at room temperature 
for 4h . prior to use. 0 .5ml fractions were collected from 
the bottom of the tube and core containing fractions 
identified by measuring absorbance at 260nm and 280nm. 
Aliquots of each fraction were treated with Proteinase K 
(100 ug/ml) and 0.5% SDS for 2h/37°C and analysed by agarose 
gel electrophoresis for the presence of adenovirus genomic 
length DNA. Core containing fractions were stored at 4°C and 
were stable for up to 2 months.
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2=11 PREPARATION OF VIRAL DNA-PROTEIN COMPLEX
An aliquot (250 ul) of banded and dialysed virions was 
incubated for 5min. on ice with an equal volume of 8 M 
Guanidinium Hydrochloride (GuHCl) in the presence of 0.5mM 
PMSF. Treated virions were then loaded on to a 10ml column 
of Sepharose 4B equilibrated with TEN containing 4M GuHCl. 
The column was developed with TEN containing 4M GuHCl and 
0.5ml fractions were collected. Fractions containing 
DNA-prote in complex were identified by measuring absorbance 
at 260nm., pooled and dialysed against TE. An equal volume 
of glycerol was added and they were stored at -20°C.
2:12 PREPARATION OF VIRAL DNA
Banded virions dialysed against TE were treated with 
lOOug/ml Proteinase K in the presence of 0.25% SDS for 2h. 
at 55°c. The viral DNA was extracted once with an equal 
volume of a 1 : 1  mixture of phenol/chloroform, once with an 
equal volume of chloroform and concentrated by ethanol 
precipitation. For long-term storage viral DNA was kept as 
an ethanol precipitate at -20°C, otherwise it was 
resuspended in sterile TE and stored at 4°c.
2:13 PREPARATION OF SUPERCOILED PLASMID DNA
Bacteria transformed with the appropriate plasmid were 
grown to saturation in 350ml cultures of LB supplemented 
with lOOug/ml of ampicillin. The cells were pelleted by 
centrifugation at 6000rpm for 5min. in a Sorvall GS3 rotor. 
Cells were resuspended in 5ml of 25% (w/v) sucrose, 50mM 
Tris/HCl pH 8 and 1ml of a freshly prepared 2 0 mg/ml solution
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of lysozyme in 0.25M Tris/HCl pH 8 was added. The cells were 
incubated on ice for 5min., 1ml of 0.5M EDTA was added, 
followed by a further 5min. incubation on ice. 8 ml of a 
solution containing 0.2% (v/v) Triton-X 100, 50mM Tris/HCl 
pH8 , 62.5mM EDTA was rapidly added and the tube contents 
mixed by inversion. After incubation on ice for 15min. the 
mixture was centrifuged for 30min. at 20,000rpm., 0°c in a 
Sorvall SS34 rotor.
lg of caesium chloride (CsCl) per ml of supernatant 
and 0.8ml of a lOmg/ml solution of ethidium bromide (EtBr) 
was added and the solution was centrifuged at 45,000rpm. for 
20h. at 20°c in a Dupont TV850 rotor. The band of 
supercoiled plasmid DNA was recovered using an 18G needle 
and recentrifuged at 40,000rpm. in a Dupont TV865 rotor. 
Supercoiled plasmid DNA was separated from unbound EtBr and 
CsCl by gel filtration through a column of Sepharose 4B CL. 
Bound EtBr was removed by ion exchange chromatography 
through a column of Dowex AG50W. The DNA was ethanol 
precipitated, resuspended in TE and treated with 50ug/ml 
RNase A for 30min. at 37°c, followed by treatment with 
lOOug/ml Proteinase K for 60min. at 55°C in the presence of 
0.25% SDS. The DNA was extracted once with an equal volume 
of a 1 : 1 mixture of phenol:chloroform, once with an equal 
volume of chloroform and ethanol precipitated. Following 
resuspension in TE the DNA concentration was determined by 
spectroscopy and the DNA was stored at 4 0 ^  For long term 
storage DNA was stored at -20c>c as an ethanol precipitate.
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2: 14 PREPARATION OF NUCLEAR AND CYTOPLASMIC EXTRACTS 
OF INFECTED AND UNINFECTED HeLa CELLS
6-8x10® Hela WS cells in 80oz roller bottles at 
approximately 90% confluence were infected with 30 plaque 
forming units/cell of virus in 5ml Tris/Saline per bottle.
At 2h.p.i. medium containing 2% calf serum and lOmM 
hydroxyurea was added back and the cells were incubated at 
370c. At 22 h .p . i . cells were dislodged by shaking with glass 
beads and collected in Tris/Saline. From this point all 
manipulations were carried out at 4°c.
The cells were pelleted by centrifugation at 2000rpm 
for lOmin. in an MSE Coolspin, washed with 30ml hypotonic 
buffer containing 0.2M sucrose, repelleted and resuspended 
in 1ml. of hypotonic buffer per 10® cells. The cells were 
swollen on ice for lOmin. and then lysed by 15 strokes with 
a tight fitting Dounce homogenizer. The nuclei were pelleted 
by centrifugation at 3000rpm for 5min. and the supernatant 
containing the cytoplasmic fraction was decanted.
The cytoplasm was clarified by centrifugation at 
ISOOOrpm for 30min., adjusted to 0.2M H a d  and applied to a 
10ml column of DEAE-cellulose equilibrated in hypotonic
buffer containing 0.2M HaCl. The column was washed with 20ml
■ . r\ 9M NaCl and the eluate
of hypotonic buffer containing
collected.
The pelleted nuclei were washed twice in 5ml of 10mM 
Tris/HCl pH 7.5. 10% sucrose and resuspended in the same
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buffer to give a total volume of 1ml per 10® cells. NaCl was 
added to give a final concentration of 0.3M and the nuclei 
were extracted by incubation for 60min. The nuclei were 
pelleted by centrifugation at 15000rpm for 30min., the 
supernatant was adjusted to 0.2M NaCl and applied to a 10ml 
column of DEAE-cellulose equilibrated in lOmM Tris/HCl 
pH 7 . 5, 10% sucrose, 0.2M NaCl. The column was washed with
2 0 ml of the same buffer and the eluate collected.
Solid ammonium sulphate was added to the column 
eluates to give 70% saturation and after 15min. incubation 
the precipitates were pelleted by centrifugation at lOOOOrpm 
for lOmin. The precipitates were resuspended in 2ml of 
either hypotonic buffer (cytoplasmic extract) or lOmM 
Tris/HCl p H 7.5# 10% sucrose (nuclear extract), dialysed
overnight against 11 of the appropriate buffer, aliquoted 
and stored at -70 C. Extracts were stable for at least 6 
months at this temperature.
2:15 IN VITRO ASSAY FOR DNA POLYMERASE ACTIVITY
Polymerase activity in vitro was determined by
measuring the incorporation of radio-labelled
deoxyribonucleotides into acid-precipitatible radio-activity 
using as a template salmon sperm DNA treated with pancreatic 
DNase I to introduce single-stranded nicks and gaps 
(activated DNA).
Enzyme fractions (2-5 ul) were incubated in a 50ul 
reaction mixture containing 50mM Tris/HCl pH 7.8, 7mM MgCl2(
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lOmM DTT, 20uM dGTP, dTTP, dCTP, 4uM dATP, 0.5-2.0uCi 
(«3 2 P)dATP (specific activity 3000Cj/mmole) and 0.2ug/ul 
activated DNA for 60min. at 370c . Reactions were stopped by 
the addition of 5ml. of ice-cold 1 0 % tri-chloro-acetic acid 
(TCA) containing 0.5% tetrasodium-pyrophosphate. After 
15min. incubation on ice the mixtures were filtered under 
vacuum through glass-fibre discs (Whatman GF-C). The discs 
were washed twice with 5ml. 10% TCA containing 0.5% 
pyrophosphate, twice with 5% TCA and once with 5ml. 95% 
ethanol. After air drying the discs were placed in 
scintillation vials and 4ml. of Ecoscint (Nuclear Medical 
Electronic Services) was added. Sample radioactivity was 
determined by counting beta emissions in an Intertechnique 
SL4000 liquid scintiHat ion counter.
2 : 1 6  IN VITRO ASSAY FOR THE FORMATION OF AN
80,000 MOLECULAR WEIGHT COMPLEX BETWEEN THE 
PRE-TERMINAL PROTEIN AND 5 ’dCMP
1 - 5  ul of the appropriate extracts were incubated in a 
30ul reaction mixture containing 25mM Tris/HCl pH 8 , 3mM 
MgCl2 , 2mM DTT, 3mM ATP, 3uC-[ (&c3 2 p)dCTP (specific activity 
3000C^/mmole) and varying amounts of template DNA for 60min. 
at 37°c. Reactions were stopped by heating at 70°C for 5min. 
and treated with micrococcal nuclease (20U/ml) in the 
presence of 2mM CaCl 2 for a further 30min. at 37°C. 12ul of 
boiling mix were added and the samples were heated at 100°C 
for 2min. Reaction products were separated on a 10% 
SDS-polyacrylamide gal with a 5% spacer gel for 3-4h. at
45mA at 4 o c .
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The gels were fixed in 47:47:6 methanol:water:glacial 
acetic acid for 30min., dried under vacuum and 
autoradiographed on Kodak XS film routinely for 15h. at 
-70°C using a Dupont Cronex intensifying screen. Bands 
corresponding to the 80K pTP-dCMP complex were cut out of
the gel and radioactivity determined by scintillation
count ing .
2:17 IN VITRO ASSAY FOR THE FORMATION OF AN ELONGATED 
PRE-TERMINAL PROTEIN-3Qmer COMPLEX
The assay system was identical to that for the 
formation of the pTP-dCMP complex except that 50uM dATP,
50uM dTTP and 20uM ddGTP were added to the reaction 
mixtures. In addition, the reaction products were not
treated with micrococcal nuclease.
2:18 QUANTITATION OF DNA
DNA concentrations were determined by measuring the 
absorbance of samples at 260nm. in a Cecil
spectrophotometer. 1 A 2 6 O unit was taken to be equivalent to 
50ug of double—stranded DNA or 20ug of single-stranded 
oligonucleotide. Concentrations were double-checked by 
separating DNA samples on agarose or polyacrylamide gels 
containing 0.5ug/ml. ethidium bromide and comparing the 
intensity of the fluorescence with that of known standards.
2:19 QUANTITATION OF PROTEIN
Protein concentrations were determined by the method
of Bradford (1976). Protein samples in a total volume of
86
80ul were mixed with lm]. of Bradford reagent (lOOmg 
Coomassie Brilliant Blue G, 30mg SDS, 50ml 95% (v/v) ethanol 
and 100ml 85% (v/v) phosphoric acid made up to 11. with
distilled water), incubated at room temperature for 15min. 
and the absorbance at 595nm. measured. Concentrations were 
calculated by comparison with a standard curve constructed 
using bovine serum albumin (Sigma).
2:20 AGAROSE GEL ELECTROPHORESIS
Gel slabs (265mm x 165mm) containing 0.8% (w/v) 
agarose, lxTBE buffer and 0.5ug/ml ethidium bromide in a 
total volume of 200ml were run at up to 5V/cm at room 
temperature. One tenth volume of dye mix (50% (w/v) sucrose, 
0.2% (w/v) bromophenol blue and lOOmM EDTA) was added to
samples prior to electrophoresis.
2:21 NON-DENATURING POLYACRYLAMIDE GEL 
ELECTROPHORESIS 
Gels were made up to the required acrylamide 
concentration (generally between 6% and 15%) from a 30% 
acrylamide stock (29% acrylamide, 1%
N , N 1-methylene-bis-acrylamide). Gels contained lxTBE buffer, 
and were polymerized by t he addition of 1/250 volume 25% 
(w/v) ammonium persulphate and 1/2000 volume TEMED stock. 
Gels were poured in ImM thick sandwiches sealed with Sylglas 
tape and run at up to lOV/cm. One tenth volume of dye mix 
(50% (v/v) glycerol, 0.2% (w/v) bromophenol blue, 0.2% (w/v) 
xylene cyanol, lOOmM EDTA) was added to the samples prior to 
electrophoresis. After electrophoresis gels were soaked m
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lxTBE containing 0.5ug/ml ethidium bromide for 30min. to 
detect DNA by ultra-violet fluorescence.
2:22 DENATURING POLYACRYLAMIDE GEL ELECTROPHORESIS
10% resolving gels were made up from a 30% acrylamide 
stock as above. Gels contained 0.375M Tris pH 8.9 and 0.1% 
SDS and were polymerized as described above. Gels were cast 
between glass plates separated by 1.5mm thick spacers and 
sealed with Teflon tape. Resolving gels were poured to leave 
room for a 1cm deep stacking gel and overlaid with 
approximately 1ml of butan-2-ol to ensure an even surface 
after polymerization.
Stacking gels contained 5% acrylamide in 0.105M Tris
pH 6.7 and 0.1% SDS. Prior to electrophoresis samples were
denatured by heating at 100°c for 2min. in a solution 
containing 8% (v/v) glycerol, 1.6% (w/v) SDS, 570mM
2-mercapto-ethanol, 33mM Tris pH 6.7 and 0.016% (w/v) 
bromophenol blue. Gels were run at 45mA in a buffer 
containing 52mM Tris, 53mM glycine and 0.1% SDS at 4°c until 
the dye front was 1cm from the bottom of the gel.
Gels were stained by soaking in 47:47:6
methanol:water :glacial acetic acid (fix) containing 0.2% 
(w/v) Coomassie Brilliant Blue R-250 for 60min. Excess stain 
was removed by soaking overnight in fix without the dye. For 
autoradiography gels were dried down under vacuum m  a 
Biorad gel drier and exposed to Kodak XS film at -70oc#
88
2:23 PREPARATION OF DEAE-CELLULOSE COLUMNS
Preswollen DEAE-cellulose (Whatman DE52) was 
resuspended in 6ml/g of 0.2M Tris/HCl pH7.5 and stirred 
gently for 15min. The slurry was allowed to settle for 
15min. and the supernatant containing any fines decanted. 
The ion exchanger was then resuspended in 6ml/g of 20mM
Tris/HCl pH7.5 and allowed to settle for lh. in a measuring 
cylinder. The supernatant was poured off until the final 
volume was the 'wet settled volume' of the ion exchanger 
plus 20%. Columns were poured with this slurry in disposable 
syringes blocked with either glass-wool in the nozzle, or a 
disc of glass-fibre filter paper (Whatman GF/c) at the 
bottom of the barrel. Columns were equilibrated with the 
appropriate buffer until the pH of the eluate was the same 
as that of the input buffer.
RESULTS
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The background to this study into the in vitro 
replication of adenovirus type 4 (Ad.4) DNA was provided in 
experiments performed in this laboratory (Hay,1985b). The 
minimal cis acting DNA sequence requirements for in vivo 
origin of replication function had previously been 
identified for adenovirus type 2 (Ad.2) (Hay,1985a) by 
constructing plasmids containing two inverted copies of Ad 2 
terminal sequences which, when cleaved with EcoRl, would 
release a linear DNA molecule with copies of these sequences 
at each end. These molecules were then co-transfected into 
susceptible cells with wildtype Ad.2 DNA to provide viral 
replication proteins. They were replicated to a high copy 
number provided that they contained a functional origin of 
replication. Using this technique it was shown that the 
terminal 45b.p. of Ad.2 was both necessary and sufficient 
for initiation of DNA replication in vivo (Hay, 1985a).
This region had previously been defined in in vitro 
replication experiments as consisting of two domains (see 
Section 4:5:1). The domain from nucleotides 1-18 could 
support a limited amount of initiation in vitro and 
contained a 10b.p. sequence completely conserved amongst 
human adenoviruses (Stillman et al,1982). The second domain, 
from nucleotides 19-48, enhanced the efficiency of 
initiation in vitro and contained the binding site for the 
cellular protein nuclear factor I (NFI) (see Section 1:6:1). 
Thus the results obtained in vitro and in vivo did not 
entirely agree: in vitro it appeared that the minimal origin 
Of replication for Ad.2 was the terminal 18b.p. and origin
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function was enhanced by the presence of the 19-45b.p.
domain. In vivo both domains were shown to be essential for 
origin function.
The ^n vivo assay was then used to examine the 
sequence requirements for Ad.4 origin function (Hay,1985b). 
It was demonstrated that in vivo Ad.4 only required the 
terminal 18b.p. of the genome and the addition of sequences 
outwith this region did not enhance replication. Ad.4 would 
replicate templates containing either Ad.2 or Ad.4 termini 
with equal efficiency whereas Ad.2 would only efficiently 
replicate homologous templates. Templates containing the 
Ad . 4 ITR were replicated by Ad. 2 at approximately 5% of the 
efficiency of Ad.2 templates, possibly due to the presence 
of a high affinity binding site for the cellular protein 
nuclear factor III (see Section 1:6:3). Sequence analysis 
revealed that the terminal 26b.p. of Ad.2 and Ad.4 were 
identical but that Ad.4 lacked the consensus sequence for 
the NFI binding site. It was concluded that, unlike Ad.2, 
Ad.4 did not require NFI for initiation of replication in 
vivo.
To characterize these differences at the molecular 
level it was decided to study the initiation of Ad.4 DNA 
replication in vitro. Two approaches were used: Firstly the
initiation of Ad.4 replication in vitro by crude extracts of 
infected cells was studied with a view both to defining the 
DNA template and as an assay to purify and characterize the 
viral and cellular proteins involved. Secondly an attempt
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was made to identify the A d .4 pre-terminal 
protein-polymerase (pTP-pol) complex in infected cells and 
define the unique properties of those proteins. A cellular 
factor that enhanced Ad.4 initiation was also identified.
3 :1 TEMPLATE DEPENDENT FORMATION OF A pTP-dCMP COMPLEX 
BY CYTOPLASMIC EXTRACT OF Ad.4 INFECTED CELLS
Initiation of adenovirus DNA replication involves the 
formation of a covalent complex between an 80K precursor 
terminal protein (pTP) and a dCMP residue, the first 
nucleotide at the 5' end of the genome. In adenovirus type 2 
(Ad.2) this reaction is catalysed by the viral DNA 
polymerase which is found tightly associated with the pTP in 
infected cells. The pTP-dCMP complex then acts as a primer 
for DNA synthesis by the viral DNA polymerase. The formation 
of a pTP-dCMP complex in vitro can be assayed by incubating 
infected cell extracts and template DNA with (o(32P)dCTP as 
the only nucleotide. The reaction products are separated by 
SDS-PAGE and an 80,000-dalton (80K) pTP-dCMP complex 
detected by auto-radiography (Lichy et al,1981). Formation 
of a pTP-dCMP complex can be quantitated by cutting out the 
appropriate area of the gel and counting in a liquid 
scintillation counter. Blank values are calculated by 
cutting out 2-3 equivalent areas of the gel not 
corresponding to pTP-dCMP complex and averaging the values
obtained.
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Four double-stranded DNA species were initially used 
as templates for the formation of an 80K pTP-dCMP complex by 
extracts of Ad,4 infected cells. These templates were*
1) A d .4 viral cores consisting of nucleocapsids separated
from the capsomeres by treatment with 0.5% sodium
deoxycholate at 56oc and glycerol gradient centrifugation 
(Russell et a l ,1971; Goding & Russell,1983) .
2) Ad.4 DNA-protein complex (DNA-prot.) consisting of
naked viral DNA covalently attached to the 55K terminal 
protein at the 5'ends. Ad.4 DNA-prot. was made by treatment 
of intact virions with guanidinium hydrochloride followed by 
gel filtration (Goding & Russell,1983).
3) Ad.4 DNA with no attached protein made by treatment of
virions with proteinase K in the presence of SDS, followed 
by extraction with phenol/chloroform and ethanol 
precipitation.
4) A plasmid DNA (p4A2; identical to p4Al;Hay, 1985b) 
containing the terminal 140b.p. of the Ad.4 genome 
linearized with EcoRl such that the terminal Ad.4 sequences 
are located at the end of a linear molecule.
Initially nuclear extracts were made from Ad.4 
infected HeLa cells as described for Ad.2 (Challberg & 
Kelly,1979a) but these extracts did not support detectable
levels of pTP-dCMP complex formation. As described in
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section 3:2:1 cytoplasmic extracts of Ad.4 infected cells 
were therefore used to characterize the system.
Figure 3:1 shows a comparison of the efficiency of 
Ad.4 cores, Ad.4 DNA-prot., Ad.4 DNA and a linearized 
plasmid containing the terminal 140b.p. of Ad.4 (p4A2; 
identical to p4Al, Hay,1985b) to support the formation of a 
pTP-dCMP complex. The reactions contained cytoplasmic 
extract of Ad.4 infected cells (4.2ug of protein) and lOOng 
of DNA, corresponding to 8.3fmoles of terminal sequences for 
cores, DNA-prot. or DNA (2 copies of the terminus per 
molecule) and 56fmoles of terminal sequences for p4A2 (1 
copy per molecule). The results show that on a molar basis 
Ad.4 cores are the most active templates for complex 
formation, between 2-4 times more active than DNA-prot. and 
8 times more active than the linearized plasmid.
It is possible that the nucleocapsid proteins closely
associated with Ad.4 DNA within the core structure play a
part in facilitating initiation. Alternatively the
DNA-terminal protein complex might be in a better condition
after treatment with deoxycholate than after the harsher
treatment with guanidinium hydrochloride. The activity of
the core structure must be highly resistant to denaturation
since t rea tm en t w ith  N -ethyl-m ale im ide or heating to 65°C
for 30min. had no effect on the ability of cores to support
initiation (Figure 3:2). There is clearly a requirement for
double-stranded DNA as exemplified by the fact that nuclease
a b o l i s h  octiv/rty,
treatment (figure 2, tracks 5 and 6 )A**«4 heating to 100oc for
Figure 3:1 Comparison of the ability of various
templates to support complex formation 
by cytoplasmic extract Ad.4 infected 
cells.
lOOng of Ad.4 cores (track 1), Ad.4 DNA-prot. 
(track 2), deproteinized Ad.4 DNA (track 3) or plasmid p4A2 
linearized with EcoRI (track 4) were incubated with lul of 
cytoplasmic extract (4.2ug protein) under the standard 
reaction conditions described in section 2:16: 25mM
Tris/HCl p H 8 , 3mM MgCl2 , 3mM ATP, 2mM D;,'T and 3uCi 
(o(32p )acTP (specific activity 3000C j/mmole) for 60min. at 
37°c. The relative efficiency of complex formation is 
presented along with an autoradiograph of the part of the 
gel containing the pTP-dCMP complex. 80K indicates the 
position of the 80,000 molecular weight pTP-dCMP complex.
1 2 3 4
TRACK TEMPLATE RELATIVE EFFICIENCY
OF COMPLEX FORMATION
1 Ad.4 cores 100%
2 Ad.4 DNA-prot. 50%
3 Ad.4 DNA 25%
4 p4A2/EcoR1 12 5%
Figure 3:2 Effect of various treatments on the
ability of Ad.4 cores to support complex 
format ion.
Prior to assaying for their ability to support 
pTP-dCMP formation under standard conditions lOOng aliquots 
of Ad.4 cores were treated as indicated. N-ethyl-maleimide 
treatment was for 5min. at 4°c followed by the addition of 
DTT to lOmM. Micrococcal nuclease and pancreatic DNase 
treatments were for 60min. at 37°c followed by either the 
addition of EDTA to 20mM or heating to 65°c for lOmin. An 
autoradiograph of the part of the gel containing the 
pTP-dCMP complex is presented. 80K indicates the position of 
the 80,000 molecular weight pTP-dCMP complex.
TREATMENT
NONE
65°C/30min.
100°C/5min.
5mM N-ethyl-maleimide 
Micrococcal nuclease 
Pancreatic DNase
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5min. (figure 2, track 3) doc^d. template activity. In 
addition the ability to support pTP-dCMP complex formation 
is stimulated by the terminal protein.
Although cores were the most active and biologically 
relevant of the templates used in this study they proved to
be unstable and rapidly lost activity on storage. Goding and 
Russell (1983) suggested that A d .2 core preparations 
contained a nuclease activity which might explain the loss 
of activity. In addition the nature of the method for the 
preparation of cores meant that no two core preparations 
were the same, making data comparisons difficult, if not 
invalid. For these reasons the bulk of experiments were 
performed with plasmid templates as these proved to be more 
stable, easier to work with and provided reproducible 
results.
3:2 CHARACTERIZATION OF THE FORMATION OF 
A pTP-dCMP COMPLEX BY EXTRACTS 
OF A d .4-INFECTED HELA CELLS
Unless specifically mentioned all the experiments in 
Section 3:2 were performed using plasmid p4A2 (identical to 
p4Al? Hay,1985b) linearized with EcoRl as template DNA. A 
detailed analysis of the template requirements for complex 
formation is deferred until Section 3:3.
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3:2:1 FORMATION OF A pTP-dCMP COMPLEX IS SUPPORTED BY
BOTH CYTOPLASMIC AND NUCLEAR EXTRACTS OF
Ad.4 INFECTED CELLS
Initially nuclear extracts of Ad.4 infected cells were 
prepared as described for Ad.2 (Challberg & Kelly,1979a). 
However these extracts did not support pTP-dCMP complex 
formation to any detectable levels. It was only when the 
extracts were depleted of nucleic acids by passage through a 
DEAE-cellulose column and concentrated by ammonium sulphate 
precipitation that template dependent pTP-dCMP complex 
formation was observed. Figures 3:3 to 3:5 show the results 
of experiments in which a constant amount of template 
plasmid DNA (0.5ug) was incubated with («X32p)dCTP as the 
only nucleotide in the presence of increasing amounts of 
either cytoplasmic extract of A d .4—infected cells (figures 
3:3 and 3:4) or nuclear extract of A d .4-infected cells 
(figure 3:5) for 60min. at 37°C. Both cytoplasmic and 
nuclear extracts of Ad.4— infected cells supported pTP-dCMP 
complex formation. No pTP-dCMP complex formation was 
observed in reactions containing only uninfected extracts 
(data not shown).
At low protein concentrations (below 0.3mg/ml) the 
amount of pTP-dCMP complex formed by nuclear extract was 
significantly greater than by cytoplasmic extract. This 
could be due to differences in the relative amounts of 
replication proteins present in the cytoplasm and nucleus: 
If a protein required for initiation was more prevalent in 
the nucleus then pTP-dCMP complex formation would be
Figure 3:3 Formation of a pTP-dCMP complex by
cytoplasmic extract of Ad.4 infected cells.
Cytoplasmic extract was prepared from Ad.4 infected 
cells as described in section 2:14. The protein
concentration of the extract was 4.2mg/ml. Assays for the 
formation of a pTP-dCMP complex were performed in the 
presence of 0.5ug plasmid p4A2 linearized with EcoRI and 
increasing amounts of cytoplasmic extract under the standard 
reaction conditions described in section 2:16. Plasmid DNA 
was cleaved with EcoRI, extracted once with an equal volume 
of a 1:1 mixture of phenol:chloroform, once with an equal 
volume of chloroform, ethanol precipitated and resuspended 
in distilled water, prior to the reaction. An autoradiograph 
of the entire gel is presented. The low molecular weight 
bands present are likely to be partial proteolytic 
degradation products of the 80K pTP. The positions of the 
80,000 molecular weight pTP-dCMP complex (80K) and the 
spacer gel (SP) are indicated.
cytoplasmic extract (jjg protein) 
0 21 42 8-4 168 252 336 42
Figure 3:4 Graphical representation of the formation 
of a pTP-dCMP complex by cytoplasmic 
extract of Ad.4 infected cells.
The amount of pTP-dCMP complex formation by varying 
amounts of cytoplasmic extract was quantitated by excising 
the area of the SDS-polyacrylamide gel corresponding to the 
80K pTP-dCMP complex and counting in a liquid scintillation 
counter. The data were converted to femtomoles (fmoles) of 
pTP-dCMP complex formed and plotted against the amount of 
protein present in the reaction. A blank value was obtained 
from track 1 which contained no protein.
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Figure 3:5 Formation of a pTP-dCMP complex by nuclear 
extract of Ad.4 infected cells.
Nuclear extract (protein concentration 4.8mg/ml) was 
prepared from Ad.4 infected HeLa cells as described in
section 2:14. Assays for the formation of a pTP-dCMP complex 
were performed in the presence of 0.5ug of plasmid p4A2 
linearized with EcoRI and increasing amounts of nuclear 
extract under standard reactions conditions (as described in 
section 2:16). An autoradiograph of the part of the gel 
containing the pTP-dCMP complex, together with a graphical 
representation of the data, is presented. 80K indicates the 
position of the 80,000 molecular weight pTP-dCMP complex.
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expected to occur more readily at low concentrations of 
nuclear protein than cytoplasmic protein. However at protein 
concentrations above 0.3mg/ml the amount of pTP-dCMP complex 
formation by nuclear extract declines, whereas the activity 
of cytoplasmic extract continues to increase up to 1.4mg/ml, 
the highest concentration tested. Clearly an inhibitor 
which exhibits maximal activity at high protein 
concentrations is present in the nucleus. The apparent
levelling off of pTP-dCMP complex formation at high
concentrations of cytoplasmic protein could be due to
saturation of the active template molecules in the reaction 
mixture: although 230 fmoles of template DNA was present in 
each reaction a maximum of 1.16 fmoles of complex was formed 
in 60min., a figure comparable to that obtained with Ad.2 
under optimal conditions.
The inhibitory activity observed in the nuclear 
extract could be due to one of many factors. It is unlikely 
to be due to low molecular weight molecules because the 
extract was extensively dialysed after ammonium sulphate 
precipitation. Two possibilities are nuclease or protease 
activity. Protease activity would inhibit the reaction in 
two ways- by degrading the pTP-pol complex and other 
replication proteins and also by degrading any pTP-dCMP 
complex formed in the reaction. In contrast a nuclease would 
only act by degrading template DNA - pTP-dCMP complex is 
resistant to nucleolytic attack (see Figure 3:14). During 
the course of experiments designed to look at the template 
requirements for complex formation it was noticed that the
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inhibitory effect of nuclear extract was more pronounced 
when a linearized plasmid instead of A d .4 cores was used as 
template. Viral cores are resistant to 5'— 3' exonuclease 
action by virtue of the TP attached to the 5' ends of the 
genome. This suggests that the inhibitory effect of nuclear 
extract is due, at least in part, to 5'-3' exonuclease 
activity. Alternatively cellular non-specific DNA binding 
proteins could be preventing the interaction between the 
template DNA and factors involved in initiation. In view of 
the presence of this inhibitor all further experiments were 
performed with A d .4-infected cytoplasmic extract.
3:2:2 THE KINETICS OF pTP-dCMP COMPLEX FORMATION
To determine the kinetics of the formation of a 
pTP-dCMP complex reactioni-were performed in the presence of 
a constant amount of plasmid template DNA (0.5ug) and a 
non-saturating amount of cytoplasmic extract of Ad.4 
infected cells (lul=4.2ug). Reactions were terminated at 
various times after the addition of extract by heating at 
70°C for lOmin. The results are shown in figure 3:6. The 
rate of the reaction was constant for a period of 
approximately 30min. and then declined to 20% of it's 
initial value (Figure 3:6). One reason for this decline 
could be depletion in the number of un—complexed pTP
molecules in the reaction. If most of the active pTP
molecules were complexed with dCMP within the first 30min.
of the reaction the concentration of uncomplexed molecules 
would decline and with it the rate of the reaction. However 
the decline in the rate of reaction could be due to other
Figure 3:6 Time course for the formation of a pTP-dCMP 
complex by cytoplasmic extract of Ad.4 
infected cells.
Assays for the formation of a pTP-dCMP complex were 
performed in the presence of 0.5ug plasmid p4A2 linearized 
with EcoRI and lul (4.2ug protein) cytoplasmic extract under 
standard reaction conditions (as described in section 2:16). 
Assays were terminated as described at the specified times. 
An autoradiograph of the relevant portion of the gel, 
together with a graphical representation of the data, is 
presented. 80K indicates the position of the 80,000 
molecular weight pTP-dCMP complex.
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factors such as instability of replication proteins at 37°C, 
degradation of proteins and/or DNA by proteases and 
nucleases or saturation of active template molecules in the 
reaction. The latter possibility is unlikely as the levels 
of complex formation in this experiment were well below 
maximal levels such as those obtained in a comparable 
experiment (Figure 3:3). It is also possible that the dCTP 
concentration in the reaction was reduced by hydrolysis 
making it unavailable for complex formation.
3:2:3 NUCLEOTIDE SPECIFICITY OF pTP-dCMP COMPLEX
FORMATION
To determine whether cytoplasmic extract of Ad.4 
infected cells could catalyse the transfer of dNMP's other 
than dCMP to the 80K pTP the following experiment was 
performed. Cytoplasmic extract (4.2ug of protein) and 
plasmid template DNA (0.5ug) were incubated in the presence 
of either (*32p)dGTP, («32P)dATP, (c*32p)dTTP, or («32P)dCTP
as the only nucleotide in the reaction. Figure 3:7 shows the 
results of this experiment. Maximal levels of a pTP-dNMP 
complex were formed in the presence of dCTP (track 4). A 
reproducible, low level of pTP-dNMP complex was formed in 
the presence of dTTP (track 3) but no pTP-dNMP complex was 
detected in the presence of dGTP or dATP (tracks 1 and 2). 
Formation of a complex with dTMP could be due to one of two 
reasons: Firstly the sequence at the 5 end of the Ad.4
fragment in p4A2 is CATCATCAAT (Hay,1985b). Complex 
formation in the presence of dTTP could therefore be due to 
transfer of dTMP to a pTP-dCMP-dAMP complex. Low endogenous
Figure 3:7 Formation of a pTP-nucleotide complex by
cytoplasmic extract of Ad.4 infected cells 
in the presence of different nucleotides.
0.5ug of plasmid p4A2 linearized with EcoRI and lul 
of cytoplasmic extract from Ad.4 infected cells (4.2ug 
protein) were incubated under standard reaction conditions 
(section 2:16) in the presence of either (t*32p)dGTP (track 
1), (cx32p)3ATP (track 2), (c*32p)dTTP (track 3) or (ck32P)dCTP 
(track 4) as the only nucleotide. The specific activity of 
all the (<X32p) labelled dNTP ' s was 3000C j/mmole. An 
autoradiograph of the part of the gel containing the 
pTP-dCMP complex and the relative amounts of pTP-dCMP 
complex formation in each case is presented. 80K indicates 
the position of the 80,000 molecular weight pTP-dNMP 
complex.
P) labelled nucleotide
G A T C
mmm -80K
0 0 8 100 
complex formation (% )
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levels of dNTP's in the extract could account for the
formation of the latter complex. However if this is the case
it would be reasonable to expect that dAMP would be
transferred to a pTP-dCMP complex. The data show that there
was no complex formation in the presence of dATP so this 
cannot explain the findings.
An alternative explanation is that in the presence of 
dTTP as the only nucleotide the degree of specificity
regarding the site for initiation on the DNA sequence could 
be relaxed. In this case pTP-dNMP complex formation could 
occur at the third nucleotide in the sequence - the first dT 
residue - instead of at the terminal nucleotide.
To further analyse the nucleotide specificity of the 
reaction complex formation with labelled dCTP in the 
presence of an excess of unlabelled dNTP’s or rNTP's was 
studied. Figure 3:8 shows the results of an experiment in 
which cytoplasmic extract (4.2ug of protein) and plasmid 
template DNA (0.5ug) were incubated with (c<32pj^cTP in the
presence of a 300-fold excess of unlabelled dNTP’s (tracks 2
to 5) or rNTP's (tracks 6 to 9). The data show that only 
unlabelled dCTP efficiently competed for complex formation.
It might be expected from the data in figure 3:7 that, as 
dTTP formja complex with pTP at a low efficiency, a large 
excess of unlabelled dTTP would compete with dCTP for 
complex formation. The data show that this is not the case. 
Given a choice of substrates for complex formation the 
pTP-pol shows a high specificity for dCTP. Complex formation
Figure 3:8 Competition by an excess of unlabelled 
nucleotides for pTP-dCMP formation by 
cytoplasmic extract of Ad.4 infected cells.
0.5ug of plasmid p4A2 linearized with EcoRI and lul of 
cytoplasmic extract (4.2ug protein) were incubated under 
standard reaction conditions (section 2:16) with 3uCj 
(<*32p )dCTP (specific activity 3000C^/mmole) in the presence 
of lOuM (a 300-fold excess) of unlabelled
deoxyribonucleotides (tracks 2-5) or ribonucleotides (tracks 
6-9) as indicated. An autoradiograph of the part of the gel 
containing the pTP-dCMP complex is presented. 80K indicates 
the position of the 80,000 molecular weight pTP-dCMP 
complex.
competitor 
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with dTTP will only occur if that nucleotide is the only one 
present. As is the case for all DNA polymerases the A d .4 DNA 
polymerase showed absolute specificity for dNTP's as a large 
excess of rCTP did not compete with (<*22P)dCTP for 
pTP-nucleotide complex formation.
3:2:4 THE ROLE OF ATP AND DIVALENT CATIONS IN
THE FORMATION OF A pTP-dCMP COMPLEX
To determine the effect of ATP concentration on 
pTP-dCMP complex formation cytoplasmic extract of Ad.4 
infected cells (4.2ug of protein) and plasmid template DNA 
(0.5ug) were incubated in the presence of a constant Mg2+ 
concentration of 3mM and a variable ATP concentration from 
0-15mM. Figure 3:9 shows the results of this experiment. 
Although the results suggest that ATP is not absolutely 
required for complex formation it is possible that low 
endogenous levels of ATP were sufficient for limited complex 
formation (track 1). The amount of complex formed increased 
to a maximum at an ATP concentration of 3mM (track 4), a 
6-fold increase over track 1. At higher ATP levels the 
amount of complex formation rapidly declined, becoming 
undetectable at 6mM. The level of stimulation by ATP varied 
between extracts and was clearly to some extent dependent on 
the endogenous ATP level.
ATP is known to chelate Mg2+ ions. In this context it 
was noticed that maximal pTP-dCMP complex formation was at a 
point where the ATP and Mg2+ concentrations were equal, and 
at higher ATP concentrations complex formation was sharply
Figure 3:9 Optimization of the ATP concentration for 
pTP-dCMP formation by cytoplasmic extract 
of Ad.4 infected cells.
lul of cytoplasmic extract (4.2ug protein) was 
incubated with 0.5ug p4A2 linearized with EcoRI under 
standard reaction conditions (section 2:16) except that the 
concentration of ATP was varied from 0-15mM. The magnesium 
concentration (as MgCl2 ) was maintained at the standard 
level of 3mM throughout the experiment. An autoradiograph of 
the part of the gel containing the pTP-dCMP complex, 
together with a graphical representation of the data, is 
presented. 80K indicates the position of the 80,000 
molecular weight pTP-dCMP complex.
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inhibited. These observations suggested either that free ATP 
(not bound to Mg2*) was inhibitory to the reaction or that 
both free Mg2+ ions and Mg2* ions chelated to ATP were 
required for the reaction. An excess of ATP over Mg2+ would 
reduce the pool of available free Mg2* ions in the reaction. 
To test this hypothesis the experiment was repeated but in 
this case both ATP and Mg2* concentrations were increased 
concurrently (Figure 3:10). In this experiment a greater 
amount of pTP-dCMP complex formation was observed in the 
presence of both ATP and Mg2* at 6mM (figure 3:10, track 9) 
than in the presence of ATP at 6mM and Mg2* at 3mM (figure 
3:9, track 7). In figure 3:10 the highest level of pTP-dCMP 
complex formation was observed in the absence of added ATP 
and Mg2*. Clearly the endogenous levels of both are 
sufficient for efficient complex formation.
The effect of varying the divalent cation 
concentration in the presence of a constant ATP 
concentration was then studied using both Mg2* (Figure 3:11) 
and Mn2* (Figure 3:12). Reactions were performed with 
cytoplasmic extract of Ad.4 infected cells (4.2ug of
protein) and plasmid template DNA (0.5ug) in the presence of
a constant concentration of ATP (3mM) and a Mg2*/Mn2*
concentration varying between 0-15mM. Complex formation 
requires the action of the Ad.4 DNA polymerase and all DNA 
polymerases thus far studied, both procaryotic and 
eucaryotic, require a divalent cation for activity. As
expected therefore, in the absence of added Mg2+ or Mn2* no 
complex was detected. This appears to contradict the result
Figure 3:10 Optimization of the ATP/Mg2* concentration
for pTP-dCMP formation by cytoplasmic
extract of Ad.4 infected cells.
lul of cytoplasmic extract (4.2ug protein) was 
incubated with 0.5ug p4A2 linearized with EcoRI under 
standard reaction conditions (section 2:16) except that both 
the ATP and MgCl2 concentrations were varied from 0-6mM. In 
each track both concentrations were equal. An autoradiograph 
of the part of the gel containing the pTP-dCMP complex, 
together with a graphical representation of the data, is 
presented. 80K indicates the position of the 80,000 
molecular weight pTP-dCMP complex.
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in Figure 3:10 track 1 which shows that in the absence of 
added Mg'1"*’ complex formation does occur. However in figure 
3:10 track 1 no added ATP was present to chelate free Mg2-*" 
and thereby inhibit the reaction. In figures 3:11 and 3:12 
ATP was present at 3mM, a concentration well in excess of 
the possible endogenous Mg2+ level so free Mg2+/Mn2+ ions 
would be at an extremely low level. The addition of EDTA to 
a reaction containing no added ATP or M g 2+ effectively 
eliminated pTP-dCMP complex formation (data not shown).
The effects of Mg2+ and Mn2 + on the formation of a 
pTP-dCMP complex were quite different. The activity in the 
presence of Mg2 + (Figure 3:11) increased sharply from ImM, 
was maximal from 2-4mM and then slowly declined to a barely 
detectable level at 15mM. In contrast the activity in the 
presence of Mn2+ (Figure 3:12) was maximal at ImM and then 
rapidly declined to become undetectable at 9mM. In a 
separate experiment (data not shown) the amount of complex 
formation was shown to increase gradually from 0—ImM thus 
eliminating the possibility that the M n 2 + peak is lower than 
ImM. The interaction of ATP with Mn2+ may be different to 
the interaction with Mg2+. The fact that maximal activity in 
the presence of Mn2+ occurs in the presence of a 3-fold 
excess of ATP may indicate that ATP is less able to chelate 
Mn2+ than Mg2+ and thus has less effect on the free Mn2+
pool .
Figure 3:11 Optimization of the Mg2+ concentration
for pTP-dCMP formation by cytoplasmic
extract of Ad.4 infected cells.
lul of cytoplasmic extract (4.2ug protein) was 
incubated with 0.5ug p4A2 linearized with EcoRl under 
standard reaction conditions (section 2:16) except that the 
concentration of MgCl2 was varied from 0-15mM. The ATP 
concentration was maintained at the standard level of 3mM 
throughout the experiment. An autoradiograph of the part of 
the gel containing the pTP-dCMP complex, together with a 
graphical representation of the data, is presented. 80K 
indicates the position of the 80,000 molecular weight 
pTP-dCMP complex.
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Figure 3:12 Optimization of the Mn^+ concent rat ion
for pTP-dCMP formation by cytoplasmic
extract of Ad.4 infected cells.
lul of cytoplasmic extract (4.2ug protein) was 
incubated with 0.5ug p4A2 linearized with EcoRI under 
standard reaction conditions (section 2:16) except that 
MnCl2 was substituted for MgCl 2 and the concentration of 
MnCl2 was varied between 0-15mM. The ATP concentration was 
maintained at the standard level of 3mM throughout the 
experiment. An autoradiograph of the part of the gel 
containing the pTP-dCMP complex, together with a graphical 
representation of the data, is presented. 80K indicates the 
position of the 80,000 molecular weight pTP-dCMP complex.
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3:2:5 THE EFFECT OF IONIC STRENGTH ON pTP-dCMP
COMPLEX FORMATION
To determine the effect of ionic strength on pTP-dCMP 
complex formation reactions containing cytoplasmic extract 
of Ad.4 infected cells (4.2ug of protein) and plasmid 
template DNA (0.5ug) were performed in the presence of an 
increasing concentration of NaCl. The initial ionic strength 
of the reaction mixture was 28mM, due to the presence of
Tris/HCl and MgCl2 . Figure 3:13 shows the results of this 
experiment. The amount of complex formation declined in a 
linear fashion as the concentration of salt was increased. 
At 80mM NaCl complex formation was 85% inhibited in 
comparison to the level obtained in the absence of NaCl. It 
is not clear whether the anion or cation are responsible for 
inhibiting the reaction, or whether both ions have an 
effect. The data correlates with that obtained from the
partial purification of the Ad.4 DNA polymerase (Section
3:4:1). The activity of the partially purified DNA
polymerase on activated DNA was shown to be 90% inhibited at 
lOOmM NaCl (Figure 3:26). It is important to bear this 
effect in mind when fractionating extracts to identify 
factors involved in pTP-dCMP complex formation. The
inhibitory effect of high salt concentrations used to elute 
factors from columns could easily mask any stimulatory
effect.
Figure 3:13 Optimization of the NaCl concentration
for pTP-dCMP formation by cytoplasmic
extract of Ad.4 infected cells.
lul of cytoplasmic extract (4.2ug protein) was 
incubated with 0.5ug p4A2 linearized with EcoRI under 
standard reaction conditions (section 2:16) the ionic 
strength of which was varied by increasing the concentration 
of NaCl from 0-80mM. An autoradiograph of the part of the 
gel containing the pTP-dCMP complex, together with a 
graphical representation of the data, is presented. 80K 
indicates the position of the 80,000 molecular weight 
pTP-dCMP complex.
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3:2:6 LIMITED ELONGATION OF THE pTP-dCMP COMPLEX TO 
THE 30th NUCLEOTIDE IN THE A d .4 SEQUENCE 
In the presence of dTTP, dATP and the chain terminator 
ddGTP, Ad. 2 pTP-dCMP complex can be elongated by the Ad.2 
polymerase (Lichy et a l ,1982) to the first dG residue in the 
sequence, the 2 6 th nucleotide. In the case of Ad.4 the first 
dG residue is the 30th nucleotide from the 5 ’ end 
(Hay,1985br Tokunaga et al,1982,1986? Stillman et al,1982). 
The product of this reaction is a complex consisting of the 
80K pTP covalently bound to a oligodeoxyribonucleotide which 
can be detected as a distinct band on SDS-PAGE, migrating 
more slowly than the pTP-dCMP complex.
Cytoplasmic extract from Ad.4 infected cells (4.2ug of 
protein) and plasmid template DNA (0.5ug) were incubated in 
the presence of (o(32p )^CTp f 50uM dATP, dTTP and 20uM ddGTP 
for 60min at 37°c. Figure 3:14a track 1 shows that, under 
these conditions, a second band migrating more slowly than 
the pTP-dCMP complex can be identified. Under the separation 
conditions used in this study the elongated product migrated 
with an apparent molecular weight of 90,000-daltons (90K).
Figure 3:14a tracks 2-4 show the effects of the 
degradative enzymes micrococcal nuclease, ribonuclease A and 
proteinase K on the products formed in the presence of 
(o<32p )dCTP, dATP, dTTP and ddGTP. Both the 80K pTP-dCMP and 
90K pTP-30mer products were resistant to ribonuclease A 
treatment and sensitive to proteinase K treatment. Only the 
80K product was resistant to micrococcal nuclease treatment.
Figure 3:14 Limited elongation of the pTP-dCMP complex
to the 30th nucleotide in the Ad.4 sequence.
lul of cytoplasmic extract from Ad.4 infected cells 
(4.2ug protein) was incubated with 0.5ug p4A2 linearized
with EcoRI in the presence of 3uC^ (<x32p)aCTp (specific 
activity 3000C*/mmole), 50uM dATP, dTTP and 20uM ddGTP as 
described in section 2:17. Following termination of the 
reaction the products were processed directly for 
electrophoresis without micrococcal nuclease treatment 
(apart from 3:13a, track 2). Reactions contained additional 
components (ddTTP and aphidicolin) as indicated. The 
reaction products in 3:13a tracks 3 and 4 were treated with 
50ug/ml RNase A or lOOug/ml proteinase K respectively for 
30min. at 37°c before processing for electrophoresis. 80K 
indicates the position of the 80,000 molecular weight 
pTP-dCMP complex and 90K indicates the position of the
90,000 molecular weight pTP-30mer complex.
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These results confirm the predictions that the 90K product 
consists of an oligodeoxyribonucleotide chain linked to an 
80K protein molecule and that the 80K product is a protein 
covalently linked to a single deoxyribonucleotide.
Figure 3:14b demonstrates that in the absence of the 
chain terminator ddGTP very little pTP-30mer product was 
formed but more radio-activity accumulated at the top of 
the gel. This was presumably due to further elongation using 
trace amounts of endogenous dGTP in the extract.
As demonstrated in Figures 3:25 and 3:26 aphidicolin 
at lOOuM inhibited Ad.4 DNA polymerase activity on activated 
DNA by 50%. Figure 3:14c shows that in contrast aphidicolin 
had no effect on the limited elongation of pTP-dCMP complex 
to the 30th nucleotide. Figure 3:14d shows the effect of 
increasing concentrations of a second chain terminator ddTTP 
on the formation of the pTP-dCMP and pTP-30mer complexes. 
Whereas the formation of the pTP-dCMP complex was unaffected 
by the presence of a second chain terminator, pTP-30mer 
production was severely inhibited. Elongation of pTP—dCMP to 
the first dG residue by the Ad.4 DNA polymerase is thus more 
sensitive to ddTTP inhibition, but less sensitive to 
aphidicolin, than Ad.4 DNA polymerase activity on activated 
DNA (figure 3:26). These results can be partly explained by 
the specificity of the assay: The Ad.4 DNA polymerase is 
likely to be able to re-initiate at another single-stranded 
gap on activated DNA after chain termination whereas if this 
occurred it would not be detected by the assay for
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elongation of the pTP-dCMP complex. The absence of 
detectable intermediate products (with apparent M.W. 1 s 
between 80K and 90K) suggests that chain termination by 
ddTTP occurs at an early stage in elongation, possibly at 
the first dT residue, the third nucleotide in the sequence. 
The effect of DBP and other replication proteins not present 
in the partially purified Ad.4 DNA polymerase fraction may 
sxplain the differences in aphidicolin sensitivity.
In all the experiments in Figure 3:14 only a 
proportion of the pTP-dCMP complex formed supported 
elongation to the 30th nucleotide. The reason for this is 
unclear. One possible explanation is that a proportion of 
pTP-dCMP complex dissociates from the template and thus is 
unable to prime elongation. Alternatively exonuclease 
activity within the extract could degrade elongated strands.
3:3 THE DNA TEMPLATE REQUIREMENTS FOR THE FORMATION 
OF A pTP-dCMP COMPLEX IN VITRO
3:3:1 CHARACTERIZATION OF THE ABILITY OF PLASMID
TEMPLATES TO SUPPORT pTP-dCMP COMPLEX FORMATION 
To determine whether complex formation could occur on 
templates in which the Ad.4 origin fragment was not at the 
molecular end assays for the formation of a pTP-dCMP complex 
were performed with 0.5ug of either circular p4A2 or p4A2 
cleaved with various restriction enzymes: EcoRl cleaves once 
in p4A2 at a site adjacent to the Ad.4 terminus, producing a 
linear molecule which at one end is identical to the
107
terminal 140b.p. of A d .4 apart from a 4b.p. 5' overhang. 
BamH1 cleaves once at the other end of the insert and Ndel 
cleaves once within the pUC8 backbone 230b.p. from the EcoRl 
site (see Figure 3:15). Figure 3:16 tracks 1-4 demonstrate 
that the Ad.4 terminal fragment was only active for pTP-dCMP 
complex formation when located in the correct orientation at 
the terminus of a linear molecule (p4A2 cleaved with EcoRl)
Tracks 5—8 demonstrate that the sequences required for 
complex formation are contained within the Ad.4 fragment; no 
complex formation was detected in the presence of either 
circular or EcoRl, BamHl or Ndel cleaved pUC8. These
negative controls rule out the possibility that either pUC8 
sequences or the 5' overhang produced by EcoRl cleavage 
supported complex formation.
To determine the effect of template concentration on 
the level of pTP-dCMP complex formation reactions were 
performed in the presence of a constant amount of 
cytoplasmic extract of Ad.4 infected cells (4.2ug of
protein) and a variable amount of plasmid template DNA
and. 318
(0-200ng) . The results are shown in figures 3:17^. At very low 
template concentration pTP-dCMP complex formation was 
minimal. Above 12.5ng per assay the amount of pTP-dCMP 
complex formed increased linearly to 50ng per assay and then 
reached a plateau which was maintained up to 200ng per 
assay. This plateau is presumably maintained as far as 500ng 
per assay, the level used for most assays, as the average
amount of pTP-dCMP complex formed in other experiments
containing 4.2ug of cytoplasmic protein and 0.5ug plasmid
Figure 3:15 The structure of plasmid p4A2.
Plasmid p4A2 is identical to p4Al - a plasmid 
constructed and described previously (Hay,1985b). The 
plasmid consists of an 140b.p. terminal Sail fragment of
Ad.4 blunt end ligated into EcoRl cleaved, T4 DNA polymerase 
treated pUC9. This figure shows the single cleavage sites of 
the three restriction endonucleases used in this study. 
EcoRl cleaves at the Ad.4 terminus, BamHI cleaves at the 
other end of the Ad.4 fragment and Ndel cleaves in the 
backbone 231b.p. from the EcoRl site.
Structure of p4A2. 
(not drawn to scale)
Ad.4 BamHIEcoRl
140bp
p4A2
Ndel
pUC9
Figure 3:16 Effect of template configuration on the
ability of plasmid templates to support
pTP-dCMP complex formation.
Plasmid DNA (either p4A2 or pUC8) treated with 
restriction endonucleases as indicated or uncut were 
extracted once with an equal volume of a 1:1 mixture of 
phenol:chloroform, once with an equal volume of chloroform, 
ethanol precipitated and resuspended in distilled water. 
lOOng aliquots of each sample were incubated with lul of 
cytoplasmic extract (4.2ug protein) under standard reaction 
conditions (section 2:16). 80K indicates the position of the
80,000 molecular weight pTP-dCMP complex.
TRACK TEMPLATE
1 p4A2/EcoR1
2 p4A2/BamHI
3 p4A2 Ndel
4 p4A 21 uncut
5 pUC8 / EcoRl
6 pUC8/BamHI
7 pUC8 / Ndel
8 p(JC8/uncut
Figure 3:17 Effect of increasing the plasmid template
concentration on pTP-dCMP complex formation.
lul of cytoplasmic extract (4.2ug protein) was 
incubated under standard reaction conditions (section 2:16) 
in the presence of increasing amounts (0-200ng) of EcoRl 
linearized plasmid DNA (either p4A2 or pl3C8) . 80K indicates 
the position of the 80,000 molecular weight pTP-dCMP 
complex.
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Figure 3:18 Graphical representation of the effect of
increasing the plasmid template concentration
on pTP-dCMP complex formation.
The data in figure 3:17 is presented as a graph of 
amount of complex formed plotted against the amount of 
template present in the reaction.
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DNA was 0.26fmoles. The apparent decline in pTP-dCMP complex 
formation between 100 and 200ng per assay is thus most 
likely due to experimental variation.
Plasmid pUC8 linearized with EcoRl was included as a 
negative control in these experiments. No pTP-dCMP complex 
formation was detected in the presence of this plasmid under 
any conditions, again emphasizing that the DNA sequence 
requirements for pTP-dCMP complex formation are located 
within the 140b.p. Ad.4 terminal fragment.
3:3:2 THE DNA SEQUENCE REQUIREMENTS FOR THE FORMATION
OF A pTP-dCMP COMPLEX
To determine the precise DNA sequence requirements for 
the formation of a pTP-dCMP complex in vitro plasmids 
containing deletions extending into the Ad.4 or Ad.2 ITR's 
were examined for their ability to support pTP-dCMP 
formation. The p4AnA plasmids contain a single copy of 
sequences from the Ad.4 ITR where n represents the number of 
bases of the ITR remaining (Hay,1985b). The pHRnA plasmids 
were constructed and described previously (Hay,1985a,b) and 
contain one copy of sequences derived from the ITR, where n 
is the number of nucleotides from the terminus present. pHRl 
is the parental plasmid of this series and contains the 
complete Ad.2 ITR (102b.p.). Figure 3:19 shows the results 
of an experiment in which reactions were performed with 
cytoplasmic extract of Ad.4 infected cells (4.2ug of 
protein) and 0.5ug of each of the p4AnA plasmids cleaved 
with EcoRl. Figure 3:20 shows the results of a similar 
experiment involving the pHRnA plasmids.
The terminal l8b.p. of the Ad.2 and Ad.4 ITR's are identical.
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The results show clearly that the terminal 18b.p. of 
either the A d . 4 or A d . 2 ITR are both necessary and 
sufficient as a template for the formation of a pTP-dCMP 
complex by cytoplasmic extract of Ad.4 infected cells. A 
plasmid containing less than 18b.p. from the Ad.2 ITR 
(pHR7o) , or a control plasmid containing no adenovirus 
sequences (pUC8) did not support any pTP-dCMP complex 
formation. Small variations in the levels of complex 
formation can be attributed to small differences in plasmid 
concentrations. These results are consistent with those 
defining the minimal sequence requirements for Ad.4 origin 
function in vivo (Hay,1985b).
The stimulatory fraction from uninfected nuclei 
described in section 3:4:2 also exerted it's effect in the 
presence of a plasmid template containing only 18b.p. from 
the Ad.4 origin (data not shown). It seems likely that host 
cell factor(s) are interacting with the terminal 18b.p., 
either in a sequence specific manner or non-spec ifically, to 
enhance pTP-dCMP complex formation. Purified nuclear factor 
III, a protein that enhances Ad.2 pTP-dCMP complex formation 
(Pruijn- et al,1986b) and which has a high affinity binding 
site on the Ad.4 ITR (Hay, unpublished observations), did 
not enhance Ad.4 pTP-dCMP complex formation either in the 
presence or absence of it's binding site.
Figure 3:19 The DNA sequence requirements for the formation 
of a pTP-dCMP complex by cytoplasmic extract of 
Ad.4 infected cells. I. Use of Ad.4 ITR 
sequences as a template.
The p4AAn series of plasmids were constructed and 
described previously (Hay,1985b). The plasmids consist of 
fragments of the Ad.4 ITR generated by Bal31 digestion 
ligated into EcoRl/BamHI cleaved pUC9. 0.5ug of each plasmid 
was cleaved with EcoRl to expose the A d .2 terminus and, 
after phenol extraction and ethanol precipitation, incubated 
under standard reaction conditions (section 2:16) with lul 
of cytoplasmic extract of Ad.4 infected cells (4.2ug of 
protein). An autoradiograph of the part of the gel 
containing the pTP-dCMP complex, together with the structure 
of the deletions, is presented. 80K indicates the position 
of the 80,000 molecular weight pTP-dCMP complex and I 
indicates the minimal Ad.4 origin in vivo. NFIII indicates 
the binding site for nuclear factor III a sequence that is 
not required for Ad.2 replication in vivo but enhances A d .2 
initiation in vitro, and is also present on the Ad.4 ITR.
1) p4A2 i
2) p4A79 '
3) P4a70 I
4) p4A35 f
5) p4A6 a 6
6) pUC8
Figure 3:20 The DNA sequence requirements for the formation
of a pTP-dCMP complex by cytoplasmic extract of
Ad.4 infected cells. II. Use of Ad.2 ITR
sequences as a template.
The pHRAn series of plasmids was constructed and 
described previously (Hay,1985a,b). The plasmids consist of 
fragments of the Ad. 2 ITR generated by Bal31 digestion 
ligated into EcoRl/BamHI cleaved pUC9. 0.5ug of each plasmid 
was cleaved with EcoRl to expose the A d . 2 terminus and, 
after phenol extraction and ethanol precipitation, incubated 
under standard reaction conditions (section 2:16) with lul 
of cytoplasmic extract of Ad.4 infected cells (4.2ug of 
protein) . An autoradiograph of the part of the gel 
containing the pTP-dCMP complex, together with the structure 
of the deletions, is presented. 80K indicates the position 
of the 80,000 molecular weight pTP-dCMP complex and I
indicates the minimal Ad.4 origin in vivo, NFI indicates the
binding site for nuclear factor I a sequence required for 
Ad. 2 replication in vivo and which enhances A d . 2 replication 
in vitro but is not present on Ad.4 ITR. NFIII indicates the 
binding site for nuclear factor III a sequence that is not 
required for Ad.2 replication in vivo but enhances Ad.2 
initiation in vitro, and is also present on the Ad.4 ITR.
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3:3:3 THE USE OF SINGLE-STRANDED DNA AS A TEMPLATE
FOR pTP-dCMP COMPLEX FORMATION
To investigate the requirements for complex formation 
on single-stranded DNA, reactions were performed in the 
presence of native and heat denatured plasmids. Cytoplasmic 
extract of Ad.4 infected cells (4.2ug of protein) was
incubated in the presence of 0.5ug of native plasmids or 
plasmids heated at 100°c for 5min. Figure 3:21 shows that 
the efficiency of complex formation on p4A2 linearized with 
EcoRl was reduced approximately 24-fold by heat 
denaturation. No complex was formed in the presence of
either native or denatured forms of p4A2 linearized with 
BamHI or Ndel. This indicated that, even on single-stranded 
templates, complex formation required the Ad.4 sequences to 
be located at the end of a linear molecule. No complex was 
formed with any of the 4 deoxyribonucleotides in the
presence of either M13mpl8 DNA, poly(dG), poly(dA), poly(dT) 
or poly(dC). This is in contrast to the results obtained 
with Ad.2 (Challberg and Rawlins,1984) in which no sequence 
specificity was exhibited when initiating on single-stranded 
templates.
Two complementary oligonucleotides corresponding to 
the 3' terminal 18b.p. of the Ad.4 genome (oligonucleotide 
1) and the 5' terminal 18b.p. (oligonucleotide 2) were made 
and used to investigate further the ability of 
single-stranded DNA to support pTP-dCMP complex formation. 
Varying amounts of the oligonucleotides (0-500ng) were 
incubated with cytoplasmic extract of Ad.4 infected cells
Figure 3:21 Ability of native and denatured plasmids
to support pTP-dCMP complex formation.
Linearized plasmid DNA was denatured by heating to 
1000c for 2min. and placed on ice. 0.5ug aliquots of either 
native or denatured plasmid DNA as indicated were incubated 
under standard reaction conditions (section 2:16) with lul 
of cytoplasmic extract of Ad.4 infected cells (4.2ug of 
protein). An autoradiograph of the part of the gel 
containing the pTP-dCMP complex is presented. 80K indicates 
the position of the 80,000 molecular weight pTP-dCMP 
complex.
TEMPLATE 
native p4A2/EcoR1 
denatured p4A2/EcoR1 
native p4A2/BamHI 
denatured p4A2/BamH1 
native p4A2/Nde1 
denatured p4A2/Nde1 
native pUC8/EcoR1 
denatured pUC8/EcoR1
Figure 3:22 Ability of single-stranded oligonucleotides
to support pTP-dCMP formation.
Two complementary oligonucleotides corresponding to 
the 3' and 5' terminal 18b.p. of the Ad.4 genome were 
synthesized on a Biosearch 8600 DNA synthesizer. For future 
use in constructing a plasmid containing multiple copies of 
this oligonucleotide for use in an affinity purification 
scheme for factors binding to the terminal 18b.p. of the 
Ad.4 genomey these oligonucleotides contained 3' and 5' 
sequences which would enable the double stranded 
oligonucleotide to be ligated in a head to tail 
configuration. Increasing amounts of single stranded 
oligonucleotides were incubated under standard reaction 
conditions (section 2:16) with lul of cytoplasmic extract of 
Ad.4 infected cells (4.2ug of protein). The sequence of the 
oligonucleotides used and an autoradiograph of the part of 
the gel containing the pTP-dCMP complex are presented. 80K 
indicates the position of the 80,000 molecular weight 
pTP-dCMP complex.
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Figure 3:23 Graphical representation of the formation 
of a pTP-dCMP complex by single stranded 
oligonucleot ides.
The data in figure 3:22 are presented as a graph of 
the amount of complex formed plotted against the amount of 
oligonucleotide present in the reaction.
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(4.2ug of protein) ( f i gur es 3 : 2 2^) . Formation of a pTP-dCMP 
complex was detected in the presence of an oligonucleotide 
corresponding to the 18b.p. at the 3' terminus of Ad.4, 
whereas an oligonucleotide corresponding to the 
complementary strand did not support pTP-dCMP complex 
formation at detectable levels. Figure 3:22 shows that the 
efficiency of pTP-dCMP complex formation was extremely low, 
in the order of 600-fold less than native, EcoRl linearized 
p4A2. The fact that, in comparison to plasmids, the molarity 
of the reaction with regard to template sequences could be 
extremely high when using oligonucleotides meant that this 
level of pTP-dCMP complex formation could be readily 
detected.
The finding that one single-stranded oligonucleotide 
was able to support pTP-dCMP complex formation and yet the 
complementary oligonucleotide did not was surprising. This 
result is unlikely to be explained by specific recognition 
of a single-stranded DNA sequence by DNA-binding proteins. 
The nucleotides in a single-strand are able to rotate in 
relation to each other making it very difficult for a 
protein bo recognize a specific sequence. There are several 
more probable explanations to explain the findings:
Firstly it cannot be ruled out that the active 
oligonucleotide can adopt a secondary structure that could 
support pTP-dCMP complex formation, whereas the 
complementary oligonucleotide was unable to do so. Secondary 
structure formation could also involve the interaction of
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the oligonucleotide with non-specific DNA binding proteins. 
The A d .4 DBP may also have an, as yet unknown, role to play 
in the process.
Secondly, examination of the sequences of the two 
oligonucleotides reveals that whereas the active 
oligonucleotide contains 5 internal dG residues at which 
pTP-dCMP complex formation could occur, the inactive 
oligonucleotide has none. It is possible that the pTP-pol 
complex and other replication proteins bind non-specifically 
to a single-stranded DNA molecule and then dCMP is 
transferred to the pTP at a dG residue near the binding 
site. The terminal dG residues of oligonucleotide 2 may not 
fulfill these requirements. This explanation is borne out to 
some extent by the data presented in figure 3:24.
Figure 3:24 shows the results of an experiment to 
determine the sequence elements on oligonucleotide 1 that 
were responsible for supporting pTP-dCMP complex formation. 
Four oligonucleotides (numbers 3-6) corresponding to the 3' 
terminal 18b.p. of the Ad.4 genome were constructed with G 
to A base, changes at the positions indicated in figure 3:24 
and 500ng of each oligonucleotide was incubated with 
cytoplasmic extract of Ad.4 infected cells (4.2ug of 
protein).
Substitution of the dinucleotide GG 18 bases from the 
3' end with the dinucleotide AA (figure 3:24, track 3) 
clearly had a profound effect on the ability of the
Figure 3:24 Ability of mutated, single-stranded 
oligonucleotides to support pTP-dCMP 
complex formation.
Oligonucleotides corresponding to the 3* terminal 
18b.p. of th Ad.4 genome were constructed with various G to 
A base changes as indicated. 500ng of each oligonucleotide 
was incubated under standard reaction conditions (section 
2:16) with lul of cytoplasmic extract of Ad.4 infected cells 
(4.2ug of protein). An autoradiograph of the part of the gel 
containing the pTP-dCMP complex, together with the sequences 
of the oligonucleotides, is presented. 80K indicates the 
position of the 80,000 molecular weight pTP-dCMP complex.
1 2 3 4 5 6
-80K
1) 3'-aG T A G T A G T T A T T A T A T G G cctag
2) S ' - g a t c t C  A T  CAT C A A T A A T  A T  ACCg
3) 3'-aG T A G T  A G T T  A T T A T A T A A cctag
U 3'-aA T A A T A A T T A T T A T A T A A cctag
5) 3' - a A T  A AT A  AT T A T T A T A T G G c c t a g
5) 3 ' - a G T A A T A A T T  A T T A T A T G G c c t a g
(altered nucleotides underlined)
oligonucleotide to support pTP-dCMP complex formation, 
reducing it at least 10-fold. However substitution of the dG 
residues 5 and 8 bases from the 3' end completely abolished 
pTP-dCMP complex formation, whether the other 3 internal dG 
residues were present or not (figure 3:24, tracks 4-6). 
These data indicate that the choice of dG residues for 
pTP—dCMP complex formation on single-stranded templates is 
not entirely random. It is possible that secondary structure 
and other proteins associated with initiation may be 
involved in the positioning of the initiation event.
3:4 PARTIAL PURIFICATION OF FACTORS INVOLVED IN THE 
FORMATION OF AN AD.4 pTP-dCMP COMPLEX
3:4:1 PARTIAL PURIFICATION AND CHARACTERIZATION OF THE 
Ad.4 SPECIFIC DNA POLYMERASE FROM INFECTED CELLS 
81 of HeLa spinner cells at a density of 4x10^ 
cells/ml. were infected with 50pfu/cell Ad.4 virus. The
cells were treated with 5mM hydroxyurea from 2-22h.p.i. to 
inhibit viral DNA synthesis and extracts were made as 
described in Materials and Methods (Section 2:14). The
clarified cytosol was adjusted to 50mM NaCl, ImM DTT and ImM 
EDTA and applied to a 50ml column of DEAE-sepharose
equilibrated in buffer A containing 50mM NaCl. The column 
was washed with 100ml of buffer A containing 50mM NaCl and 
protein was eluted with buffer A containing 0.2M NaCl. 7ml 
fractions were taken, the absorbance at 280nm measured and 
peak protein-containing fractions pooled. Protein was
precipitated by adding ammonium sulphate to 70% saturation,
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resuspended in buffer A and dialysed. 5ml samples were then 
loaded on to a Pharmacia FPLC system fitted with a Mono-Q 
anion exchange column. The column was washed with 5ml buffer 
A and developed with a 20ml linear gradient from 0-0.35M 
NaCl followed by a 4ml linear gradient from 0,35-lM NaCl,. 
both in buffer A. The column was finally washed with 4ml 
buffer A containing 1M NaCl. 1ml fractions were collected 
throughout the fractionation.
Fractions were assayed for DNA polymerase activity 
using an activated DNA template as described in Materials 
and Methods both in the presence and absence of aphidicolin 
(O.lmM) (Figure 3:25). Three peaks of DNA polymerase 
activity were obtained which differed greatly in their 
sensitivity to aphidicolin. To identify the virus-specific 
DNA polymerase the effect of various inhibitors on the 
activity of each of the peaks was determined. 5 inhibitors 
were used in this study: dideoxythymidine triphosphate 
(ddTTP) and l-JjJ-D-arabinof uranosylcytosine 5 '-tr iphosphate 
(ara-CTP) are nucleotide analogues which cause chain 
termination. Aphidicolin is a tetracyclic diterpenoid known 
to inhibit purified DNA polymerase alpha and the growth of 
herpes simplex and vaccinia viruses (Longiaru et a l ,1979) as 
a result of inhibition of the viral DNA polymerases. 
N-ethylmaleimide (NEM) binds to sulphydryl groups and is 
known to inhibit both DNA polymerases alpha and gamma 
(Weissbach,1977). lOOmM NaCl inhibits only DNA polymerase 
alpha but not DNA polymerases beta or gamma 
(Weissbach,1977). The results are shown in Figure 3:26.
Figure 3:25 FPLC fractionation of DNA polymerase activity
from the cytoplasm of Ad.4 infected cells.
Cytoplasmic extract from Ad.4 infected cells was 
fractionated as described in the text and 2ul aliquots of 
each fraction were assayed for DNA polymerase activity on 
gapped duplex DNA both in the presence and absence of 
aphidicolin at lOOuM. Fractions 16 (peak A), 26 (peak B) and 
30 (peak C) were taken for further characterization (figure 
3:26).
70
60
+ aphidicolin (IOOjjM ) 
-  aphidicolin50
50
20
10
fracfion number
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DNA polymerase beta has been shown not to bind to 
DEAE-cellulose either in phosphate buffer at pH 7.5 
(Edenberg et a l ,1978) or Tris buffer at pH 7.7 (Longiaru et 
<al, 1979). It was probable therefore that the material loaded 
on to the Mono-Q column did not contain any DNA polymerase 
beta and that the three peaks of DNA polymerase activity 
obtained represented alpha, gamma and an Ad.4 specific 
activity. This was borne out by the data obtained from the 
inhibitor study (Figure 3:26). DNA polymerase beta is 
resistant to N-ethyl-maleimide whereas none of the DNA 
polymerase peaks exhibited resistance to this compound,
indicating that they do not correspond to DNA polymerase
beta. Although peak A was sensitive to both ddTTP and 
ara-CTP it was more sensitive to ddTTP, as is the case for 
DNA polymerase gamma. Clearly peak C corresponds to DNA 
polymerase alpha as it is the only peak to show resistance 
to ddTTP and is sensitive to all other inhibitors tested. 
Peak B however bears no ressemblance to any of the cellular 
DNA polymerases in that is was sensitive to all inhibitors 
tested except aphidicolin, to which it was partially 
resistant. Peak B clearly represents an Ad.4 specific DNA
polymerase activity. This activity is very similar to the
Ad.2 DNA polymerase activity studied by Lichy et al (1982) 
in it's sensitivity to ddTTP, ara-CTP, NaCl and NEM. It 
differs only in that it is 50% resistant to aphidicolin at 
0.ImM, as opposed to 85% for Ad.2. Given the variability
encountered in this assay system the difference may not be 
significant.
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Several attempts were made to detect A d .4-specific 
initiation activity in the A d .4 polymerase fraction. Neither 
fractions containing peak B alone, or in combination with 
uninfected nuclear extract, uninfected cytoplasmic extract 
or both uninfected nuclear and cytoplasmic extracts showed 
any pTP-dCMP complex formation. In addition pTP-dCMP complex 
formation was not observed when other fractions from the 
Mono-Q column were added back to peak B. Although it is 
likely that this would have replaced factors required for 
pTP-dCMP formation they may have been too dilute to have any 
effect.
3:4:2 PARTIAL PURIFICATION OF A CELLULAR FACTOR THAT 
STIMULATES THE FORMATION OF AN Ad.4 pTP-dCMP 
COMPLEX IN VITRO
A fraction from uninfected HeLa cell nuclei that 
stimulated pTP-dCMP complex formation by cytoplasmic extract 
of Ad.4 infected cells was partially purified as follows: 
Nuclei were prepared from uninfected HeLa cells as described 
(Challberg and Kelly, 1979a) and washed three times in 25mM 
Tris/HCl pH7.5, 5mM KC1, 0.5mM MgCl2, 0.5mM DTT, 0.2M 
sucrose. Nuclei were resuspended in the same buffer 
containing 0.35M NaCl, stirred on ice for 30min. and 
particulate material removed by centrifugation at 100,000 x 
g for 60min. The supernatant was adjusted to 0.3M NaCl and 
applied to a DEAE-sepharose column equilibrated in buffer A 
containing 0.3M NaCl. The flow-through was dialysed against 
buffer A containing 30mM NaCl and particulate material 
removed by centrifugation at 100,000 x g for 30min. The
Figure 3:26 Characterization of the inhibitor profiles of 
the DNA polymerase peaks isolated from the 
cytoplasm of Ad.4 infected cells.
2ul aliquots of each of the peak fractions described 
in figure 3:1 were assayed for DNA polymerase activity on 
gapped duplex DNA in the presence of various inhibitors as 
follws: Aphidicolin at lOOuM, ddTTP and ara-CTP at
ddTTP:dTTP and ara-CTP:dCTP ratios between 0.1-50:1, NaCl at 
lOOmM and N-ethyl-maleimide at 5mM. All the inhibitors were 
added tothe reaction mixture except N-ethyl-maleimide Which 
was added to the enzyme fraction for 5min. at 4°c and then 
neutralized with lOmM DTT. As described in the text the 
inhibitor profile of peak B identifies it as the most likely 
candidate for an Ad.4 infected cell specific DNA polymerase 
activity.
To facilitate a comparison between the inhibitor 
profiles of the three DNA polymerase peaks isolated from the 
cytoplasm of Ad.4 infected cells, the cellular DNA 
polymerases and the Ad.2 specific DNA polymerase the latter 
are set out. Data for the Ad.2 specific DNA polymerase were 
taken from Lichy et al (1982) and data for the cellular DNA 
polymerases were taken from Krokan et al (1979) and 
We i ssbach (1977).
PEAK N -e th y l -
maleimide
Aphidicolin ddTTP
(SO: 1^
ara-CTP
(so-, i)
100mM
NaCl
A I R s, \ R
B S I % 4 S
C S S R I s
1YMERASE N-ethyl -  
maleimide
Aphidicolin ddTTP ara-CTP 100mM
NaCl
Alpha S S R S S
Beta R R S R R
Gamma S R S R R
Ad.2 S R S S S
S -  sensitive (%)«eoucT\oisi 
R -  resistant
I -  intermediate (50%  inhibition)
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supernatant was applied to a DEAE-sepharose column
equilibrated with buffer A containing 30mM NaCl. The column
was washed with 2 column volumes of buffer A containing 30mM 
NaCl and proteins were eluted with a linear gradient from 
30mM to 0.3M NaCl in buffer A. Fractions were taken and 5ul 
aliquots were assayed for stimulation of Ad.4 pTP-dCMP 
complex formation activity.
Figure 3:27 shows the results of the experiment. Five 
ul of every second fraction from the column was incubated
with cytoplasmic extract of Ad.4 infected cells (4.2ug of
protein) and 50ng of plasmid template DNA. Sub-optimal 
quantities of extract and template DNA were used so that any 
stimulatory effect was not obscured by saturating the assay 
system. The data show that a peak of stimulatory activity 
eluted from the column in fractions 15-21 (50-BOmM NaCl). 
This stimulatory activity was also active on a template 
containing only 18b.p. from the Ad.4 terminus (data not 
shown)’. Thus if the stimulatory activity is a 
sequence-specific DNA-binding protein it must therefore 
recognize a sequence within the terminal 18b.p. 
Alternatively it could be interacting with the viral 
proteins involved in the initiation reaction bo as to 
enhance the specific interaction or the pTP—pol and other 
factors with the Ad.4 origin. The fraction did not alter the 
specificity of the reaction as no pTP-dCMP complex Mas 
formed in the presence of pUCS linearized with BcoRl either 
with or without the stimulatory factor. Mo pTP-dCMP complex 
formation was observed in the presence of fractious 25-53. 
These fractions presumably contained the inhibitory activity 
previously observed in unfractionated nuclear extracts.
Figure 3:27 Fractionation of uninfected cell extract on 
DEAE-sepharose: Identification of a fraction 
that stimulates Ad.4 pTP-dCMP complex formation.
Uninfected nuclear extract was fractionated as 
described in the text and 5ul of each fraction were 
incubated in a standard reaction mixture (section 2:16) with 
lul of cytoplasmic extract from Ad.4 infected cells and 50ng 
plasmid DNA template. Throughout the assay the salt 
concentration of the reaction mixture was kept constant.
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The objective of this study was to develop an in vitro 
system capable of authentically reproducing the in vivo 
initiation of adenovirus type 4 DNA replication. This system 
would then be utilized to investigate the mechanistic 
differences between the initiation of adenovirus type 2 
(Ad.2) and adenovirus type 4 (Ad.4) DNA replication. The 
data presented in this thesis concerns two aspects of this 
system. Firstly the characterization of the initiation of 
Ad.4 DNA replication in vitro by extracts derived from 
infected cells. Secondly the partial purification and 
characterization of an Ad.4 specific DNA polymerase activity 
present in infected cells and the identification of a 
fraction from uninfected cell nuclei that stimulates Ad.4 
initiation in vitro. In chapter 4 I shall compare the data 
obtained with that published by other workers concerning 
Ad.2 DNA replication in vitro and make some suggestions as 
to the precise nature of the differences between the two 
viruses at the level of initiation of DNA replication.
4:1 THE USE OF FULL-LENGTH VIRAL DNA AS A TEMPLATE FOR THE
INITIATION OF ADENOVIRAL DNA SYNTHESIS IN VITRO.
The use of adenoviral cores as templates for in vitro 
replication was first described by Goding and Russell 
(1983). They showed that Ad.2 cores produced by deoxycholate 
treatment of virions were as efficient as DNA-protein 
complex (DNA-prot.) produced by guanidinium hydrochloride 
treatment in supporting initiation and limited elongation. 
Ad.4 cores proved to be reproducibly more efficient than
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template for in vivo DNA synthesis. This result may be due 
to the fact that deoxycholate treatment of virions is 
certainly less severe than guanidinium hydrochloride and may 
leave the DNA-terminal protein in a more active state for 
replication. The effect of the major core protein on Ad.2 
pTP—dCMP complex formation has not been documented. 
Presumably the termini of the genome in adenovirus cores 
must be accessible to initiation factors both in Ad.2 
(Goding & Russell,1983) and Ad.4 (this thesis).
Unlike Ad . 2 (Lichy et a l ,1981) deproteinized Ad.4 DNA 
reproducibly supported pTP-dCMP complex formation at about 
25% of the efficiency of Ad.4 cores. Tamanoi and Stillman
(1982) demonstrated that the ability of deproteinized Ad.2 
DNA to support pTP-dCMP complex formation was restored by 
piperidine treatment. This treatment removed residual amino 
acids not digested by Pronase which were presumably 
interfering with pTP-dCMP complex formation. There are two 
reasons why deproteinized Ad.4 DNA could support pTP-dCMP 
complex formation: Firstly the residual amino acids left 
after treatment with proteinase K may not interfere with 
Ad.4 complex formation in the same way as they interfere 
with Ad.2 complex formation. This would imply differences in 
the protein-DNA interactions at the Ad.4 origin compared to 
the Ad.2 origin. Secondly the phosphodiester bond between 
the terminal protein and the 5 ‘ terminal dC may be very 
sensitive to alkaline hydrolysis in Ad.4. Even at pH 8 — the 
conditions used in this study — the bond between residual 
amino acids and the DNA may be unstable.
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DNA-prot. in supporting initiation in vitro although this 
ability varied greatly between core preparations.
In vivo adenovirus infection results in the 
introduction of cores into the nucleus at lh.p.i. 
(Chardonnet & Dales,1972). However soon after this viral 
genomes in the nucleus have been reported to be almost 
protein free (Lonberg-Holm & Phi 1ipson,1969) suggesting that 
the cores are not used as templates for in vivo DNA 
replication. In addition Tate and Philipson (1979) showed 
that between 1 and 6h.p.i. viral DNA in the nucleus became 
increasingly present in nucleosome-like structures, larger 
than those found in isolated cores (Corden et a l ,1976). Tate 
and Philipson (1979) suggested that viral DNA was stripped 
of core proteins and possibly became associated with 
cellular histones prior to DNA replication. Later in 
infection (20h.p.i.) adenovirus DNA is found associated with 
core proteins (Weber & Phi 1ipson,1984).
However the major core protein pVII has been shown to 
inhibit Ad.2 DNA synthesis in vitro by binding 
non-specifically to DNA and presumably preventing the 
interaction of the DNA with replication proteins (Korn & 
Horwitz,1986). If this inhibition is also the case in vivo 
then core proteins must be removed from the DNA prior to 
replication. It is somewhat surprising therefore that cores 
are the most efficient template for pTP-dCMP complex 
formation in vitro, given that they appear not to be the
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4:2 COMPARISON OF THE A d .2 AND A d .4 IN VITRO 
INITIATION REACTIONS
Formation of an Ad.4 pTP-dCMP complex in vitro was 
catalysed by either cytoplasmic or nuclear extracts of Ad.4 
infected HeLa cells (figures 3:3 and 3:4). Ad.4 initiation 
in vitro thus differs from A d . 2 initiation in vitro. Lichy 
et al (1981) demonstrated that formation of an Ad.2 pTP-dCMP 
complex was only catalysed by cytoplasmic extract of A d .2 
infected cells in the presence of uninfected nuclear 
extract. In the absence of the latter no pTP-dCMP complex 
was detected. The activity of cytoplasmic extract of Ad.4 
infected cells in forming pTP-dCMP complex alone was 
comparable to that of cytoplasmic extract of Ad.2 infected 
cells in the presence of uninfected nuclear extract: In the 
system of Lichy et al (1981) 0.93 fmoles of complex were 
formed in 60min. by a reaction mixture containing 70ug of 
cytoplasmic protein and 15ug of nuclear protein. In the Ad.4 
system described here 1.16 fmoles of complex were formed in 
60min. by a reaction mixture containing 33ug of cytoplasmic 
protein. Thus Ad.4 initiation is occurring at a similar (if 
not higher) efficiency to A d .2 in the absence of the 
specific nuclear factors required by A d .2.
Ad.2 initiation is strongly inhibited by the viral 
DNA-binding protein (DBP) in the absence of purified nuclear 
factor I (Nagata et a l ,1982? De Vries et a l ,1985). DNase I 
footprinting studies demonstrated (Nagata et al ,1983b) that 
DBP protects the entire ITR from DNase I digestion. In the
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presence of both DBP and NF1 small amounts of DNase I 
digestion were observed at the boundaries of the NFI site 
suggesting that NFI displaces DBP from the NFI binding site, 
enabling initiation to occur. However additional experiments 
are required to prove this point. It is possible that DBP
binds only to the phosphate backbone of the DNA as is the
case for the bacteriophage T4 gene 32 protein 
(Kowalczykowski et a l ,1981). DBP and the gene 32 protein are 
similar in that they both bind to single- and 
double-stranded DNA. They also both stimulate the in vitro
activity of the homologous DNA polymerases but not other DNA
polymerases. Inhibition of pTP-dCMP complex formation by DBP
seems unlikely in the case of Ad.4 as the Ad.4 DBP is known
to be present in the cytoplasm of infected cells (Hay, 
unpublished observations). Cellular non-sequence specific 
DNA-binding proteins are also likely to be present in the
cytoplasm. In spite of this initiation occurs with high
efficiency (in comparison with Ad.2) in the absence of 
nuclear extract.
The specificity of complex formation with different 
nucleotides varies between Ad.2 and Ad.4: Both viruses 
exhibit the most efficient complex formation with dCMP. A d .2 
DNA polymerase will also transfer dAMP to pTP (Challberg et_ 
a^, 1982; Tamanoi & Stiliman,1982) at a level that is at 
least 20-fold lower than complex formation with dCMP. This 
is presumably due to the formation of a pTP-dCMP-dAMP 
complex, dA being the second residue in the sequence at the 
5 ’ end of Ad.2 DNA. A trace amount of complex was formed
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with dTMP (Tamanoi & Sti1lman,1982), presumably due to the 
formation of a pTP-dCMP-dAMP-dTMP complex. This is also 
consistent with the sequence of the 5'end of Ad.2. No 
complex was formed with dGMP (Lichy et a l ,1981; Tamanoi &
Stiliman,1982).
In contrast cytoplasmic extract of Ad.4 infected cells 
reproducibly catalysed the formation of a low level of a 
pTP-dTMP complex in the presence of dTTP and either Ad.4 
cores or plasmid p4A2 linearized with EcoRI as template. By 
analogy with Ad.2, if the mechanism of initiation is the 
same, the Ad.4 DNA polymerase should transfer dAMP to a 
pTP-dCMP complex given that the sequence of the terminal 
18b.p. of Ad.2 and Ad.4 are identical (see figure 4:1). 
Figure 3:7 shows that this is not the case: no pTP-dNMP 
complex was formed in the presence of either dATP or dGTP. 
The formation of a low level of a pTP-dNMP complex in the 
presence of dTTP cannot therefore be explained by the 
transfer of dTMP to a pTP-dCMP-dAMP complex.
It is possible that the Ad.4 DNA polymerase is 
transferring dTMP on to pTP at the terminal 3' nucleotide in 
the Ad.4 sequence, i.e. the terminal dG residue. This is 
unlikely because it would not be possible for the primer to 
base pair with the template. In general terms efficient 
priming of DNA synthesis must involve hydrogen bonding 
between the primer and the template. Data obtained for Ad.2 
(Challberg & Rawlins,1984) suggests that in the presence of 
a template containing no dG residues the Ad.2 DNA polymerase
Figure 4:1 Comparison of the DNA sequence of the 5 ‘ 
termini of Ad.2 and Ad.4.
Adapted from Hay (1985b). The box labelled conserved 
sequence is the 9-18b.p. AT-rich sequence perfectly conserved 
in all human adenoviruses. The NFI box is the minimal 
sequence requirements for NFI binding (Leegwater et a l ,1985) 
whereas the NFIII box is the sequence protected from DNase I 
digestion by NFIII (Pruijn et a l ,1986b). The variant 
nucleotides are marked by black dots.
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will only transfer to the pTP a nucleotide that can base
pair with the template, i.e. in the presence of poly(dA) as
template only a pTP-dTMP complex was formed.
What seems more likely is that pTP-dTMP complex
formation is occurring at one of the dA residues at the 
3'end of the Ad.4 sequence - nucleotides 3, 6 or 10. In this 
case hydrogen bonding would be possible and a stable 
primer-template complex would be generated. Clearly this 
would result in an aberrant initiation event and, if 
followed by DNA synthesis, would produce a genome lacking at 
least the terminal 2 nucleotides. There must be an 
evolutionary pressure to prevent this occurrence in vivo but 
it should be recognized that initiation in vitro in the 
presence of a single nucleotide species is a highly
artificial environment. It is unlikely that the Ad.4 DNA 
polymerase would ever be in the situation of being unable to 
choose between nucleotides in vivo. This is borne out by the 
data in figure 3:8 which demonstrate that, given a choice 
between dCTP and a vast excess of dTTP, the Ad.4 DNA 
polymerase transfers only dCMP to the p T P .
The use of aberrant start sites has been documented 
for Ad.2 initiation in vitro (Tamanoi & Stiliman,1982; van 
Bergen et a l ,1983). In both these studies initiation on Ad.2 
DNA-prot. was highly specific for the terminal nucleotide. 
When plasmid DNA containing an Ad.2 terminal fragment was 
used as a template initiation occurred at both the 3' 
terminal dG and at the second dG residue 4 nucleotides in
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from the 3 terminus. It was suggested that one function of 
the A d .2 terminal protein may be to prevent these internal 
starts. This relaxed specificity for start sites in the 
absence of the TP may be mimicked in Ad.4 by coercing the 
DNA polymerase to transfer dTMP to the p T P . The fact that 
pTP-dTMP complex formation occurred in the presence of 
either Ad.4 cores or linearized plasmid DNA suggests that 
the Ad.4 TP is not influencing the initiation site as 
strongly as the Ad.2 TP.
4:3 OPTIMIZATION OF THE CONDITIONS FOR Ad.4 
pTP-dCMP COMPLEX FORMATION
To characterize the Ad.4 in vitro initiation system 
fully experiments were performed to elucidate the optimal 
concentrations of divalent cations and ATP, and the optimal 
ionic strength (figures 3:9 to 3:13).
The rate of the reaction proved to be highly sensitive 
to the level of divalent cations. Substitution of M n 2 +  for 
Mg2+ gave a higher level of activity which was attained at a 
lower concentration. In this respect the reaction is similar 
to that catalysed by eucaryotic DNA polymerase beta 
(Kornberg,1980). DNA polymerase beta shows a 100-fold 
increased affinity for primer—templates in the presence of 
Mn2+ instead of Mg2+.
The ATP concentration also had a profound effect upon 
the formation of a pTP—dCMP complex and as expected this
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effect was influenced by the divalent cation concentration 
(figures 3:9 to 3:10). In the presence of a constant Mg2+ 
concentration (3mM) the level of pTP-dCMP complex formation 
was maximal at an ATP concentration of 3mM and then declined 
rapidly. When the ATP and Mg2+ concentrations were increased 
concurrently pTP-dCMP complex formation was most efficient 
in the absence of exogeously added ATP and M g 2 +  an(j
thereafter declined gradually. The fact that the highest 
level of pTP-dCMP complex formation was observed in the 
absence of added ATP and M g 2 +  implies that the endogenous 
levels of both are sufficient for efficient pTP-dCMP complex 
formation. This was further shown by the fact that in the 
absence of exogenously added ATP and Mg2+ the addition of 
EDTA completely inhibited the reaction (data not shown).
ATP and Mg2+ form an equimolar chelate so clearly when 
the concentrations of both are equal neither is present as a 
free entity. The formation of a pTP-dCMP complex may require 
both A T P : M g 2 +  and free Mg2+ ions. In this case any excess of 
ATP over Mg2+ will result in a reduction of the pool of free 
Mg2+ ions, thus inhibiting the reaction. This prediction is 
borne out by the results in figures 3:9 and 3:10. 
Cytoplasmic extracts were prepared using a buffer containing 
0.5mM MgCl2 and were present at a 1 in 30 dilution in these 
assays, giving a minimal Mg2+ concentration (excluding that 
bound by proteins and other factors in the extract) of 17uM. 
The endogenous levels of ATP in Ad.5 infected HeLa cells has 
been reported as 0.16uM (De Jong et al ,1983) in a suspension 
of 5x107 nuclei/ml. Clearly there is an excess of M g 2 +  ions
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unchelated to ATP in the endogenous population. It appears 
that the requirement for ATP in the formation of an Ad.4 
pTP-dCMP complex is negligible - the energy requirements may 
come from the hydrolysis of phosphates on the dCTP 
substrate.
However exogenously added ATP has been shown to 
stimulate Ad.2 pTP-dCMP complex formation (Lichy et al,1981) 
and A d .5 pTP-dCMP complex formation (De Jong et a l ,1983). In 
both these systems the absence of added ATP resulted in the 
labelling of additional bands of higher and lower molecular 
weights than the pTP-dCMP complex. This phenomenon was also 
observed for Ad.4 (data not shown). In Ad.4 it may be 
related to the presence of added MgCl2 in the absence of ATP 
because in the absence of both these other bands are not 
seen (figure 3:10 track 1). The explanation for this is as 
yet unknown.
4:4 LIMITED ELONGATION OF THE pTP-dCMP COMPLEX TO THE 
FIRST dG RESIDUE IN THE ADENOVIRAL SEQUENCE
Figure 3:13 shows that, in the presence of dATP, dTTP 
and ddGTP, the Ad.4 pTP-dCMP complex is capable of limited 
elongation to the first dG in the sequence of the 5'end. 
This results in the formation of a complex between the pTP 
and a 30 base oligonucleotide. As is the case for Ad.2 
(Lichy et a l ,1981) this limited elongation reaction is 
insensitive to the action of aphidicolin. Elongation in the 
Ad.4 system is highly sensitive to premature chain
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termination by ddTTP, much more so than the A d .2 system: 
Ad.4 elongation is virtually undetectable at a ddTTP:dTTP 
ratio of 1:1 whereas A d .2 elongation is still apparent at a 
ratio of 6:1 and is only undetectable at a ratio of 20:1.
Although Ad.4 contains more dT residues at the 5'end 
than Ad.2 most of these are clustered between base pairs 
18-30 (Hay,1985b) (see figure 4:1). Presumably premature 
termination by ddTTP in this region would result in the 
formation of a complex migrating between pTP-dCMP and 
pTP-30mer on an SDS-polyacrylamide gel and would thus be 
easily detectable. No such products were observed. 
Incorporation of ddTTP is most likely to be occurring at an 
early stage in elongation, close to the 5'end, such that the 
products would be indistinguishable from the pTP-dCMP 
complex. At first sight it seems unusual that the Ad.4 DNA 
polymerase should be so strongly inhibited by a low ratio of 
ddTTP:dTTP, one might expect a 50% inhibition at a 1:1 
ratio. However activity of both DNA polymerases beta and 
gamma and Ad.2 DNA synthesis in isolated nuclei are 50% 
inhibited by ddTTP:dTTP ratios of between 0.02-0.2 (Krokan 
et al,1979). Clearly ddTTP is not only inhibiting chain 
elongation by acting as a chain terminator but it must also 
be having a direct effect on the DNA polymerase to inhibit 
polymerizat ion.
In contrast, when assayed on gapped duplex DNA, 
purified Ad.2 DNA polymerase activity is more sensitive to 
ddTTP inhibition (Lichy et al ,1982) than the partially 
purified Ad.4 DNA polymerase studied here: At a ddTTP:dTTP
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ratio of 2.5:1 the A d .2 DNA polymerase is 97% inhibited 
whereas the A d .4 DNA polymerase is only 80% inhibited at a 
ratio of 50:1 (figure 3:26). Both enzymes are more sensitive 
to ddTTP when assayed for elongation of a pTP-dCMP complex 
than for DNA polymerase activity on gapped duplex DNA. This 
effect can be explained by the differences in the two assay 
systems. The gapped duplex DNA polymerase assay will detect 
reinitiation by the DNA polymerase following chain 
termination by ddTTP but this will not be detected by the 
specific assay for formation of the pTP-30mer complex.
Again it must be emphasized that the limited 
elongation of the Ad.4 pTP-dCMP complex to the first dG 
residue in the sequence was catalysed by cytoplasmic extract 
of Ad.4 infected cells alone, whereas Ad.2 elongation also 
required the presence of uninfected nuclear extract.
4:5 DNA SEQUENCE REQUIREMENTS FOR INITIATION OF 
ADENOVIRUS DNA SYNTHESIS IN VITRO
As is the case for Ad.2 (Tamanoi & Sti1lman,1982;
Challberg & Rawlins,1984) a plasmid-borne Ad.4 origin of
replication had to be located at the end of a linear DNA
molecule, such that the end of the DNA molecule was
analogous to the end of intact viral DNA (Figure 4:2). 
Embedded origins were not active on either a linear molecule 
or a closed-circular molecule, but activity of the origin 
was not inhibited by the presence of a 4b.p. 5' overhang 
(the result of EcoRI cleavage). As shown in figure 4:2 the
Figure 4:2 Comparison of the structure of the ends of 
Ad.4 DNA-protein complex and plasmid p4A2 
linearized with EcoRI.
In both cases the 5' end of the Ad.4 sequence is 
protected, either by the terminal protein (TP) or by a 4b.p. 
5' overhang, whereas the 3' end is at the very end of the 
molecule. Sequence from Hay (1985b).
Ad.4 DNA-protein complex
( jp ) -C ATCATCAAT. . . .
GTAGTAGTTA.. . .
3'
AATTCATCATCAAT.. . .
GTAGTAGTTA.. . .
3'
p4A2 linearized with EcoR I
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ends of both Ad.4 cores/DNA-prot. and EcoRI cleaved p4A2 are 
similar in that the 3' end of the viral sequence is exposed. 
This may represent a requirement for the binding of either 
the pTP-pol or another initiation factor.
There were important differences between A d .2 and Ad.4 
regarding the sequence requirements for pTP-dCMP complex 
formation in vitro. In the A d .2 system the terminal 18b.p. 
alone could support a low level of pTP-dCMP complex 
formation (Tamanoi & Stillman,1983; Lally et a l ,1984; 
Challberg & Rawlins,1984). This level was enhanced by the 
presence of sequences up to nucleotide 48 and the protein 
nuclear factor I (NFI), which binds to a specific sequence 
within the 19-48b.p. region (Guggenheimer et a l ,1984a; 
Rawlins et a l ,1984). Recently another cellular protein which 
enhances adenovirus DNA replication in vitro has been 
purified from uninfected HeLa nuclei (Pruijn et a l ,1986b). 
This factor, termed nuclear factor III (NFIII), enhanced 
Ad.2 replication 4-6 fold in the presence of NFI, exerting 
it's effect at the level of pTP-dCMP formation. NFIII bound 
to a specific DNA sequence between bases 34 and 54 in the 
Ad.2 ITR, overlapping the NFI site. Whereas Ad.4 lacks the 
consensus sequence for binding of NFI (Hay,1985b), it does 
contain the sequences required for binding of NFIII (Pruijn 
et al,1986b) and NFIII has been shown to protect analogous 
regions on both the A d .2 ITR (Pruijn et a l ,1986b) and the 
Ad.4 ITR (Hay, unpublished observations) from digestion by 
DNase I. NFIII showed a higher affinity for the binding site 
on the Ad.4 ITR than on the Ad.2 ITR (Hay, unpublished
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observations). Kelly (personal communication) has also 
purified a factor, termed ORP-C, with similar properties to 
NFIII.
There is, as yet, no evidence indicating a role for 
NFIIl/oRP-C in either A d .2 or Ad.4 DNA replication in vivo. 
The minimal Ad.2 origin of replication in vivo has been 
localized to the terminal 45b.p. of the ITR (Hay,1985a), 
including the 9-18b.p. AT-rich conserved sequence and the 
binding site for NFI. The addition of sequences spanning the 
NFIII site (up to base 56) did not enhance replication. The 
minimal Ad.4 origin in vivo was defined as the terminal 
18b.p. of the genome (Hay,1985b) which are identical to the 
terminal 18b.p. of Ad.2. Addition of sequences spanning the 
NFI and NFIII sites did not enhance replication.
The results obtained in this study confirm those 
obtained for Ad.4 in vivo (Hay,1985b). Figures 3:19 and 3:20 
demonstrate that the terminal 18b.p. of either the Ad.4 or 
the Ad.2 ITR are both necessary and sufficient for pTP-dCMP 
complex formation by cytoplasmic extract from Ad.4 infected 
cells. Although neither NFI or NFIII appear to enhance Ad.4 
initiation in vitro (this thesis) or in vivo (Hay,1985b) it 
cannot be ruled out that another cellular factor is 
interacting with the terminal 18b.p. of the genome to 
enhance initiation. A candidate for this cellular factor may 
be the stimulatory factor described in figure 3:27 which was 
active on a template containing only the terminal 18b.p of 
the Ad.4 ITR. Kelly (personal communication) has recently
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identified a cellular factor which binds to the terminal 
15b.p. of the A d .2 genome and protects that region against 
DNase I digestion. Although this factor did not enhance A d .2 
complex formation in vitro it is possible that it has a role 
in Ad.4 initiation. The terminal 15b.p. of A d .2 is identical 
to that of the Ad.4 strain used in this study but not to
other Ad.4 strains sequenced (Tokunaga et a l ,1982,1986; 
Stillman et al ,1982). If this factor is involved in Ad.4 
initiation in vivo then clearly it would have to be able to 
tolerate some degeneracy within it's (as yet undefined.) 
recognition sequence.
It is likely that there are other, as yet 
unidentified, factors involved in Ad. DNA replication. Kelly 
(personal communication) suggested that, in addition to NFI 
and ORP-C (NFIII), other fraction(s) are required in order 
to obtain levels of DNA replication comparable with those 
obtained from crude extracts. Pruijn et al (1986a) 
demonstrated that sera from patients with various autoimmune 
diseases inhibited A d .2 DNA replication in vitro. They 
showed that this inhibitory effect was due to an antibody to 
a nuclear component. The inhibitor was only effective in the 
presence of crude nuclear extract, assays performed in the 
presence of purified NFI were not inhibited. The antibody 
only inhibited elongation on terminal restriction fragments 
of Ad.2 DNA-prot., it did not inhibit pTP-dCMP formation or 
elongation to the first dG (Pruijn et a l ,1986a). Thus the 
factor(s) inhibited by auto-immune sera cannot include 
NFIII/ORP-C as the latter enhanced pTP-dCMP formation.
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4:6 THE USE OF SINGLE-STRANDED DNA AS A TEMPLATE FOR THE
INITIATION OF ADENOVIRUS DNA SYNTHESIS IN VITRO
The ability of single-stranded DNA to act as a 
template for the formation of an A d .2 pTP-dCMP complex 
depends, at least in part, on the DNA concentration. Tamanoi 
and Stillman (1982) observed that at a DNA concentration of 
4ug/ml initiation on single-stranded DNA required a specific 
sequence (an A d .2 terminal fragment) which had to be present 
at the end of a' linear molecule. Ikeda et al (1982) showed 
that initiation took place at two specific sites on circular 
single-stranded ^X174 DNA. Both of these sites contained the 
sequence 5 ’TATTTTG, present between nucleotides 19-25 of 
Ad.2. This reaction also occurred at low DNA concentration- 
2ug/ml. In contrast Challberg and Rawlins (1984) found no 
sequence specificity for pTP-dCMP complex formation at a DNA 
concentration of 20ug/ml. All the single-stranded DNA 
species that they tested, including circular M13 DNA with 
and without an A d . 2 insert, and the synthetic 
oligonucleotide (dG-dT)5 , were effective.
The results obtained in this study show that the 
situation is quite different for Ad.4. The specificity of 
Ad.4 pTP-dCMP complex formation on single-stranded templates 
was independent of DNA concentration and required the 
presence of sequences from the Ad.4 terminus at the end of a 
linear molecule. Cytoplasmic extract from Ad.4 infected 
cells was unable to catalyse complex formation with any 
(«32p)aNTP in the presence of single-stranded Ml3.mpl8 DNA,
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an Ad.4-M13 recombinant, poly(dG), poly(dA), poly(dT) or 
poly(dc). The only active single-stranded templates were 
heat-denatured, EcoRI linearized p4A2 and a synthetic 
oligonucleotide corresponding to the 3*terminal 18b.p. of 
Ad.4. It appears that, unlike Ad.2, at high DNA 
concentrations Ad.4 retains a requirement for the presence 
of a defined DNA sequence when initiating on either single- 
or double-stranded DNA.
As mentioned previously it is highly unlikely that■the 
sequence specificity for Ad.4 pTP-dCMP complex formation on 
single-stranded templates is mediated by sequence-specific 
DNA-binding proteins. To date no such proteins recognizing a 
specific single-stranded DNA sequence have been identified 
in either procaryotic or eucaryotic systems. Protein binding 
to single-stranded DNA is non-specific, binding occurs 
mainly to the phosphate backbone eg. T4 gene 32 protein 
(Kowalczykowski et al ,1981).
Secondary structure may be involved in the formation 
of an active configuration for pTP-dCMP complex formation. 
The active oligonucleotide (figure 3:22, number 1) may have 
the potential to form some type of secondary structure which 
the inactive oligonucleotide (figure 3:22, number 2) cannot. 
For example the active oligonucleotide contains the sequence 
element 3'-GGCC-5' which could conceivably base pair with 
the same element on a second molecule, especially at the 
high DNA concentration used in the assay. Formation of a 
stable secondary structure could be assisted by the action
of non-specific DNA binding proteins.
135
However it is more likely that the reason for the 
ability of oligonucleotide 1 to support pTP-dCMP complex 
formation is due to the presence of internal dG residues. 
Both oligonucleotides 1 and 2 contain an AT rich sequence 
corresponding to the 9-18b.p. conserved sequence in Ad.4. 
The active oligonucleotide has dG residues both 3' and 5'
relative to this sequence whereas the inactive 
oligonucleotide only has terminal dG residues (figure 3:22). 
One hypothesis is that the pTP-DNA polymerase complex and 
other replication proteins may bind non-specifically to a 
single-stranded AT-rich sequence and the DNA polymerase then 
transfers dCMP to the pTP at a dG residue adjacent to the 
binding site. The strongest evidence for this comes from the 
data in figure 3:24 which demonstrates that substitution of 
the dG residues 1 and 4 base 3' of the AT-rich sequence 
completely abolished template activity. Substitution of the 
dG residues 5' to the AT-rich sequence severely reduced 
template activity but did not abolish it completely.
Interestingly the dG residue 7 bases 3' to the AT-rich
sequence did not appear to be utilized as a site for
pTP-dCMP formation (compare tracks 5 and 6, figure 3:24).
Only limited studies have been carried out into the 
formation of an Ad.2 pTP-dCMP complex on single-stranded 
oligonucleotides corresponding to the viral termini. 
Stillman and Tamanoi (1983) demonstrated that an 
oligonucleotide corresponding to the 3'terminal 15b.p. of 
the Ad.2 genome supported complex formation whereas an 
oligonucleotide corresponding to bases 16-30, or a random
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15mer oligonucleotide, were inactive. Tamanoi and Stillman
(1983) showed that an oligonucleotide corresponding to the 
3'terminal 20b.p. of Ad.2 was active. However they also 
found that a mutated 20mer, in which bases 13 and 14 in the 
middle of the conserved sequence were changed from TA to GG, 
was also active. This mutated oligonucleotide, unlike the 
wildtype, was inactive as part of a duplex, linear plasmid 
template. The complementary 5'strand of the mutated 
oligonucleotide was also inactive. They did not mention 
whether the complementary wild type oligonucleotide was 
active or not. All their experiments were done at low DNA 
concentrations and are therefore consistent with the their 
earlier data (Tamanoi & Stillman,1982) showing that at low 
DNA concentrations initiation on single-stranded DNA 
required a specific sequence. These results are also 
explicable in the context of internal dG residues available 
for pTP-dCMP complex formation.
It is not clear how relevant pTP-dCMP complex 
formation on single-stranded templates is to initiation in 
vivo. It has been postulated that initiation in vivo 
involves unwinding of the helix and that pTP-dCMP complex 
formation takes place on the single-stranded terminus of the 
genome (Nagata et a l ,1983b). Formation of a pTP-dCMP complex 
in vitro on single-stranded DNA templates may involve only 
those events that occur after helix unwinding. The 
inefficiency of pTP-dCMP complex formation on 
single-stranded DNA could be due to the fact that 
sequence—specific interactions between cellular or viral
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DNA-binding proteins and the origin cannot occur on 
single-stranded DNA. This would preclude the formation of a 
specific nucleoprotein complex which may be required for 
replication. Assembly of this complex may also require a 
longer DNA molecule than the 24b.p. oligonucleotides used in 
this study.
4:7 PARTIAL PURIFICATION OF THE COMPONENTS OF THE 
ADENOVIRUS TYPE 4 INITIATION REACTION
4:7:1 COMPARISON OF THE CHARACTERISTICS OF THE Ad.4 
SPECIFIC AND THE A d .2 SPECIFIC DNA POLYMERASES 
The Ad.4 specific DNA polymerase appears to be very 
similar in inhibitor profile to the A d .2 specific polymerase 
described by Lichy et al (1982). When assayed for polymerase 
activity on gapped duplex DNA both enzymes are sensitive to 
N-ethyl-maleimide, ddTTP, ara-CTP and 0.1M NaCl. The Ad.2 
polymerase is more resistant to O.lmM aphidicolin; 85% as 
opposed to 50%. This difference may not be significant and 
may conceivably represent differences in experimental 
conditions. The levels of dNTP's in the reaction may be 
responsible, at least in part, for this difference. 
Aphidicolin is known to inhibit purified DNA polymerase 
alpha in a manner that is competitive for dCTP, whereas it 
inhibits Ad.2 DNA synthesis in vitro in a manner that is 
competitive with dTTP (Pincus et al,1981). The purified Ad.2 
DNA polymerase was assayed at a dNTP concentration of 40uM 
(Lichy et al,1982) whereas the DNA polymerase assays in this 
study were performed at a dNTP concentration of 20uM. The
ratio of aphidicolin to dNTP’s was thus higher in the Ad.4
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assays, a fact which may well explain the difference in 
aphidicolin sensitivity.
Although the purified A d .2 polymerase is resistant to 
aphidicolin when assayed on gapped duplex DNA, extensive 
synthesis of adenoviral DNA both in vivo (Longiaru et 
a1 ,1979; Pincus et a l ,1981) and in vitro (Longiaru et 
a_l, 1979; Ikeda et a l , 1981; Lichy et a l , 1982 ; Nagata ejt 
a_l, 1983a) is inhibited by the drug. These data suggest that 
the site of aphidicolin action in A d .2 DNA replication is 
not the virus specific polymerase itself but some other 
factor involved in Ad. DNA synthesis. Nagata et al (1983a) 
demonstrated that DNA synthesis on Ad.2 DNA-prot. with five 
purified proteins (pTP, pol., DNA-binding protein, NFI and 
NFII) was inhibited by aphidicolin. However the 
topoisomerase activity of NFII, as assayed by it's ability 
to change the linking number of a plasmid DNA species, was 
unaffected by aphidicolin. It appears therefore that 
aphidicolin does not affect the activity of individual 
proteins when assayed separately but may affect the 
organization of these proteins into large nucleo-protein 
complexes involved in DNA replication. Alternatively the 
drug could inhibit an as yet unidentified replication factor 
contaminating one of the purified fractions.
Aphidicolin does not inhibit pTP-dCMP formation or 
partial elongation to the first dG residue in either Ad.2 
(Pincus et__al, 1981; Lichy et a l , 1981) or Ad.4 (this thesis) 
so the effect must occur during more extensive elongation.
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In this respect, the effect of aphidicolin is similar to the 
inhibitory effect of sera from patients with various 
autoimmune diseases observed by Pruijn et al (1986a) (see 
section 4:5).
There are several reasons why no pTP-dCMP complex 
forming activity was observed in the Ad.4 specific 
polymerase fraction: Firstly the Ad.4 pTP-polymerase complex 
might have dissociated during the FPLC fractionation. 
Secondly the polymerase could have been separated from one 
or more cellular factors required for Ad.4 initiation. 
However no activity was detected in combination with crude 
extracts of uninfected cells so this seems unlikely. Finally 
a virus-specific factor other than the pre-terminal protein 
could have been separated from the DNA polymerase. One 
possible candidate for a virus-specific factor is the viral 
DNA-binding protein. In the presence of purified nuclear 
factor I (NFI) A d .2 initiation is enhanced at least 3-fold 
by the addition of the purified A d .2 DNA-binding protein 
(Nagata et al,1983), in Ad.4 which does not require NFI this 
effect may be greater. However, in the absence of NFI A d .2 
initiation is strongly inhibited by the DNA-binding protein 
(see Section 4:2) (Nagata et a l ,1983; De Vries et a l ,1985). 
Experiments were also performed in which other fractions 
from the Mono-Q column were mixed with the Ad.4 specific DNA 
polymerase fraction. It is possible that the lack of 
pTP-dCMP complex formation in these assays was due to the 
low concentrations of other components required.
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4:7:2 PARTIAL PURIFICATION OF A CELLULAR FACTOR
THAT STIMULATES THE FORMATION OF A pTP-dCMP 
COMPLEX IN VITRO
Figure 3:27 shows that a factor that stimulates the 
formation of a pTP-dCMP complex by cytoplasmic extract of 
Ad.4 infected cells is present in the nuclei of uninfected
HeLa cells. This factor was identified during the course of
an experiment to determine the role of NFIII in Ad.4 
pTP-dCMP complex formation. Whereas the peak of stimulatory 
activity eluted from the DEAE-sepharose column between 
50-80mM NaCl the peak of NFIII activity, as detected by 
DNase I footprinting to an Ad.4 ITR fragment ( Hay, personal 
comwunKtxltot) , eluted from the column in the 30mM wash fractions. 
The stimulatory factor is clearly not NFIII and the latter
factor does not appear to enhance the formation of an Ad.4
pTP-dCMP complex.
NFIII appears not to be required for DNA replication 
in vivo by either Ad.2 or Ad.4 (Hay,1985a,b). It seems 
surprising therefore that NFIII, which binds more strongly 
to the Ad.4 ITR than to the Ad.2 ITR, enhances A d .2 pTP-dCMP 
complex formation in vitro but has no effect on Ad.4 
pTP-dCMP complex formation in vitro. There are several 
possible explanations for this: Firstly the stimulation of 
Ad.2 pTP-dCMP complex formation appears to be dependent on 
the presence of NFI (Pruijn et a l ,1986b). It may be that 
another factor is required for the stimulation of Ad.4 
pTP-dCMP complex formation by NFIII. Secondly an inhibitory
factor for Ad.4 pTP-dCMP complex formation may have
141
co-eluted from the column with NFIII, thus masking any 
stimulation. Lastly the NFIII activity may be labile under 
the conditions used or simply too dilute to have any effect.
The Ad.4 pTP-dCMP complex formation stimulatory factor 
was active on plasmid templates containing either the 
complete ITR or the terminal 18b.p. as well as on Ad.4 cores 
(data not shown). The fact that it stimulated the formation 
of a pTP-dCMP complex in the presence of Ad.4 cores suggests 
that, unlike factor pL which stimulates Ad.2 pTP-dCMP 
complex formation on protein-free templates (Nagata et^  
al,1984c), it is not a 5 ’— 3 * exonuclease. If the stimulatory 
factor is a sequence-specific DNA-binding protein it must 
recognize a sequence within the terminal 18b.p. As mentioned 
earlier Kelly (personal communication) has purified a factor 
that binds to the terminal 15b.p. of the Ad.2 ITR but did 
not enhance pTP-dCMP complex formation. This factor may have 
a role in Ad.4 initiation and may correspond to the factor 
purified in this study. Attempts to purify the stimulatory 
activity further were unsuccessful. No stimulatory activity 
was recovered from either phosphocellulose or denatured 
DNA-cellulose columns indicating that the factor may be 
unstable or possibly may be a complex of proteins.
In conclusion an in vitro system that faithfully 
initiates adenovirus type 4 DNA replication has been 
developed and characterized. The DNA template requirements 
of the system have been defined and progress has been made
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towards the purification and identification of the 
components of the system. Future work should concentrate on 
this latter aspect. Detailed information about Ad.4 DNA 
replication, and the ways in which it differs from Ad.2, 
will only be obtained by reconstituting the system from 
purified components. The system described here can be used 
as an assay system for the purification of cellular factors 
involved in the initiation of Ad.4 DNA replication. However 
the first step should be to purify, in an active form, the 
viral proteins involved - the preterminal protein/ DNA 
polymerase complex and the DNA-binding protein. The role of 
the DNA-binding protein in particular should be studied in 
detail as it clearly differs from it ’s Ad.2 counterpart in 
it's effect on initiation in vitro.
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